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ABSTRACT
ABSTRACT
Background: The haem oxygenase-1 (HO-1) pathway plays a key role in the 
preservation of tissue integrity against damaging insults such as oxidative 
stress and inflammatory injuries. Thus, HO-1 is regarded as a potential 
therapeutic target in conditions which are mediated by oxidative stress and 
inflammation, e. g ischaemic heart disease, septic shock, and ischaemia 
reperfusion injury.
Aims: The objective of the study was to investigate if the up-regulation of the 
HO-1 expression by two plant-derived polyphenolic compounds, i.e. curcumin 
and 2’-hydroxychalcone (2-HC) offers protection to against stress-induced 
cellular damage in cardiovascular tissue. And to elucidate the molecular and 
cellular signalling mechanisms involved.
Methods: Parallel experiments were conducted using 1) Lipopolysaccharide
(LPS)-induced model of inflammation in RAW 264.7 murine macrophages, the
inflammatory response was assessed using nitrite assay, Western blot for the
determination of the inducible nitric oxide synthase (iNOS), HO-1 protein
expression and the activation of the transcriptional factor NF-KB. The role of
HO-1 in this process was elucidated using small interfering RNA (siRNA). The
involvement of the mitogen-activated protein kinase (MAPK), the
phosphoinositide 3-kinase pathway (PI3K) pathway and the nuclear
transcription factor (Nrf2) was also studied. 2) We also utilised Carbon
Monoxide-Releasing Molecules (CO-RMs) as a method to study the effects of
CO, one of the products of HO-1 enzymatic activity, in vitro model of
inflammation. 3) in vitro model of H202-induced oxidative stress, using human
cardiac myoblasts. 4) In vitro model of ischaemia-reperfusion injury and cold
2
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preservation in cardiac myoblasts. HO-1 mRNA expression during hypothermia 
was determined using RT-PCR.
Results: The major findings indicated that up-regulation of HO-1 gene and 
protein expression resulted in the protection of cells against oxidative and 
inflammatory injuries. We also found that 2-HC is a potent inducer of HO-1 
protein expression in bovine aortic endothelial cells and in macrophages, in 
mechanisms which involve the activation of PI3K pathway. Treatment of 
macrohages with 2-HC resulted in the reduction of pro-inflammatory cytokines 
(TNF-a), and down regulation of iNOS expression but did not inhibit the 
activation of NF-KB. Using HO-1 siRNA, we confirmed that HO-1 mediated the 
anti-inflammatory actions of 2-HC. We also identified two novel CO-RMs 
(CORM-43 and CORM-319) as potent anti-infallamtory compounds. We also 
found that curcumin mitigated the cellular dysfunction-mediated by H2O2. This 
study also demonstrated that cold storage of human cardiac myoblasts caused 
marked increase in cytotoxicity primarily due to loss of cell membrane integrity 
as a result of necrosis. The addition of curcumin to the cold preservation 
solution (Celsior solution) resulted in preservation of cellular membrane integrity 
as well as cellular metabolism in cells exposed to cold storage and rewarming. 
Conclusion: up-regulation of HO-1 is an effective therapeutic strategy to 
ameliorate cardiovascular injury and protect cardiac tissue during pathological 
conditions mediated by oxidative and inflammatory stresses.
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QUATATION
QUOTATION
There are two kinds o f truth; the truth that fights the way and the truth 
that warms the heart. The firs t o f these is science, and the secondis art
(Raymond Chandler
1888-1959
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MAPK Mitogen-activated protein kinase
NF-KB Nuclear factor kappa B
NO Nitric oxide
NOS Nitric oxide synthase
PI3K Phosphoinositol 3 kinase
ROS Reactive oxygen species
SnPPIX Tin Protoporphyrin
TNF-a Tumour necrosis factor-a
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1 INTRODUCTION
1.1 Anatomy and Physiology of the Cardiovascular System
The cardiovascular system consists of the blood, heart, and blood vessels. The
heart is the pump that circulates the blood though blood vessels. It lies in the
mediastinum, about two-thirds of its mass is to the left of the midline. The heart
has four chambers, the two superior chambers are the left and right atria, and
the two inferior chambers are the left and right ventricles (Figure 1.1 A). As
each chamber of the heart contracts, it pushes a volume of blood into a
ventricle or out of the heart into arteries. The right ventricle receives blood from
the right atrium and then pumps it to the lungs through the pulmonary
circulation. Oxygenated blood enters the left atrium through the pulmonary
veins and then exists through the mitral valve to the left ventricle. The left
ventricle then pumps it to the systemic circulation. There are four valves which
open and close to ensure one way flow of blood by opening to let blood through
and closing to prevent back flow (Figure 1.1 B). The blood supply of the heart
comes from coronary arteries. The wall of the heart consists of three layers, the
epicardium (the external layer), the myocardium (middle layer) and the
endocardium (inner layer). The epicardium is the thin, transparent outer layer of
the wall. It is composed of mesothelium and delicate connective tissue that
imparts a slippery texture to the outermost surface of the heart. The
myocardium is cardiac muscle tissue, making up the bulk of the heart and
responsible for its pumping action. The endocardium is a thin layer of
endothelium overlying a thin layer of connective tissue. Blood vessels form a
closed system of tubes that carries blood away from the heart, transports it to
the tissues, and then returns to the heart. Arteries are vessels that carry blood
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from the heart to the tissues. Arterioles are small arteries that deliver blood to 
capillaries, which are microscopic blood vessels through which nutrients and 
oxygen are exchanged between blood and tissue. Blood then get transported 
through small vessels (venules) that merge to form veins, which drain blood into 
the heart.
Reviewed from : Anatomy and Physiology in Health and Illness, Janet S. Ross, 
Kathleen J.W. Wilson, Anne Waugh and Allison Grant (2001).
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1.2 The Pathophysiology of Cardiovascular Disease
Cardiovascular disease is the leading cause of death in the western world 
(Singh et al., 2005) (Baguneid et al., 2004). A number of well defined 
cardiovascular diseases have been characterised, including, coronary artery 
disease, angina, myocardial infarction, hypertension, congestive heart disease, 
arrhythmias and atherosclerosis (Chen et al., 2000). Research data suggest 
that endothelial dysfunction plays a major role in the pathogenesis of the 
cardiovascular disease risk factors, which include hypertension, dyslipidaemia, 
hypoxia/ischaemia, diabetes, smoking, and obesity (Kinlay et al., 2001). These 
risk factors contribute to oxidative stress, which in turn impairs endothelial 
vasomotor function leading to endothelial dysfunction (Ceconi et al., 2003). The 
sequence of reactions from associated cardiovascular risk factors which cause 
oxidative stress, leading to endothelial dysfunction, imbalance of vasoactive 
substances and vascular inflammation (Molavi and Mehta, 2004) can result in 
cardiac disease, such as angina, myocardial infarction, and heart failure 
(Granger et al., 2004).
1.2.1 Oxidative Stress
Oxidative stress refers to the disturbance in the oxidation reduction state of the 
cell (Haddad, 2002). The uncontrolled production of reactive oxygen species 
(ROS) or a reduction in antioxidant species (superoxide dismutase, catalase 
and glutathione) is regarded as oxidative stress, and is thought to be 
deleterious to protein structure and function (Halliwell and Cross, 1994). An 
increasing body of evidence suggests that oxidative stress is involved in the 
pathogenesis of cardiovascular diseases (Ceconi et al., 2003). The important 
forms of ROS in the cardiovascular system include superoxide (02_), hydrogen
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peroxide (H202), hydroxyl radical ('OH) and nitric oxide (NO) (Parthasarathy et
al., 2001). Oxygen is an abundant molecule in biological systems, and it 
undergoes reduction to form superoxide (02‘) (Figure 1.3), by enzymes such as 
xanthine oxidases (Chen et al., 2000). The bulk of oxygen reduction in most 
cells, such as in the heart, occurs by the mitochondrial cytochrome oxidase 
pathway (Molavi and Mehta, 2004), these radicals are capable of destroying 
biomolecules through oxidation (Ceaser et al., 2004) (Figure 1.3). However, in a 
physiologic environment, various ROS are formed by different systems, 
whereby they exert physiologic actions; for example, oxygen radicals are key 
intermediates in metabolic reactions (Halliwell and Cross, 1994). Furthermore, 
in the vascular endothelium, NO radicals cause relaxation of vascular smooth 
muscle (Singh et al., 2005). In addition, phagocytic cells synthesize 
hypochlorous acid through oxidation of chloride ions by H2O2 through a reaction 
catalyzed by myeloperoxidase (Singh et al., 2005). However, excessive ROS 
production causes lipid peroxidation and depletion of cellular energy via 
disruption of mitochondrial enzymes and nucleic acids (Holtzclaw et al., 2004), 
which lead to functional damage of the endothelium (Hamilton et al., 2004).
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Figure 1.2: A schematic model of the pathways leading to the generation of 
ROS/RNS
Superoxide (02-) anion is metabolized via the dismutation reaction 202' + 2H 
->02+H20 2l which is catalyzed by superoxide dismutase (SOD), a cytoplasmic enzyme 
that is constitutively expressed, and a mitochondrial enzyme that is induced in 
response to oxidant stress. The H20 2 produced by the dismutation of 0 2* is converted 
by one pathway to H20  and 0 2 by catalase (CAT) in peroxisomes and by glutathione 
peroxidase in the cytoplasm, at the expense of reduced glutathione (GSH), leading to 
the formation of oxidized glutathione disulphide (GSSG) that is recycled back to GSH 
by glutathione reductase (GSSG-RD). H20 2 could be further converted by another 
pathway involving iron into hydroxyl radical (OH), an injurious ROS causing cellular 
damage. This iron-catalyzed reaction, known as the Fenton-like reaction, is impeded by 
the iron chelator desferrioxamine (DSF), which is also capable of neutralizing the 
toxicity of OH. Phagocytic cells synthesize hypochlorous acid through oxidation of 
chloride ions by H20 2 through a reaction catalyzed by myeloperoxidase. NO reacts 
rapidly with superoxide anion (O.) leading to the formation of 0N 0 02, which reacts with 
H+ to form ONOOH potent oxidant species that has been shown to cause nitration of 
proteins, as well as lipid peroxidation and cytotoxicity (Motterlini et al., 2002b).
Adapted from reference (Haddad, 2002).
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Figure 1.3: Selective dismutation of ROS
Superoxide (02-) anion is metabolized via the dismutation reaction to yield H20 2 which 
could be further converted by another pathway which involves an iron-catalyzed 
reaction converting iron into hydroxyl radical (OH), known as Fenton-like reaction. 
Adapted from biology.plosjournals.org
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1.2.2 Inflammation
There is a growing body of evidence suggesting that inflammation plays an 
important role in the initiation and progression of cardiovascular diseases 
(Schiffrin, 2002). Epidemiological studies have revealed strong associations 
between biochemical markers of systemic inflammation and the future risk for 
symptomatic cardiovascular disease (Granger et al., 2004). Several studies 
have provided convincing evidence that the known risk factors for 
cardiovascular diseases (hypertension, hypercholesterolemia, and smoking) 
can elicit both an inflammatory in the vascular system (Singh et al., 2005). The 
designation of cardiovascular disease as a chronic inflammatory process is 
supported by evidence that the risk factors for cardiovascular disease cause 
endothelial cells of the vasculature to assume an inflammatory phenotype 
(Kinlay et al., 2001). These activated endothelial cells characteristically exhibit 
oxidative stress and increased adhesiveness for circulating leukocytes (Hayashi 
et al., 1999), which are recruited to sites of inflammation by a highly coordinated 
and well-regulated process that involves the expression and/or activation of 
adhesion molecules on endothelial cells and circulating inflammatory cells 
(Fuller et al., 2003).
1.2.3 Ischaemia-Reperfusion Injury
Although the functional consequences of depriving tissue of its blood supply 
have been appreciated for many years, it has become apparent that 
reperfusion, the restoration of blood flow after a period of ischaemia, can place 
ischaemic organs at risk of further cellular necrosis, and thereby limit the 
recovery of function of the organ (Carden and Granger, 2000). It is widely 
recognized that the microvasculature, particularly the endothelial cells lining
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microscopic blood vessels, is very vulnerable to the deleterious consequences 
of ischaemia and reperfusion (l/R) (Carden and Granger, 2000). Reperfusion of 
ischaemic tissues is often associated with microvascular dysfunction that is 
manifested as impaired endothelium-dependent dilation in arterioles, enhanced 
fluid filtration and leukocyte plugging in capillaries, and the trafficking of 
leukocytes and plasma protein extravasation in venules, which leads to the loss 
of microvascular integrity and decreased blood flow (Kupiec-Weglinski and 
Busuttil, 2005). Indeed, l/R-induced microvascular dysfunction has been 
described in most organs, and it is recognized as a potentially serious problem 
that is encountered during a variety of standard medical and surgical 
procedures, such as thrombolytic therapy, organ transplantation, coronary 
angioplasty, and cardiopulmonary bypass (Burns et al., 1998). Considerable 
research effort has been directed at elucidating the mechanisms underlying the 
patho-physiologic alterations associated with reperfusion of ischaemic tissues. 
Furthermore, a number of putative etiological factors have been identified. 
These include free radical generation (Carden and Granger, 2000), alternation 
of calcium concentration (intracellular calcium overload) (Dhalla et al., 1999) 
ATP depletion (Lavitrano et al., 2004) and apoptosis (Bums et al., 1998) (Fuller 
et al., 2003).
1.2.4 Ischaemic Heart Disease
Ischaemic heart disease (IHD) is the generic designation of a group of closely 
related syndromes resulting from myocardial ischaemia-an imbalance between 
the supply (perfusion) and demand of the heart for oxygenated blood (Ceconi et 
al., 2003). In more than 90% cases, the cause of myocardial ischaemia is 
reduction of coronary blood flow because of atherosclerotic coronary arterial
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obstruction. In general, the clinical manifestation of IHD can be divided into four 
syndromes, myocardial infarction, angina pectoris, chronic ischaemic heart 
disease, and sudden cardiac death. The dominant influence in the causation of 
the IHD syndromes is diminished coronary perfusion relative to myocardial 
demand, owing largely to a complex dynamic interaction among fixed 
atherosclerotic narrowing of the coronary arteries, intraluminal thrombosis 
overlying a disrupted atherosclerotic plaque, platelet aggregation and 
vasospasm. Ischaemia results in several metabolic changes in cells, including 
decreased production of ATP (Lavitrano et al., 2004). Continued need for high- 
energy phosphate bonds results in further catabolism of ATP to ADP and 
ultimately to hypoxanthine, which accumulates in the ischaemic tissue, with 
reperfusion, the excess hypoxanthine is converted to xanthine by xanthine 
oxidase (Hamilton et al., 2004), this reaction generates large amounts of 
reactive oxygen species (ROS). The aftermath of this uninhibited release of 
ROS in the myocardium is activation of an inflammatory reaction, which is 
responsible for functional deterioration of myocardial performance during the 
immediate reperfusion period (Hamilton et al., 2004). The signaling pathway of 
these events is thought to involve activation of nuclear factor-KB (NF-KB) 
(Molavi and Mehta, 2004). Activation of NF-KB is then followed by modification 
of the expression of inflammatory mediator genes such as interleukin-6 (Singh 
et al., 2005), which determines the extent of myocardial inflammation, and thus 
outcome during the reperfusion period (Carden and Granger, 2000). Therefore, 
ROS seem to trigger a cascade of cellular events leading to inflammation and 
eventually cardiac injury (Kinlay et al., 2001).
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1.2.5 Atherosclerosis
Oxidized lipids play an integral role in the pathogenesis of atherosclerosis, in 
which the production of ROS and nitrogen species in the vasculature leads to 
oxidation of low-density lipoprotein (LDL) (Kinlay et al., 2001). The responses of 
the endothelium, neutrophils and vascular smooth muscle cells to these 
oxidation products are thought to contribute to the development of the 
atherosclerotic process (Schiffrin, 2002). Endothelial dysfunction is thought to 
be one of the initial events in atherogenesis (Schiffrin, 2002), in addition, 
inflammatory cell infiltration and vascular smooth muscle cell migration along 
with oxidized LDL deposition generate fatty streaks and ultimately 
atherosclerotic plaques (Singh et al., 2005). Atherosclerosis, and particularly 
plaques responsible for acute coronary syndromes, characteristically contains 
inflammatory cells that play an important role in the pathogenesis of 
atherosclerosis (Schiffrin, 2002). Endothelial cells play an active role in the 
recruitment of inflammatory cells into the vessel wall, by producing cytokines 
and expressing cellular adhesion molecules (Kinlay et al., 2001). The NF-KB 
signal transduction pathway is a particularly important regulator of the 
transcription of a number of pro-inflammatory genes, including those that lead to 
the expression of adhesion molecules (Lakatta, 2003). NF-KB is a heterodimer 
containing two protein subunits that are normally held in an inactive state in the 
cytoplasm by the inhibitory component l-KB (Li et al., 2004). NF-KB is redox 
sensitive and activated by the degradation of its inhibitory component l-KB 
(Verma and Stevenson, 1997), a process that is accelerated by oxidized LDL 
cholesterol (Lakatta, 2003). Therefore, oxidative stress and inflammation play
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an important role in the pathogenesis of atherosclerosis (Parthasarathy et al.,
2001).
1.2.6 Hypertension
Elevated blood pressure (hypertension) affects both the function and the 
structure of blood vessels. Hypertension is a common health problem and it one 
of the most important risk factors in IHD (Chen et al., 2003). Endothelial 
dysfunction and remodeling of the vessel wall of large and small arteries is 
associated with hypertension (Schiffrin, 2002). These changes alter vascular 
function, aggravate high blood pressure, and may accelerate the progression of 
atherosclerosis (Carden and Granger, 2000). Activation of oxidative stress by 
angiotensin II is a key component of this process (Ceconi et al., 2003). 
Angiotensin II stimulates NADPH/NADH oxidase in endothelium, smooth 
muscle cells, and the adventitia of blood vessels to generate ROS, leading to 
endothelial dysfunction and inflammation (Granger et al., 2004). Up-regulation 
of endothelin-1, adhesion molecules, NF-KB, and other inflammatory mediators, 
as well as increased breakdown of NO, contribute to the progression of vascular 
disease and hypertension (Molavi and Mehta, 2004).
1.2.7 Overview of Heart Transplantation
Heart transplantation is a proven modality for the treatment of end stage cardiac 
disease (Demmy et al., 1997), however, an important determinant of 
transplantation outcome is the adequacy of organ preservation (Jahania et al.,
1999). Currently, heart preservation is limited to 4 to 6 hours of cold ischemic 
storage, and the effectiveness depends to a great extent on the preservation 
solution (Muhlbacher et al., 1999), furthermore, longer periods of ischemia are
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known to adversely affect survival (Demmy et al., 1997). This is in contrast to 
preservation of the liver and kidney, which have been successfully preserved for 
24 to 36 hours, although graft function may be transiently compromised (St 
Peter et al., 2002). The principles of organ preservation are flushing, cooling 
and pharmacologic intervention (Muhlbacher et al., 1999). Currently, several 
preservation solutions are being used clinically; amongst them are the 
University of Wisconsin Solution (UW), Celsior and St. Thomas solution 
(Southard and Belzer, 1995). However, UW solution is certainly the most used 
preservation solution for livers, kidneys and pancreas with excellent clinical and 
experimental preservation data (McLaren and Friend, 2003). Currently, organs 
are kept in the preservation solutions (static cryopreservation) before being 
implanted into the recipient body; the cold storage minimizes cellular swelling 
and membrane pump mechanisms and therefore maintains cellular ATP 
(McLaren and Friend, 2003). Cold ischaemia and re-oxygenation during organ 
preservation leads to a variety of stresses, including expression of adhesion 
molecules, which can lead to inflammatory responses and compromised 
functions (Fuller et al., 2003). Furthermore, hypothermia slows biochemical 
reactions and metabolic rates; during hypothermia, most enzymes show a 1.5 to 
2 fold decrease in activity for every 10 degrees Celsius decrease in 
temperature, which retards lysis of lysosomes and leads to the release of 
enzymes that eventually cause cell death (Jahania et al., 1999). The formulation 
of preservation solutions is based on hypothermic arrest of metabolism, 
supplementation of a physical and biochemical environment that maintains 
viability of the tissue during hypothermia, and minimizing the damaging effects 
of the IR injury (Demmy et al., 1997). Preservation solutions can be classified
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into extracellular and intracellular, based on Na+ and K+ concentrations (Jahania 
et al., 1999). The main purpose of the ionic ingredients in the preservation fluid 
is to induce rapid myocardial cellular membrane depolarization by reducing the 
transmembrane K+ gradient, which results in electrical and mechanical activity 
arrest of the cardiac tissue (Land et al., 1994; Michel et al., 2002) (Sasaki et al.,
1999) (Ramella-Virieux et al., 1997).
1.3 Strategies to Mitigate Cardiovascular Disease
1.3.1 Preconditioning
It is generally thought that the damaging effects of l/R injury arise from the 
generation of ROS after reoxygenation, which initiate a cascade of deleterious 
cellular responses eventually leading to inflammation and apoptosis which 
eventually leads to organ failure (Garcia-Criado et al., 1997). Therapeutic 
strategies aimed at ameliorating l/R injury are focusing mainly on preventing the 
production of ROS and down-regulating the signal transduction cascades, and 
related pro-inflammatory genes (Sato et al., 2000). Among the most promising 
strategies is preconditioning (Baguneid et al., 2004). Preconditioning confers 
resistance to the subsequent deleterious stress that the graft is subject to during 
transplantation by inducing the expression of various endogenous protective 
mechanisms, including heat shock proteins (HSPs) (Okubo et al., 1999). To 
date, three types of preconditioning have been described, ischaemic 
preconditioning, thermal preconditioning and pharmacological preconditioning. 
Ischaemic preconditioning consists of a brief period of ischaemia followed by a 
short interval of reperfusion before the actual surgical procedure, which is 
characterized by a prolonged ischaemic stress (Peralta et al., 1997). In mouse
35
4 __________________!_____________________________INTRODUCTION
liver, ischaemic preconditioning confers dramatic protection against prolonged 
ischaemia via inhibition of apoptosis (Yadav et al., 1999). Thermal 
preconditioning, the elevation of the core temperature above normal before the 
injury, has been demonstrated to attenuate subsequent injury. Studies have 
suggested that the protective role of thermal preconditioning might be mediated 
by HSPs (McCormick et al., 2003). HSP induction after heat preconditioning 
improved the outcome in experimental models of renal grafts in rats (Redaelli et 
al., 2002b). It was shown that HSPs may inhibit renal tubular cell apoptosis by 
preventing the activation NF-KB and TNF-a production (Meldrum et al., 2003).
1.3.2 Modulation of Endogenous Cytoprotective Enzymes
Using pharmacological preconditioning to modulate the expression of 
intracellular pathways in organs or tissues can offer protection against oxidant- 
mediated injury; can be regarded as a novel strategy to combat different stress 
conditions that affect the cell (Lee and Surh, 2005). This strategy results in 
increase of cell defenses by inducing endogenous pathways, which are capable 
of restoring cellular homeostasis (Otterbein and Choi, 2000). HSPs, exemplify 
this concept because of their function as molecular chaperones and their high 
inducibility in stress conditions (Ryter and Choi, 2005). The induction of HSPs 
and other antioxidant genes in various stress conditions is being regarded as a 
refined stratagem by tissues to counteract a variety of patho-physiological 
states such as l/R injury (Redaelli et al., 2002a) and oxidative stress(Calabrese 
et al., 2003).
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1.4 Endogenous Cytoprotective Machinery
Living cells are continually challenged by conditions which cause acute or 
chronic stress (Motterlini et al., 2002b). To adapt to environmental changes and 
survive different types of injuries, eukaryotic cells have evolved networks of 
different responses which detect and control diverse forms of stress (Otterbein 
et al., 2003). Among these responses, are the heat shock proteins (HSP) 
(Calabrese et al., 2003) and phase II enzymes (Owuor and Kong, 2002).
1.4.1 Heat Shock Proteins (HSPs)
HSP have attracted a great deal of attention as a universal fundamental 
mechanism necessary for cell survival under a wide variety of toxic conditions 
(Redaelli et al., 2002b). In mammalian cells, HSPs synthesis is induced not only 
after hyperthermia, but also following alterations in the intracellular redox 
environment, exposure to heavy metals, amino acid analogs or cytotoxic drugs 
(McCormick et al., 2003). While prolonged exposure to conditions of extreme 
stress is harmful and can lead to cell death, induction of HSP synthesis can 
result in stress tolerance and cytoprotection against stress-induced molecular 
damage (Maines, 1997). The discovery of HSP has opened new perspectives in 
medicine and pharmacology, as molecules activating this defense mechanism 
appear as possible candidates for novel cytoprotective strategies.
1.4.2 Phase II Enzymes
It was suggested that the metabolism of xenobiotics involves the actions of two 
families of enzymes, phase I and phase II (Williams, 1967). Phase I enzymes 
(such as cytochromes P450) convert mild pro-oxidant toxins or electrophiles, to 
highly reactive electrophilic and hydrophobic toxins, that cause structural and
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functional damage to the cell (Xu et al., 2005). However, Phase II enzymes 
protect cells against damage by electrophiles through multiple mechanisms, 
which include prompt conjugation of the phase I products with endogenous 
ligands such as glutathione (by glutathione S-transferases) and glucuronic acid 
(by UDP-glucuronosyltransferases), or via their anti-oxidant products which 
inactivates these agents resulting in the production of more water-soluble 
products that could be easily excreted (Talalay and Fahey, 2001). The phase II 
response is therefore emerging as a very important component of cellular 
defenses against oxidants (Talalay, 2005). Indeed, an ample literature now 
supports the view that induction of phase II enzymes is an important protective 
mechanism against the reactive oxygen species and essential for redox 
regulation (Moskaug et al., 2005). It is therefore of great importance to search 
for different pharmacological agents which possess intrinsic abilities to 
modulate the expression and the activity of these protective enzymes (Talalay 
and Fahey, 2001).
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Three cellular components are centrally involved in phase II gene regulation: 
Firstly, Antioxidant Response Elements (ARE), cis-acting promoters of 
transcription which are present in the upstream regions of many phase II genes 
(Chen et al., 2004). Secondly, Nrf2 (nuclear factor-erythroid-related factor 2), a 
basic leucine zipper transcription factor, binds in heterodimeric combination with 
other transcription factors to the ARE promoters, and signals enhanced 
transcription of phase II genes (Lee and Surh, 2005). And thirdly, Keapl, a 
repressor protein that is normally localized in the cytoplasm, where it is tethered 
to the cytoskeleton (Motohashi and Yamamoto, 2004), Keapl binds to Nrf2 very 
tightly and is thereby largely retained in the cytoplasm, so that its activity is 
repressed (Alam et al., 1999). Inducers of phase II enzymes disrupt the Keapl- 
Nrf2 complex, thereby releasing Nrf2 for translocation to the nucleus and 
activation of the transcription of phase II genes (Kobayashi and Yamamoto, 
2005).
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Figure 1.4: Signalling pathways involved in the ARE-mediated gene transcription 
through activation of Nrf2.
Keapl, as a cytoplasmic repressor, sequesters Nrf2 in the cytoplasm, thereby blocking 
the nuclear translocation of Nrf2 and subsequent transactivation of ARE. Alterations in 
cellular redox balance towards prooxidative status leads to the translocation of Nrf2 to 
the nucleus, where it binds to the ARE regulatory region of phase II genes. After 
translocation to the nucleus, Nrf2 may dimerize with a Maf proteins. The resultant 
heterodimer binds to the ARE and up-regulates the ARE-driven genes, including 
GSTA2, NQ01, g-GCL (gamma-glutamate cysteine ligase), and HO-1. Activated PKC 
may directly phosphorylate Nrf2. Three MAPKs, extracellular signal-regulated protein 
kinase (ERK), c-Jun N-terminal kinase (JNK), and p38, may also stimulate the Nrf2 
activation. Alternatively, PI3K can phosphorylate Nrf2, inducing its translocation to the 
nucleus. Some phase II enzyme inducers trigger the Nrf2 signal transduction by 
activating upstream kinases via phosphorylation and/or covalent modification/oxidation 
of cysteine thiol groups present in Keapl (Lee and Surh, 2005).
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1.4.3 The Haem Oxygenase System
Haem oxygenase is the rate-limiting step in the catabolism of haem; it breaks 
down the protoporphyrin ring into equimolar amounts of biliverdin, free iron and 
carbon monoxide (CO) (Clark et al., 2000a). In mammals, biliverdin is rapidly 
converted to bilirubin whereas in non-mammals such as birds, amphibians and 
reptiles, biliverdin is the end product of haem breakdown (Maines, 1997). After 
its discovery in 1968 (Tenhunen et al., 1969), haem oxygenase received little 
attention, until the last decade, when this enzyme started to draw the attention 
of scientists after a review written by Maines in 1993 (Maines, 1997). The haem 
oxygenase pathway plays a key role in the preservation of tissue integrity 
against oxidative stress and contributes to the modulation of inflammatory 
responses, acting in synchrony with other enzymatic systems that are involved 
in cytoprotection (Foresti et al., 2001) (Foresti et al., 2004). Recently, the crucial 
role of haem oxygenase in vascular biology was highlighted by the case of a 
child with haem oxygenase deficiency. In this patient, (who died at the age 6 
years due to intracranial haemorrhage (Ohta et al., 2000)) haemolysis and 
endothelial cell injury were prominent features, furthermore, he suffered from 
severe growth retardation, persistent haemolytic anaemia characterized by 
marked erythrocyte fragmentation and intravascular haemolysis, and the 
presence of severe and persistent endothelial damage (Shibahara et al., 2002; 
Yachie et al., 1999). Similar features, including growth retardation, anaemia, 
iron deposition and vulnerability to stressful injury are all characteristics recently 
described in HO-1 null mice (Yachie et al., 1999). The clinical symptoms in this 
patient demonstrated the critical importance of HO-1 in iron metabolism and 
cytoprotection from oxidative damage (Yachie et al., 1999).
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The catabolism of haem by haem oxygenase is the only biological process 
which is colorimetric, and can be noted as a gradual change in colour of a 
bruise. After receiving a blow to the skin, the colour of the skin becomes black 
or purple which is the colour of haem released from red blood cells after trauma, 
then black is gradually transformed to green, the colour of biliverdin, and finally 
to yellow, the colour of bilirubin (Figure 1.5) (Otterbein and Choi, 2000).
Haem
Oxygenase
Biliverdin
Reductase Bilirubin
Ferritin
Figure 1.5: The haem oxygenase reaction
Haem oxygenase catalyzes the first and rate-limiting step in the degradation of haem, 
to yield equimolar quantities of biliverdin, CO, and free iron. Biliverdin is subsequently 
converted to bilirubin via the action of biliverdin reductase, and free iron is promptly 
sequestered into ferritin. Catabolism of haem is the only biological process in humans 
that is colorimetric; after receiving a blow to the skin, shortly thereafter a black or purple 
bruise would be observed. These are colours of haem, released into the dermis from 
pulverized erythrocytes. The black hue (haem) gradually transformed to green, the 
colour of biliverdin, and finally to yellow, the colour of bilirubin, the concluding product 
of this elegant enzymatic reaction (Otterbein and Choi, 2000).
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To date, three isoforms of haem oxygenase have been identified to date haem 
oxygenase-1 (HO-1), haem oxygenase-2 (HO-2) and haem oxygenase-3 HO-3) 
(Maines, 1997), with molecular weights of approximately 32, 36 and 33 KD 
respectively (Table 1-2). The three enzymes are products of different genes and 
vary in their tissue distribution and regulation (Maines, 1997). Both HO-1 and 
HO-2 catalyze identical biochemical reactions, but differ in reaction rates, 
primary structure, and thermostability (Maines, 1988). In contrast, HO-3 has a 
similar sequence to HO-2, but has poor catalytic activity (McCoubrey, Jr. et al., 
1997). In addition to a catalytic domain, both HO-2 and HO-3 contain two 
additional haem regulatory domains (HRD) (Maines, 1988) (McCoubrey, Jr. et 
al., 1997). HO-2 is the constitutive form; it is up-regulated by a few agents, 
opiates and adrenal glucocorticoids (Maines, 1997). HO-1 is the inducible 
isoform and it is expressed in response to stressful stimuli (Clark et al., 1997). 
Differences between HO-1 and HO-2 regulation relate to the presence of 
regulatory elements in their promoter regions (Muller et al., 1987) (Camhi et al., 
1995) (Camhi et al., 1998). The consensus sequences necessary for binding 
several regulatory factors such as heat shock, and NF-KB are present only in 
the HO-1 promoter region whereas in contrast, a single functional glucocorticoid 
response element (GRE) is present in the promoter region of HO-2 (Liu et al., 
2000).
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Table 1-2: Characteristics of the haem oxygenase isoforms
Properties HO-1 HO-2 HO-3
Microsomes Mitochondria unknown
22 q 12 (Kutty et 
al., 1994)
16p13.3 (Kutty et 
al., 1994)
unknown
32 KD 36 KD 33 KD
Liver, kidney, 
heart, vascular 
smooth muscle, 
endothelium, lung 
and brain
Nervous system 
Blood vessels 
Testes 
Intestine
Thymus
spleen
heart
testes
brain
Cellular
homeostasis,
anti-inflammatory
Neural signalling 
and vascular 
regulation
unknown
Haem
oxidative stress 
heavy metals 
nitric oxide 
hypoxia
Glucocorticoids,
opiates
unknown
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The specific activity of haem oxygenase varies in different organs (Maines, 
1997). The highest haem oxygenase activity is found in the spleen, testes and 
the brain (Maines, 1988). The spleen is the only organ in which, under normal 
conditions, HO-1 is the predominant form (Braggins et al., 1986). In the 
cardiovascular system, HO-2 is the predominant form expressed under normal 
conditions; HO-2 is normally expressed in the endothelial and smooth muscle 
layers of the blood vessels under stressful conditions, the expression of HO-1 
increases dramatically, particularly in the atrioventricular node and in myocytes 
(Ewing et al., 1994). In the liver, the expression of haem oxygenase isozymes 
shows a developmentally-related expression as the total haem oxygenase 
activity (which is mainly due to the increased expression of HO-1 protein) in the 
liver decreases as the newborn matures; on the other hand, HO-2 expression 
gradually increases as the animal matures (Sun and Maines, 1990). In the 
reproductive system, expression of HO-1 and HO-2 expression shows a cell- 
type specific pattern of expression, e.g. HO-2 is expressed in germ cell lines, 
predominantly in the mature spermatocytes whereas HO-1 is expressed in 
Sertoli cells (Ewing and Maines, 1995), the highest levels of HO-2 are found in 
the testis (Liu et al., 2000).
The products of the HO-1 pathway have been shown in many experiments to 
exert important biological and cytoprotective functions (McLaren and Friend,
2003) (Sato et al., 2001; Song et al., 2003). In particular, HO-1 has important 
antioxidant and anti-inflammatory functions (Alcaraz et al., 2003). The beneficial 
effects of HO-1 induction occur via several postulated mechanisms. Firstly, 
increased HO-1 activity results in the degradation of the haem moiety, which is 
per se a pro-oxidant molecule and potentially toxic (Balia et al., 1991).
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Furthermore, HO-1 results in the generation of bilirubin, which possesses 
antioxidant properties which are involved in scavenging peroxy radicals and 
exerting inhibitory effects on lipid peroxidtaion (Llesuy and Tomaro, 1994; 
Stocker et al., 1987b). In addition, HO-1 produces CO, which has anti-apoptotic 
and anti-inflammatory actions as well as vasoregulatory activity (Clark et al.,
2003) (Figure 1.6). Furthermore, HO-1 system also plays an important role in the 
homeostasis of iron by stimulating the up-regulation of ferritin; the storage 
protein for iron, endothelium may be protected from oxidant damage through 
ferritin, the iron chelator, which is co-induced with HO-1 (Balia et al., 1992).
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Figure 1.6: The mechanisms of cytoprotection of the HO-1 system
HO-1 (checkered diamond) degrades haem to produce three products: Fe2, CO, and 
biliverdin, in cooperation with cytochrome P-450 reductase (shaded diamond). (A) 
Haem is derived from both extracellular and intracellular compartments. (B) CO not 
stimulates leads to vasodilatation or prevention of platelet aggregation, induces cell 
arrest and inhibits apoptosis. CO also interferes with cyclooxygenase (COX), 
lipoxygenase (LOX), and NO synthase (NOS) activity, resulting in reduction of NO and 
prostaglandins (PG)-LT. (C) Fe+2 released into endoplasmic reticulum (ER) by Fe- 
ATPase, may be redistributed or neutralized in ER. (D) Biliverdin, rapidly reduced to 
bilirubin by biliverdin reductase, is distributed in both intracellular and extracellular 
compartments. ROS can be scavenged by bilirubin to maintain redox status and 
protect cells from oxidative stress. Adapted from (Katori et al., 2002a)
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1.4.3.1 Haem Molecule
Haem is a crucial substance which is required for aerobic life (Shibahara et al.,
2002). However, free haem can be quite cytotoxic, particularly in the presence 
of oxidants or activated phagocytes (Balia et al., 2003). Of all sites in the body, 
the vasculature and in particular the endothelial lining may be at greatest risk of 
exposure to free haem (Balia et al., 1993), because erythrocytes contain haem 
at a concentration of 20mmol/l and are vulnerable to unexpected lysis (Balia et 
al., 1991). Furthermore, extracellular haemoglobin is easily oxidized to 
methaemoglobin which, in turn, will readily release haem (Nagababu and 
Rifkind, 2004) .Given the hydrophobic nature of haem; it is no surprise that it 
easily crosses cell membranes and can synergistically enhance cellular oxidant 
damage (Maulik et al., 1996).
1.4.3.2 The Catalytic Pathway of Haem Oxygenase
Haem oxygenase cleaves the substrate haem to form biliverdin, water, CO, and 
iron (Foresti and Motterlini, 1999). Haem degradation can also be carried out by 
other proteins, such as xanthine oxidase and NADPH-cytochrome P-450 
reductase (Guengerich, 1978). In this case the end products of these enzymatic 
reactions are not biliverdin and CO, but a mixture of pyrrolic complexes 
(Shibahara et al., 2002). The haem oxygenase reaction requires NADPH: 
cytochrome P-450 reductase, which reduces the ferric haem complex, three 
molecules of oxygen and at least seven electrons provided by NADPH- 
cytochrome-P450 reductase (Maines, 1997). The haem oxygenase system is a 
mixed-function oxidase, for each mole of oxygen consumed in the reaction, one 
mole of H20  is produced (Kikuchi et al., 2005). In each mono-oxidation cycle,
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the reduced iron binds molecular oxygen that accepts the electron from 
NADPH, the first cycle forms hydroxyl-haem, the second cycle forms 
verdohaem and thus breaks the a methane bridge carbon which will be 
released as CO, and the third cycle forms ferribiliverdin IX (BV-Fe III) a complex 
(Maines, 1997). An additional NADPH-dependent reduction of the (BV-Fe III) is 
needed before the dissociation of ferrous iron from biliverdin, then NADPH 
biliverdin reductase reduces the water soluble biliverdin to the hydrophobic 
bilirubin. The released ferrous iron is then chelated by apoferritin and stored in a 
ferric state within the ferritin molecule or transported to the bone marrow (Balia 
et al., 1992).
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Figure 1.7: Schematic diagram of haem catabolism via the haem oxygenase 
pathway.
The haem oxygenase catalyzed reaction, haem (iron protoporphyrin IX) is cleaved 
between rings A and B by haem oxygenase to yield equimolar quantities of iron (Fe2+), 
carbon monoxide (CO) and biliverdin. 0 2 and NADPH are required for this reaction. 
Biliverdin is then converted to bilirubin by biliverdin reductase (Agarwal and Nick,
2000).
50
j£l_______________________________________________ INTRODUCTION
1.4.4 The Biological Roles of Haem Oxygenase Pathway
HO-1 up regulation is associated with inhibitory effects in various models of 
cardiovascular diseases; in inflammatory states (Laniado-Schwartzman et al., 
1997), in graft rejection (Agarwal and Nick, 2000) and in atherosclerosis (Wang 
et al., 1998). HO-1 up regulation results in the inhibition of oxidative stress and 
apoptosis with significant reductions in inflammatory response including 
oedema, leukocyte adhesion and migration, and production of cytokines 
(Alcaraz et al., 2003).
1.4.4.1 Carbon Monoxide
The existence of carbon monoxide (CO) as a poisonous gas has been 
documented since the 17th century. Only recently however, evidence has 
accumulated showing that CO has beneficial biochemical and physiological 
properties, which are similar to those of (NO). CO is present in biological 
systems as a product of catabolism of haem by haem oxygenase. In humans, 
endogenous CO arises mainly from haem degradation (>86%). The rest arises 
from other pathways that include lipid peroxidation and xenobiotic metabolism 
(Stevenson et al., 2000). HO-1 derived CO has been recognized to be an 
important cellular messenger with various physiological functions. CO is 
relatively inert compared to NO. Both gases bind to haem ligands and form 
complexes with most haemoproteins at the haem iron centre, CO binds only to 
ferrous (Fe2+) haem whereas NO binds both ferrous and ferric haem. NO, a free 
radical gas, participates in numerous redox reactions, including the reaction 
with superoxide anion radicals (O2') to form peroxynitrite (Immenschuh and 
Ramadori, 2000). In contrast, CO is a stable non-radical molecule. Both CO and 
NO are involved in neural transmission and modulation of blood vessel function,
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including smooth muscle relaxation, and inhibition of platelet aggregation. CO 
reacts exclusively with haem and/or iron and thus can accumulate in cells to 
levels much higher than those of NO (Soares et al., 2001). Adding to this many 
cells have a constitutively high capacity to generate CO and/or can be induced 
in very high levels (Maines, 1997), mammalian tissue has a very high capacity 
to produce CO, and in some organs, such as the brain, it exceeds the 
production of NO (Maines, 1997).
The beneficial effects of CO were demonstrated in a number of experimental 
models, for example, in a model of acute lung injury (Otterbein et al., 1999) CO 
was found to be protective in rat orthotopic lung transplantation (Song et al.,
2003), in another model, it protects against septic shock, (Yachie et al., 1999) 
and provides protection in atherosclerosis (Shi et al., 2000a) (Shi et al., 2000b). 
Data in the literature provide evidence for the beneficial effects of CO in heart 
transplantation, HO-1-derived CO prevents l/R injury associated with cardiac 
transplantation possibly based on its anti-apoptotic action (Akamatsu et al.,
2004). In intestines, perioperative CO inhalation at a low concentration resulted 
in protection against l/R injury to intestinal grafts with prolonged cold 
preservation (Nakao et al., 2003). The anti-inflammatory activity of CO may 
underlie the protective effects of CO in graft rejection (Ke et al., 2001) (Ke et al.,
2002) (Sato et al., 2001). Exposure to CO gas has been shown to exert potent 
anti-apoptotic effects in vivo and in vitro. In vitro, CO prevented TNF-a-induced 
apoptosis in murine fibroblasts (Petrache et al., 2000). Similarly, CO prevented 
oedema formation and apoptosis during reperfusion after cardiopulmonary 
bypass in pigs (Lavitrano et al., 2004).
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1.4.4.2 Biliverdin, Bilirubin and Iron
Biliverdin and bilirubin are reducing species and hence potential antioxidants 
formed by the action of haem oxygenase and biliverdin reductase (Stocker,
2004). Biliverdin is rapidly converted to bilirubin by biliverdin reductase (Katori 
et al., 2002a). Biliverdin administration has been shown to be protective against 
various cellular stresses, such as ischaemic heart injury (Vachharajani et al.,
2000). Bilirubin is the most abundant endogenous antioxidant in mammalian 
tissues and accounts for most of the antioxidant activity in human serum 
(Gopinathan et al., 1994), it forms a complex with serum albumin (Kapitulnik,
2004), this complex prevents the peroxidation of albumin-bound fatty 
acids(Stocker et al., 1987a), bilirubin also reacts with peroxyl radical and lipid 
peroxides (Stocker et al., 1987b). Furthermore, bilirubin has been shown to 
inhibit the adhesion of neutrophils elicited by l/R (Hayashi et al., 1999). Bilirubin 
formed by the activation of HO-2 protects neurons against oxidative damage 
injury (Dore et al., 1999). Furthermore, bilirubin administration was proved to be 
protective in a model of ischaemic heart injury (Clark et al., 2000b). The haem 
oxygenase pathway also releases free iron, which has two free electrons 
capable of generating hydroxyl radicals through Fenton chemistry (Winterboum, 
1995) once released, iron is rapidly sequestrated into the iron storage protein 
ferritin (Harrison and Arosio, 1996). The release of iron by haem oxygenase 
also results in the up-regulation of ferritin, which acts as a scavenger of iron 
(Otterbein et al., 2003).
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1.4.5 The Role of HO-1 in Inflammation
Over-expression of HO-1 results in a significant reductions in inflammatory 
events including edema, leukocyte adhesion and migration (Alcaraz et al., 
2003) and production of inflammatory cytokine (Otterbein et al., 2003). 
Modulation of signal transduction pathways by HO-1 or its products mediate the 
anti-inflammatory effects of this protein (Ryter and Otterbein, 2004). HO-1 
exerts its anti-inflammatory actions by down regulation of pro-inflammatory 
cytokines (Terry et al., 1998) (Rizzardini et al., 1993) (Otterbein et al., 2000) 
and up-regulation of ant-inflammatory mediators (Willis et al., 1996) (Lee and 
Chau, 2002) (Abraham and Kappas, 2005). HO-1 deficiency in humans is 
associated with susceptibility to oxidative stress and an increased pro- 
inflammatory state with severe endothelial damage (Yachie et al., 1999).
1.4.6 Haem Oxygenase System in Transplantation
Increased HO-1 expression has beneficial effects in a number of transplantation 
models (Katori et al., 2002b). It is thought that HO-1 exerts its protective effects 
through its anti-apoptotic (Akamatsu et al., 2004), anti-inflammatory (Song et 
al., 2003) and antioxidant functions (Tsuchihashi et al., 2003). It was 
demonstrated that the expression of HO-1 is up-regulated in the vascular 
endothelium of transplanted organs (Soares et al., 1998). The reason for this is 
that the endothelium in the vasculature of the graft is exposed to high levels of 
free haem following transplantation (Sato et al., 2001). Haem released from 
haemoglobin and myoglobin from the erythrocytes or myocytes through 
haemolysis or necrosis which occurs after transplantation (Balia et al., 1993). 
Once released from these proteins, free haem become incorporated into the 
lipid bilayer of the cytoplasmic membrane, and act as a potent pro-oxidant
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(Ryter and Tyrrell, 2000), probably related to the fact that iron which is in the 
core of the haem molecule becomes available to participate to the generation of 
free radicals through the Fenton reaction (Ryter and Tyrrell, 2000). The 
generation of free radicals initiates a group of signal transduction pathways that 
induce both the expression of pro-inflammatory and pro-apoptotic genes 
(Gueler et al., 2004), which results in the up-regulation of cytokines and other 
mediators of inflammation (Carden and Granger, 2000). These events lead to 
the deleterious effects that cause l/R injury and ultimately, transplant rejection 
(Gueler et al., 2004). Under these conditions, HO-1 up-regulation plays a major 
role in combating these cellular and tissue stresses (Akamatsu et al., 2004). 
Once up-regulated, HO-1 produces CO which exerts its anti-apoptotic and anti­
inflammatory actions, along with bilirubin, which act as antioxidants, in addition 
to the clearance of the pro-oxidant haem (Akamatsu et al., 2004) (Kato et al.,
2003) . Furthermore, HO-1 action on haem promotes the release of free iron, 
which in turn up-regulates ferritin (Harrison and Arosio, 1996). The anti- 
apoptotic effect of HO-1 can be mimicked by the administration of iron chelator 
desferoxamine (Brouard et al., 2000). CO exposure protected transplanted 
lungs (Song et al., 2003). Furthermore, HO-1 induction attenuated oxidative 
injury in a rat kidney ischaemia-reperfusion model (Maines et al., 1999). It has 
been shown that HO-1 induction resulted in a longer cold storage of the 
harvested liver and reduced apoptosis in the hepatic graft using a model of liver 
transplantation in the rat (Redaelli et al., 2002a). Furthermore, expression of 
HO-1 in rodent liver, heart, and kidney allograft correlates with long-term graft 
survival (Coito et al., 2002) (DeBruyne et al., 2000) (Avihingsanon et al., 2002) 
(Tullius et al., 2001).
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1.5 Regulation of HO-1 Expression
Great strides have been made in defining cellular events that govern HO-1 
regulation. Arguably, HO-1 gene transcription is activated by far a greater 
number of stimuli than that of any gene in fact, only a handful of agents, among 
them being its own products, reduce HO-1 transcription (Maines and Gibbs,
2005) (Kitamuro et al., 2003). The overwhelmingly vast number of stimuli that 
activate HO-1 reflects the presence of multiple response elements within its 
promoter that bind activated factors and the multiplicity of interactions between 
components of the cell signaling cascades (Wright, 2000). The cellular 
processes underlying HO-1 induction are complex and tightly regulated, 
however, one feature common to most of the stimuli that up-regulate HO-1 is a 
significant shift in cellular redox (Motterlini et al., 2002b).
1.5.1 Transcriptional Regulation of HO-1 Gene
Induction of HO-1 expression is regulated primarily at the gene transcription 
level (Alam, 1994). It is regulated by two upstream enhancers, E1 and E2 (Alam 
and Cook, 2003) (Alam, 1994), both enhancer regions containing multiple stress 
responsive elements (stRE) (Alam and Cook, 2003). The signal transduction 
pathways that mediate HO-1 induction remains only partially understood 
(Maines and Gibbs, 2005).
1.5.1.1 Regulatory Elements of the HO-1 Gene Promoter
The induction of HO-1 is mediated through c/s-regulatory DNA sequences 
located in the promoter region, known as antioxidant responsive elements 
(AREs) (Alam et al., 1995), which are regulated by Nrf2 (Alam et al., 1999). Nrf2 
is a member of Cap’n’Collar transcription factor/basic leucine zipper b, and
56
4 _______________________________________________INTRODUCTION
plays a major role in the transcriptional regulation of anti-oxidant and detoxifying 
genes (Lee and Surh, 2005). The transcription factor Nrf2 was recently 
identified as a general regulator of one defense mechanism against 
electrophiles. Nrf2 regulates the inducible expression of a group of detoxifying 
enzymes, such as HO-1, the important role of Nrf2 in the stress-dependent 
induction of HO-1 is confirmed by the finding that HO-1 is not inducible in Nrf2- 
null mice (Chan and Kan, 1999). Using peritoneal macrophages from Nrf2- 
deficient mice, it was demonstrated that Nrf2 controls the expression of HO-1 
(Ishii et al., 2000), the response to electrophilic agents was profoundly impaired 
in Nrf2-deficient cells (Ishii et al., 2000). When un-stimulated, Nrf2 is located in 
the cytosol by binding to Keap1(ltoh et al., 1999), upon stimulation by oxidant 
stress, the Keap1-Nrf2 complex uncouples, leading to the translocation of Nrf2 
from the cytosol to the nucleus and bind to a specific DNA sequence, thereby 
potentiating the ARE response (Itoh et al., 1999), (Owuor and Kong, 2002).
1.5.1.2 Repression of HO-1 Gene Expression
Bachl and Bach2 are transcriptional repressors (Blouin et al., 1998). It has 
demonstrated that HO-1 is constitutively expressed at high levels in Bachl- 
deficient mice (Sun et al., 2002). Bach2 is present only in B lymphocytes and 
the brain (Blouin et al., 1998) and is a known antagonist of the Nrf2- mediated 
induction of HO-1 (Blouin et al., 1998) 78}. These findings were highlighted by 
the observation that expression of HO-1 mRNA and protein is significantly high 
in several organs of Bach-null mice, which was comparable to the basal levels 
of HO-1 detected in the spleen (an organ which normally exhibits high basal 
levels of HO-1 because of constant exposure the erythrocytes-derived haem) 
(Alam and Cook, 2003). On stimulation by haem, Bachl is displaced, allowing
57
Jl  in t ro d u c t io n!xl — ------------------------------------------------------------------------------------------------
binding of Nrf2 to its DNA binding sites and consequently allowing the activation 
of different transcription factors (Sun et al., 2002). It is also worth mentioning 
that striking interspecies variations are noted in the regulation of HO-1 
expression by hypoxia, heat shock, or interferon-gamma, each of which 
represses HO-1 expression in human cells, in human glioblastoma cells, 
interferon-y repressed HO-1 mRNA expression (Takahashi et al., 1999). 
Hypoxia suppressed HO-1 mRNA expression in cultures of human umbilical 
vein cells, human astrocytes and human coronary arterial endothelial cells 
(Nakayama et al., 2000). Bachl participates in hypoxia-inducible repression of 
human HO-1 expression (Kitamuro et al., 2003). Furthermore, it was shown that 
the regulation of HO-1 involves a direct sensing of haem levels by Bachl; 
expression of HO-1 m RNA is highly increased in human cells by haem 
(Yoshida et al., 1988).
1.5.1.3 Role of MAPK Pathways
The mitogen-activated protein kinase (MAPK) signalling pathways play 
important roles in regulating gene expression in the cell (Kyriakis and Avruch,
2001). One of the major mechanisms for changes in gene expression appears 
to be through MAPKs, altering the activity of transcription factors and hence the 
transcription of their target genes (Torres, 2003). MAPK signalling pathways 
can either stimulate the translocation of transcription factors to the nucleus to 
promote their activity (Alam et al., 1999), or conversely, stimulate the export of 
transcription factors from the nucleus and hence facilitate their inactivation 
(Yang et al., 2003). MAPKs encompass a large number of serine/threonine 
kinases involved in regulating a wide range of cellular processes, including 
stress response and apoptosis (Sarkar and Li, 2004). There are four groups of
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MAPK in mammalian cells; extracellular signal-regulated kinases (ERK), c-Jun 
N-terminal Kinases (JNK), P38 Kinases, and extracellular signal regulated 
kinase-5 ERK5; also called Big MAP kinase-1 (BMK1)(Kyriakis and Avruch,
2001). The ERK, JNK and p38 are activated through independent (sometimes 
overlapping) signalling cascades involving a MAPKK, MAPK kinase that is 
responsible for phosphorylation of the MAPK and a MAPK Kinase Kinase 
(MAPKKK) that phosphorylates and activates MAPKK (Torres, 2003) 
Figure1.8). MAPKs mediate their effects through phosphorylation of a wide 
range of transcriptions factors which are involved in many biological processes 
(Shimizu and Weinstein, 2005). ERK pathway is linked to the regulation of cell 
proliferation (Kolch, 2000), while, JNK and p38 are involved in the stress-related 
conditions (Sugden and Clerk, 1998). JNK and p38 pathways are involved in a 
wide range of stresses which include cytokines, heat shock and oxidative 
damage (Adler et al., 1999b). Furthermore, it has been demonstrated that p38 
pathway is involved in curcumin-mediated induction of HO-1 (Balogun et al., 
2003b). JNK activity is inhibited in un-stressed conditions, glutathione S- 
transferase (GST) binds to JNK and inhibits its activation, and this interaction is 
uncoupled under oxidative stress (Adler et al., 1999a) (Chen et al., 2001) (Ono 
and Han, 2000) (Ivanov and Ronai, 2000). NO induces HO-1 ERK and p38 
(Chen and Maines, 2000), furthermore, HO-1 gene induction by quercetin in rat 
aortic smooth muscle cells involved p38 pathway (Lin et al., 2004) (Ryter et al.,
2002) (Owuor and Kong, 2002). The anti-apoptotic effect of HO-1 in endothelial 
cells is mediated by the activation of p38 MAPK by CO (Brouard et al., 2000).
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1.5.1.4 The Role of Phosphoinositide 3-Kinase Pathway
Lipid second messengers play a pivotal role in several cell signaling networks 
(Radeff-Huang et al., 2004), phosphoinositide 3-kinases (PI3Ks) generate 
specific inositol lipids that have been implicated in a plethora of cell functions 
(Neri et al., 2002). One of the best-characterized targets of PI3K lipid products 
is the serine/threonine protein kinase Akt. Recent findings have implicated Akt 
in cancer progression because it stimulates cell proliferation and suppresses 
apoptosis (Squires et al., 2003). Data in the literatures suggest that lipid 
molecules are important components of signaling pathways operating within the 
nucleus (Martin et al., 2004). PI3Ks, their lipid products, and Akt have also been 
identified as important cellular pathways and play a major role in the regulation 
of the phase II enzymes including HO-1 (Lee et al., 2001), PI3K leads to Nrf2 
nuclear translocation and subsequent ARE activation (Nakaso et al., 2003) 
(Tiwari et al., 2004). Furthermore, PI3K has been implicated in the protective 
functions of the HO-1 pathway, for example, in a model of l/R injury (Fujimoto et 
al., 2004).
1.5.1.5 The Role of NO in the Regulation of HO-1
The signaling molecule NO, which is generated in mammals by a family of 
constitutive (nNOS and eNOS) and inducible (iNOS) NO synthase (NOS) 
enzymes (MacMicking et al., 1997; Maines, 1997), plays an essential regulatory 
role in a variety of physiological and pathophysiological processes that take 
place within the cardiovascular system (Chen et al., 2003). The distinctive 
biological activities evoked by NO can be explained by virtue of its nature as 
free radical, and by the reactivity of the NO group with the intracellular milieu 
(Motterlini et al., 2002b). HO-1 pathway is central to the regulation of many
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physiological and pathophysiological processes, mainly due to its established 
function in haem catabolism (Otterbein et al., 2003). Furthermore, HO-1 is 
closely linked to NO molecule in the modulation of the tissue stress response, 
and is widely regarded as a key player in the restoration of vascular function 
under conditions of increased generation of ROS (Foresti et al., 2004). The HO- 
1 system may counteract the excessive production of NO and reactive nitrogen 
species (RNS), because of its high inducibility in response to NO and NO- 
related species, and therefore, actively participates in NO detoxification 
(Motterlini et al., 2002b). Induction of HO-1 by NO donors involves the activation 
of MAPK pathways (Chen and Maines, 2000) and is mediated through Nrf2 
(Naughton et al., 2002).
1.5.1.6 The Role of Intracellular Glutathione
Glutathione plays a critical role in cell physiology and is considered as a vital 
intra-cellular and extra-cellular protective anti-oxidant (Adler et al., 1999b). 
Glutathione exists in either a reduced (GSH) or oxidised (GSSG) form (Rahman 
and MacNee, 2000). It plays a vital role in cellular protection against oxidative 
stress and detoxification of exogenous and endogenous reactive heavy metals 
and electrophiles, cell cycle regulation and differentiation (Hammond et al.,
2001).The GSH redox status is critical for various biological events (e.g. 
transcription of genes, modulation of redox-regulated signal transduction, 
regulation of apoptosis and inflammation (Rahman and MacNee, 2000). 
Changes in the cellular redox state may modify the activity of specific regulatory 
protein kinases and protein phosphatases which affect gene expression (Finkel, 
1998). Glutathione redox homeostasis controls the level of ROS formed during 
cellular metabolism. It has been reported in a large number of studies that HO-1
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gene expression is induced by stimuli that increase the production of ROS, 
including haem, H2O2 or by conditions that deplete cellular glutathione stores, 
including buthionine sulfoximine (BSO) which inhibits, the rate limiting step in 
the synthesis of glutatione. In rat brains, Maines et a/ demonstrated that 
glutathione depletion was associated with HO-1 induction in the brain (Ewing 
and Maines, 1993). Furthermore, it has been shown that scavengers of ROS, 
such as N-acetylcysteine inhibit oxidant-mediated HO-1 induction in many 
systems (Foresti et al., 1997) (Borger and Essig, 1998). Evidence suggests that 
both ultraviolet radiation and oxidizing agents potently induce HO-1 expression 
in human fibroblasts (Keyse and Tyrrell, 1987).
1.5.2 Regulation of Haem Oxygenase by Haem
Haem, a ubiquitous iron-containing compound, is present in large amounts in 
many cells and is also inherently dangerous, particularly when it escapes from 
intracellular sites (Balia et al., 1992). Free haem can be cytotoxic, especially in 
the presence of oxidants or activated phagocytes (Balia et al., 2003). The 
endothelium is at greatest risk of exposure to free haem, because erythrocytes 
contain high concentrations of haem (Maines, 1997), furthermore, extracellular 
haemoglobin is easily oxidized to methaemoglobin, which in turn releases free 
haem, which then (because of its hydrophobic nature) can easily cross the 
endothelial cell membrane and act to enhance cellular oxidant damage 
(Harrison and Arosio, 1996). Once within the cell, haem can promote oxidative 
damage directly by the release of iron, which, if in excess is toxic via the 
production of ROS by Fenton chemistry (Immenschuh and Ramadori, 2000).
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1.6 Biological Effects of Dietary Phenolic Compounds: Relevance to 
Cardiovascular Disease
Plants have played a central role in the prevention and treatment of diseases 
since prehistoric times (Talalay and Talalay, 2001). Furthermore, a significant 
number of many of the drugs which are clinically used today are of plant origin 
(Table 1-3) (Talalay and Talalay, 2001). Recently, considerable attention has 
been focused on identifying dietary and medicinal phytochemicals that have 
intrinsic cytoprotective properties (Frusciante et al., 2000). Polyphenolic 
compounds form a major part of the dietary antioxidant capacity of fruits and 
vegetables (Blomhoff, 2005), and include Resveratrol (red wine) (Shimizu and 
Weinstein, 2005), curcumin (curry) (Motterlini et al., 2000b), chalcones (apples) 
(Tsao et al., 2003) and flavonoids (Lee et al., 2003). Flavonoids are the most 
abundant polyphenols in our diets and are found in fruits, vegetables, nuts, wine 
and tea (Kim et al., 2004). Polyphenolic compounds are receiving interest from 
scientists because epidemiological studies have suggested an association 
between the consumption of polyphenol-rich foods or beverages and the 
prevention of diseases such as cancer (Menon et al., 1999) (Ruby et al., 1995) 
(Talalay and Fahey, 2001), inflammatory diseases (Salh et al., 2003), 
neurodegenerative disorders (Lim et al., 2001), and cardiovascular diseases 
(Suzuki et al., 2001). The basic structure of flavonoids allows for a multitude of 
hydroxyl substitution patterns in the benzene rings, which give flavonoids the 
ability to scavenge ROS (Blomhoff, 2005).
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Digitalis Digitalis purpurea congestive heart failure
Colchicine Colchicum autumnale Gout
Opium Pa paver somniferum Analgesic
Quinine Cinchona Malaria
Vinblatine Madagascar periwinkle Cancer
Etoposide Mayapple rhizome Cancer
1.6.1 Phytochemical-Regulated Signal Transduction Pathways
(Shimizu and Weinstein, 2005) Several mechanisms have been implicated in 
the cytoprotective properties of phytochemicals, including, scavenging of 
oxygen radicals and other highly reactive compounds (Blomhoff, 2005) and 
induction of detoxifying enzymes, such as phase II enzymes (Moskaug et al., 
2005). Recent studies have emphasized a third mechanism, i.e. the ability of 
several phytochemicals to modify the activities of various receptor tyrosine 
kinases (RTKs) and related downstream pathways of signal transduction (Frigo 
et al., 2002), and thereby altering the expression of genes involved in 
inflammation, cell proliferation, and apoptosis (Shimizu and Weinstein, 2005) 
(Figure1.8). The activation of membrane-associated RTKs located at the cell 
surface by specific ligands (growth factors and cytokines) plays an important 
role in the control of many cellular processes (Kyriakis and Avruch, 2001). 
MAPK pathway is a downstream effectors can be activated in response to a
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wide variety of extracellular stimuli, it has been shown that several 
phytochemicals activate MAPK (Frigo et al., 2002). The PI3K/Akt pathway is 
another important effector of the RTKs (Avruch et al., 2001), which appears to 
play a critical role in cell survival (Kim et al., 2005). The transcription factors AP- 
1 and NF-KB are critical downstream effectors of MAPK and PI3K/Akt signaling 
pathways, respectively (Schabbauer, 2004).
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Figure1.8: Signal transduction pathways involved in the function of
phytochemicals
A simplified scheme indicating how activation of of RTKs induces pathways of signal 
transduction that lead to activation of the transcription factors AP-1 and NF-KB. RTK 
are activated by specific ligands, thus leading to activation of their intrinsic tyrosine 
kinase and autophosphorylation of tyrosine residues. These activated RTKs then 
phosphorylate several downstream molecules, thus activating several signaling 
pathways. Activation of the small G protein Ras and effector proteins, such as Raf-1 
and PI3K, stimulates several intracellular processes; which includes MAPKK, and 
MEK1/2 cascade which then phosphorylates the MAPK protein ERK1/2. The other 
MAPKs JNK and p38 are mainly activated by various stress events and cytokine 
stimuli. Once activated, MAPKs can activate a variety of transcription factors. PI3Ks 
are heterodimeric lipid kinases that are composed of a regulatory (p85) and a catalytic 
(p110) subunit. Among the RTKs, HER3 is the most efficient activator of PI3K because 
this receptor contains multiple binding sites for p85. Activation of PI3K causes the 
synthesis of the lipid PIP3, which activates downstream pathways that involve Akt, 
which enhances cell survival. Akt play roles in phosphorylation and activation of the 
kinase IKK. Activated IKK phosphorylates l-KB, which triggers the degradation of l-KB. 
The loss of l-KB enhances NF-KB activity through activation of MEK1/2 and ERK1/2. 
Adatpted from (Shimizu and Weinstein, 2005).
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1.6.2 The Role of Phytochemicals in the Modulation of HO-1
The use of naturally-occurring compounds that possess intrinsic anti­
inflammatory, and antioxidant properties and which can trigger the intracellular 
protective cascades offers a promising stratagem for therapeutic applications 
(Talalay, 2005). An interesting class of agents that might fill these criteria are 
the polyphenolic compounds. The chemical structure of these compounds share 
a common basic structure, characterized by two carbons bound to two aromatic 
rings. The side chains on the aromatic rings diversify the compounds and 
influence their ability to induce HO-1 (
). In many experimental systems they have been shown to possess antioxidant, 
oxygen scavenging and anti-inflammatory properties (Pataki et al., 2002) 
(Woodman and Chan, 2004) (Alcaraz et al., 2004). HO-1 is a highly sensitive 
inducible protein that is involved in the protection of the cell against a wide 
variety of stress (Foresti et al., 2001). Thus, HO-1 can be regarded as a 
potential therapeutic target in a variety of disease conditions that are mediated 
by inflammation and oxidative stress caused by production of free radicals, such 
as, IHD, septic shock, atherosclerosis and carcinogenesis (Clark et al., 2000a; 
Scapagnini, 2004) and contributes to the modulation of inflammatory responses 
(Alcaraz et al., 2003) (Owuor and Kong, 2002; Willis et al., 1996). Therefore, the 
search for potent inducers of HO-1 pathway can be regarded as a novel 
approach for the development of therapeutic applications for different 
pathological states.
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Table 1-4: Phytochemicals as Inducers of HO-1
Compound Diet
source
Chemical structure Ref.
Curcumin tumeric O 0
H,C |  ]j | J| CM>
HO V
[186]
Chalcone hops
(X ^O
[86]
Resveratrol grapes HO
r^ ~^ -Cy~0"HO ^
[55]
Quercetin apples
X X X ^ 0H
OH 0
[153]
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1.6.3 Hypothesis and Aims 
The hypothesis of this thesis is:
Increased haem oxygenase activity and induction of HO-1 protein expression by 
polyphenolic compounds offer protection to cardiovascular tissue against 
oxidative stress and inflammatory insults.
To verify this theory a number of objectives were set:
(i) Establish that two plant-derived phytochemicals, 2-HC and curcumin 
activate the haem oxygenase pathway in different cardiovascular 
tissues, i.e., vascular endothelial cells, macrophages and cardiac 
cells.
(ii) To verify that preconditioning of cells with 2-HC and curcumin protect 
cardiovascular cells against inflammation and oxidative stress.
oii) Dissect the mechanisms and identify possible molecular targets that 
lead to the HO-1 induction in response to 2-HC.
(iv) Utilise CO, an end product of the haem oxygenase pathway, as an 
effective means to counteract inflammatory stress.
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2 MATERIALS AND METHODS
2.1 Reagents and Solutions
Haemin (ferriprotoporphyrin IX chloride) and tin protoporphyrins (SnPPIX) were 
obtained from Porphyrin Products INC (Logan, Utah, USA). 2-HC was 
purchased from INDOFINE chemical company INC (Belle Mead, NJ 08502). 
Polyclonal antibodies for HO-1 were purchased from (Stressgen 
Biotechnologies Corporation, Victoria, BC, Canada), polyclonal antibodies for 
iNOS, NF-KB and Nrf2 were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA, U.S.A.). All other reagents were purchased from Sigma unless 
otherwise specified. Celsior solution was obtained from IMTIX SANGSTAT 
(Lyon, France). Stock solutions of different reagents were prepared in different 
solvents according to manufacturers’ instructions. Curcumin and 2-HC were 
prepared in ethanol. Lipopolysaccharide (LPS-E. coli serotype 026:B6) was 
obtained from Sigma and the stock solution was prepared in phosphate buffer 
solution (PBS). CO-Releasing Molecules (CO-RMs) are synthesized on regular 
basis (in house) by collaborators of our group, (CORM-43 and CORM-319) 
were obtained from Brian E. Mann, Department of Chemistry, University of 
Sheffield, Sheffield. CORM-43 and CORM-319 were freshly prepared as 10 mM 
stock solution in distilled water (dH20). CORM-43 and CORM-319 were 
inactivated by adding cell culture medium to the compounds and leaving the 
solution for 24 h at 37°C in a 5% CO2 humidified atmosphere to liberate CO. 
The inactive CORM-43 and CORM-319 (iCORM-43 and iCORM-319) solutions 
were finally bubbled with nitrogen to remove the residual CO present in the
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solution. Haemin was dissolved in 0.1 M NaOH and 0.01 M PBS pH 7.4. SnPPIX 
was prepared by dissolving the compound in 0.1 M NaOH and dH20.
2.2 Cell Culture
2.2.1 Preparation and Maintenance of Cells
In this thesis, commercially available cell lines were used instead of a primary 
cell lines because of their convenience, and because the primary cultures are of 
mixed nature, and have a limited culture lifespan and have potential 
contamination problems. In contrast, the cell lines are more stable and less 
labour intensive to maintain. Admittedly, the advantages of primary cultures are 
that the cells have not been modified in any way (other than by enzymatic or 
physical dissociation by trypsin). The following cell lines were used in the 
experiments documented in this thesis: RAW 264.7murine macrophages and 
human cardiomyocytes (Girardi) were purchased from European Collection of 
Cell Cultures (ECACC) (Salisbury, Wiltshire, UK). Bovine Aortic Endothelial 
Cells (BAEC) were purchased from Coriell Cell Repositories (Camden, NJ, 
U.S.A.). The cells were received in the frozen state, in a 1 ml vial containing a 
cryoprotectant (DMSO). Upon receipt of cells, they were quickly thawed in a 
water bath at 37°C, the medium containing the cryoprotectant was removed and 
replaced with fresh complete medium. The contents were transferred carefully 
to a 25 cm2 cell culture flask (Sarstedt Ltd., Leicester, UK) containing 6 ml of 
complete medium. The flask was incubated at 37°C in an incubator in a 95% 02, 
5% CO2 environment. Subsequent medium changes took place every two days. 
The cells were grown in specific culture medium as outlined in Table 2-1.
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Table 2-1: The culture medium of the different cell types
Cell type Media FBS
(%)
L-glutamine
(mM)
Penicillin- 
Streptomycin (U/ml)
Additives
Girardi DMEM 10 3.5 mM 100 1% NEAA
Raw 267.4 DMEM 10 2 mM 100 Nil
BAEC ISCOVES’ 10 2 mM 100 Nil
*NEAA = non essential amino acids
Foetal bovine serum (FBS, 10%) was added to the medium, Dulbecco's 
modified Eagle's medium (DMEM) or ISCOVES’, in addition to 100 U/ml 
penicillin, 0.1 mg/ml streptomycin and (2-3.5) mM L-glutamine (Fluka 
Biochemika). Confluent cells were incubated with different reagents in 75 cm2 
flasks or 24 well plates in a final volume of 10 ml or 1 ml, respectively, of fresh 
complete DMEM. Cells were grown in 75 cm2 tissue culture flasks and kept at 
37°C in a 5% C 02 humidified atmosphere. For hypothermia experiments, cells 
were kept in a temperature-controlled incubator (Sanyo MIR-153) and flushed 
with gas composed of 21% 0 2, 5% C 02.
2.2.2 Subculturing of Cells
In order to maintain the cell line, cells were subcultured every 3-4 days till they
reached about 70%-80% confluence. The old medium was discarded and
replaced with 10 ml of warm sterile phosphate buffered saline (PBS) (10X)
(Invitrogen Life Technologies Ltd.). After a brief wash the latter was removed
and replaced with 4 ml of warm 0.25% (w/v) trypsin-0.02% (w/v)
ethylenediaminetetraacetic acid (EDTA) solution. The flasks were then placed in
the incubator for few minutes to allow the trypsin to detach the cells from the
base of the flask and each other. The contents of the flasks were transferred
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carefully to individual 15 ml tubes containing 7 ml of warm (37°C) fresh DMEM. 
After centrifuging (500 xg) for 5 min at room temperature in a bench-top 
centrifuge (MSE Harrier 15/80, Sanyo Gallenkamp Pic., Leicestershire, UK). 
The supernatant was discarded and the pellets were resuspended gently in 
sufficient DMEM to prepare a new set of flasks, with a final volume 10 ml, in a 1 
to 3 ratio. The flasks were returned to the incubator to allow the cells to grow. 
Cells were subcultured until certain passage number (25 for BAEC and RAW 
264.7 macrophages, and 230 for Girardi cells), after which time a new batch of 
cells was subcultured.
2.2.3 Collection of Cells
For this procedure, all reagents and collecting tubes (15 ml) were kept on ice. At 
the end of an experiment, the medium was discarded and cells were washed 
with 10 ml of ice-cold non-sterile PBS (10X). After a brief wash the latter was 
discarded and replaced with 5 ml of ice-cold PBS (1X) (PBS 10 X diluted 1:10 
with dH20). Cells were then gently scraped from the base of the flasks with a 
plastic scraper (Sarstedt Ltd.) The mixture was then transferred to pre-labelled 
collecting tubes. A further 5 ml of PBS (1X) was added to each flask to collect 
any residual cells and then transferred to its respective tube. The tubes were 
centrifuged (500 g) for 5 min at 4°C to pellet the cells, the supernatants were 
discarded. Cell pellets requiring haem oxygenase activity analysis were 
resuspended in 550 pi of phosphate buffer (2 mM MgCI2 and 100 mM KH2P0 4 , 
pH 7.4). Samples for HO-1 protein analysis were resuspended in 150 pi of PBS 
(pH 7.4), containing 1% (v/v) Triton X-100 to lyse the cells. Samples for RNA 
extraction were suspended in PBS 1 X, samples were dissolved fully using a 
bench-top vortexor and stored at '80°C until required for analysis.
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2.3 Cytotoxicity and Cell Metabolism Assays
2.3.1 Cell Metabolism Assay
The oxidized blue, non-fluorescent Alamar Blue is reduced to a pink fluorescent 
dye in the medium by cell activity. Likely to be by oxygen consumption through 
metabolism or as now being suggested, reduced by mitochondrial enzymes 
(Nakayama et al., 1997) but it is not known whether this occurs intracellularly, at 
the plasma membrane surface or just in the medium as a chemical reaction 
(Ahmed et al., 1994). Cell metabolism was determined using a colorimetric 
viability assay kit (Serotec, Kidlington, Oxford, U.K.). The Alamar Blue stock 
solution was diluted 1:10 (v/v) in the culture medium according to the 
manufacturers’ instructions. Cells were subcultured in a 24-wells plate, at the 
end of the experiment, after cells had been treated with various reagents, the 
medium was washed, and 1000 ml of the Alamar Blue dilutions was added into 
each well and left in the incubator at 37°C for 5 hours, or until a colour change 
was seen. The absorption at 570 and 600 nm was read in a microtitre plate 
reader (VersaMax. Molecular Devices U.K), the relative metabolic activity was 
determined by subtracting the absorbance measured at 600 nm from the 
absorbance at 570 nm.
2.3.2 LDH Assay
Lactate dehydrogenase (LDH) is a cytosolic enzyme present within all 
mammalian cells; the normal plasma membrane is impermeable to LDH, but 
damage to the cell membrane results in a change in the membrane permeability 
and subsequent leakage of LDH into the extracellular fluid (Abou El Hassan et 
al., 2003). In vitro release of LDH from cells correlates with the amount of cell
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death and membrane damage and provides an accurate measure of cell 
membrane integrity and cell viability (Baudin et al., 1996). Extracellular LDH 
activity was measured using a cytotoxicity detection kit (Roche), according to 
manufacturer’s instructions. At the end of the period of incubation, cell 
supernatant was collected; any cell residue is removed by centrifugation at 250 
g. The reaction mixture (which is composed of the catalyst and the dye solution) 
was then added to the cell-free supernatant, incubated for 15 minutes, and then 
the absorbance was measured at 490 and 600 nm. Cellular LDH activity was 
determined after lysis of the cells with Triton X-100 (1% in DMEM at 25°C). 
Released LDH was expressed as percentage of total LDH activity.
2.3.3 Trypan Blue Assay
Trypan Blue is a dye, its reactivity is based on the fact that the dye is negatively 
charged and does not interact with the cell unless the membrane is damaged 
(Carpentier et al., 1981). Therefore, all the cells which exclude the dye are 
viable (Filman et al., 1975), cells were seeded in 6-well plates at 1 * 104 
cells/well, and then after each treatment, cells were trypsinized, and centrifuged 
to produce cell pellet. Cells were suspended in culture medium and pipetted up 
and down several times to ensure a uniform cell suspension. 1:1 dilution of the 
cell suspension and Trypan Blue solution (0.4% in PBS) was prepared (cell 
suspension combined with the Trypan Blue solution). To obtain an accurate cell 
count, a uniform suspension containing single cells is necessary. The cell 
suspension was pipetted up and down in the tube 4-5 times. After 1-2 min 
incubation with Trypan Blue, the number of dead cells, which retained the dye, 
was compared to the total number to calculate the percentage of dead cells, 
using a haemocytometer. Both the counting chambers of the haemocytometer
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were loaded with the 10 |jl of the diluted cell suspension using a micropipette 
and tips, cell suspension was allowed to fill the space by capillary action. The 
number of viable cells harvested from each 6-well plate was obtained by the 
following equation: UC * D * 104/SQ, where UC = unstained cell count (viable 
cells), D = dilution of the cell suspension, and SQ = number of squares of the 
haemocytometer counted. The viability percentage of the cell population of each 
6-well plate was obtained by the following equation: UC/TC * 100, where UC = 
unstained cell count (viable cells) and TC = total cell count (stained plus 
unstained cells). {Freshney, R. (1987) Culture of Animal Cells: A Manual of 
Basic Technique, p. 117, Alan R. Liss, Inc., New York}.
2.4 Biochemical Assays
2.4.1 Protein Determination in Cells
The DC Protein Assay kit (Bio-Rad Laboratories Ltd., Hemel Hempstead,
Hertfordshire, UK) was used to determine protein concentration. A standard
curve was prepared using serial dilutions (0 to 2.8 mg/ml) of a bovine serum
albumin (BSA) standard (Bio-Rad Laboratories Ltd.), prepared in triplicate, in
phosphate buffer (pH 7.4). The absorbance readings at an optical density of
750 nm (OD750) were plotted against their respective protein standard
concentrations (Figure 2.1) for a representative plot. The procedure for protein
determination in cell and tissue samples was performed as follows. A 100 pi
aliquot of the cell suspension and a blank of phosphate buffer or PBS Triton X-
100 were added to 10 ml polystyrene tubes (Sarstedt Ltd.). When tissue
samples were used, the aliquot was diluted 1:10 in phosphate buffer (pH 7.4).
To each tube, 500 pi of A’ (20 pi of Reagent S per ml of Reagent A) was added,
then vortexed briefly without frothing. Next, 4 ml of Reagent B was added to
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each tube, mixed well then left at room temperature for 20 min before reading 
the OD750 against the blank using an UVikon 81 OP spectrophotometer 
(Tegimenta AG, Switzerland). A numerical value (mg/ml) for the protein 
concentration in the unknowns was derived by multiplying the respective OD750 
by the slope of the standard curve (Figure 2.1). Serial dilutions of bovine serum 
albumin (BSA) (0-2.8 mg/ml) were prepared. The OD750 was plotted against its 
respective protein concentration.
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Figure 2.1: Representative standard curve for protein determination
O D 750x Slope of standard curve
Equation 2-1: Calculation of protein concentration
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2.4.2 Preparation of Liver Cytosol and Liver Microsomes
A male Sprague Dawley rat (250-300 g) was used as a source of liver cytosol, 
following sacrifice by anaesthetization with phenobarbitone Lethobarb® sodium 
BP (500 pi, i.p.) and cervical dislocation, liver cytosol was prepared as 
previously described (Motterlini et al., 1996). A 50 ml syringe was used to 
perfuse cold (4°C) buffer (1.15% (w/v) KCI) through the liver lobes to remove 
any residual blood, while clotted tissue was discarded. The organ was weighed, 
finely chopped with scissors and homogenised in 2-3 volumes of homogenising 
buffer (20 mM Tris-HCI, pH 7.4, containing 1.15% (w/v) KCI), followed by 
partition among a set of polyallomer centrifuge tubes (Beckman Coulter Ltd., 
High Wycombe, UK). After centrifuging (5,000 g) for 20 min at 4°C in a 
refrigerated ultracentrifuge (Optima LE 80, Beckman Instruments, Palo Alto, 
California, USA), the supernatant was retained and recentrifuged (105,000 g) 
for 90 min at 4°C. Following each centrifugation, the lipid layer was removed 
with a Pasteur pipette. The supernatant was collected, then aliquoted and 
stored at-80°C.
The preparation of liver microsomes is similar to that for liver cytosol with the 
following variations. The rat was pre-treated with haemin (50 mg/kg, i.p.) 24 h 
beforehand to induce haem oxygenase activity. The lobes were perfused with 
cold (4°C) saline (0.9% (w/v) NaCI) and homogenised in 5 volumes of sucrose 
solution (0.25 M sucrose, 0.05 M Tris-HCI, pH 7.4) then centrifuged. After the 
last centrifugation step, the resulting microsomal pellet was resuspended gently 
in 1 ml of phosphate buffer (pH 7.4) and followed by storage at '80°C to be later 
used in the haem oxygenase activity.
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2.4.3 Determination of Haem Oxygenase Activity
Stock solutions of the assay reagents, i.e., glucose-6-phoshate (G6P) (20 mM), 
glucose-6-phoshate dehydrogenase (G6PDH) (50 U/ml) and NADPH (40 mM), 
were prepared with phosphate buffer (pH 7.4) and stored at '80°C until required. 
Haemin (2 mM) was prepared freshly for each assay as described in section 
2.1. Rat liver cytosol and liver microsomes were prepared according to section 
2.4.2. Samples were disrupted by three rounds of freeze-thawing ('80° to 37°C). 
To a set of glass tubes, which were kept on ice, the cell suspension (400 pi) 
was added to the reaction mixture (final volume, 900 pi) containing: phosphate 
buffer (pH 7.4), 25 pM haemin, 2 mM G6P, 0.5 U/ml G6PDH, 3 mg of rat liver 
cytosol, as a source of biliverdin reductase, and 0.8 mM NADPH. The negative 
and positive controls (rat liver microsomes) contained proportionate volumes of 
phosphate buffer (pH 7.4) instead of cell suspension. The tubes were vortexed 
and incubated in the dark for 1 h at 37°C. The reaction was terminated by 
addition of chloroform (1 ml), followed by thorough vortexing and centrifuging 
(200 g) for 5 min at room temperature until three distinct layers were formed. 
Using a quartz cuvette and the UVikon 81 OP spectrophotometer, the 
absorbance (at 464 nm and 530 nm) of the lower layer, which contains bilirubin 
(extinction coefficient (e) for bilirubin in chloroform, 40 mM'1cm'1), was read 
against a blank of chloroform. Haem oxygenase activity was expressed as Pico 
moles of bilirubin formed/mg protein/h using Equation 2-2.
pmoles bilirubin 
mg protein in 60 min
AOD (OD464 - OD530) 
40
rnig protein x  1 0 f
Equation 2-2 Calculation of haem oxygenase activity
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2.4.4 Determination of Nitrite Levels
Determination of nitrite (NO2') can give an indication of the level of NO 
produced by the cells. Cells were subcultured in 24-well plates, when confluent; 
cells were exposed to LPS 1 pg/ml in the presence or absence of different 
reagents. Nitrite production was determined as described previously (Sawle et 
al., 2005). At the end of the experiment, 50 pi of each serial dilution and 50 pi of 
medium from each well were transferred into a 96-well plate (NUNC A/S Kam 
strupvej 90, Roskilde, Denmark). 50 pi of Greiss reagent (125 mg of 
sulphanilamide and 12.5 mg of N-1-naphtyl ethylenemine dihydrochloride 
dissolved in 8.65 ml of dhhO and 1.35 ml HCI) was then added to the samples 
and to the serial dilutions of the standard. The wells were then shaken for 10 
minutes on a shaker (AM69 microshaker, from Cooke microtiter system, ZUG, 
Switzerland ).The absorbance was read at 550 nm using a plate-reader 
(VERSA max microplate reader from Molecular Devices). To prepare the serial 
dilutions for a standard curve, 6.5 mg of sodium nitrite (NaN02) was dissolved 
in 10 ml of dhhO to give a 10 mM stock solution of NaN02. It was dissolved 1 in 
10 in warm DMEM to give a 1 mM concentration of NaN02 and then serial 
dilutions of the 1 mM NaN02 were prepared with DMEM to give a final volume 
of 1 ml.
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Figure 2.2 : Standard curve for nitrite determination 
2.4.5 Determination of CO Release f
The release of CO from CORM-43, CORM-319 and their inactive forms was 
assessed spectrophotometrically by measuring the conversion of 
deoxymyoglobin (deoxy-Mb) to carbonmonoxy myoglobin (MbCO) as previously 
described (Motterlini et al., 2002a). The amount of MbCO formed was quantified 
by measuring the absorbance at 540 nm (extinction coefficients 5.4 mmol/L-1 ■ 
cm-1). Myoglobin solutions (66 pmol/L final concentration) were prepared fresh 
by dissolving the protein in 0.04 mol/L phosphate buffer (pH 6.8). Sodium 
dithionite (0.1%) was added to convert myoglobin to deoxy-Mb prior to each 
reading. In contrast, CO released from both CORMs (CORM-43 and CORM- 
319) was quantified by adding aliquots of stock solutions (10 pL) of the carbonyl 
complex in water directly to the myoglobin solution. All the spectra were 
measured using a Helios a-spectrophotometer.
* Measurement of CO release was kindly performed by Mr. Philip Sawle.
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2.5 Molecular Biology Procedures
2.5.1 Determination of TNF-a
The levels of TNF- a present in samples was determined using a commercially 
available kit from R&D Systems (Abingdon, U.K.). The assay was performed 
according to the manufacturers' instructions, as previously described (Sawle et 
al., 2005). Briefly, cell culture supernatants were collected immediately after the 
treatment and spun at 2000 g for 2 min to remove any particulates. 50 pi of the 
standard, the standard curve is demonstrated in Figure 2.3, and the samples 
was added to a 96-well plate pre-coated with affinity-purified polyclonal 
antibodies specific for mouse TNF- a and left to react for 2 hours, followed by a 
thorough wash using the wash buffer to remove any unbound antibody-enzyme 
reagent. Followed by incubation with 100 pi for 2 hours of mouse conjugate, 
100 pi of the substrate solution was then added to each well and left for 30 
minutes to allow the colour to develop. Finally, stop solution was added and the 
optical density was measured. The colour density was detected at 450 nm 
(correction wavelength 570 nm) as proportional to the amount of TNF-a 
produced. The standard curve was created using Prism software capable of 
generating a four parameter logistic (4-LP).
82
MATERIALS AND METHODS
TNF-a (pg/ml)
Figure 2.3: Standard curve for the determination of TNF-a level
2.5.2 Determination of Interleukin-10 (IL-10) Levels
IL-10 present in each sample was determined using commercially available kit 
from R&D Systems. The assay was performed according to the manufacturers' 
instructions. Briefly, cell culture supernatants were collected immediately after 
the treatment and spun at 2000 g for 2 min to remove any particulates. 50 pi of 
the standard, and the samples were added to a 96-well plate pre-coated with 
affinity-purified polyclonal antibodies specific for the mouse IL-10 and left to 
react for 2 hours, followed by a thorough wash using the wash buffer to remove 
any unbound antibody-enzyme reagent, followed by incubation for 2 hours with 
100 pi of mouse conjugate, 100 pi of the substrate solution was then added to 
each well and left for 30 minutes to allow the colour to develop. Finally, stop 
solution was added and the optical density was measured. The colour density 
was detected at 450 nm (correction wavelength 570 nm) as proportional to the 
amount of IL-10 produced. The standard curve was created using Prism 
software capable of generating a four parameter logistic (4-LP).
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Figure 2.4: Standard curve for the determination of IL-10 levels 
2.5.3 Preparation of Nuclear Extracts
For the determination of the translocation of Nrf2 and NF-KB, nuclear extracts 
were prepared as previously described (Balogun et al., 2003b) (Naughton et al.,
2002). Cells were washed twice with PBS (1X), then harvested in 1 ml of PBS 
(1X) followed by centrifugation (800 g) for 3 min at 4°C. The resulting pellet was 
then resuspended carefully in 200 pi of cold Buffer A (10 mM HEPES (pH 7.9), 
10 mM KCI, 0.1 mM EDTA, 0.1 mM EGTA, to a final volume 950 pi, followed by 
10 pi of 0.1 M dithiothreitol (DTT) and 40 pi of protease inhibitor cocktail. Next, 
pellets were placed on ice for 15 min to allow cells to swell, and then 15 pi of 
10% Nonidet P-40 was added, followed by a 10 sec vortex-mix and centrifuging 
(800 g) of the resulting homogenate for 3 min at 4°C. The supernatant was 
discarded and the nuclear pellet was resuspended in 30 pi of cold Buffer B (20 
mM HEPES (pH 7.9), 0.4 M NaCI, 1 mM EDTA, 1 mM EGTA, 10 pi of 0.1 M 
DTT and 40 pi of complete protease inhibitor cocktail. The pellet was placed on 
ice for 15 min and vortex-mixed for 10-15 sec every 2 min. After a final
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centrifugation (15000 g) for 5 min at 4°C the supernatant, which contains the 
nuclear proteins, was retained and stored at -80°C freezer until further analysis 
of Nrf2 and NF-KB, p-actin was used as an internal control for loading, fc-Actin, 
once thought to be an exclusively cytoplasmic protein, is now known to have 
important functions within the nucleus (Olave et al., 2002). Nuclear fc-actin 
associates with and functions in chromatin remodeling complexes, ribonucleic 
acid polymerase complexes, and at least some ribonucleoproteins (McDonald et 
al., 2006), and therefore (J-Actin is suitable as a loading control for nuclear 
extracts (Ishii et al., 2000).
2.5.4 HO-1 and PI3K siRNA Transfection
RNA Interference (RNAi) is one of the most exciting discoveries of the past 
decade in functional genomics. RNA interference is the biological mechanism 
by which double-stranded RNA (dsRNA) induces gene silencing by targeting 
mRNA, resulting in a reduction in the expression of a particular gene in 
mammalian cell systems (Nencioni et al., 2004). It is clear that RNAi has rapidly 
become an important research tool for gene silencing. Long double-stranded 
RNAs (dsRNAs) can be used to silence the expression of target genes in a 
variety of organisms and cell types (Zhang et al., 2004). Upon introduction, the 
long dsRNAs enter a cellular pathway that is commonly referred to as the RNA 
interference (RNAi) pathway. The dsRNAs are processed by an RNase-like 
enzyme (Dicer) into small interfering RNAs (siRNAs). Then, the siRNAs 
assemble into endoribonuclease-containing complexes known as RNA-induced 
silencing complexes (RISCs). Activated RISCs subsequently bind to 
complementary transcripts by base pairing interactions and cause gene 
silencing (Figure 2.5).
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Figure 2.5: Overview of RNA Interference
Upon introduction of the dsRNAs into the cell, they are processed by an RNase-like 
enzyme (Dicer) into small interfering RNAs (siRNAs). The siRNAs assemble into 
endoribonuclease-containing complexes known as RNA-induced silencing complexes 
(RISCs). Activated RISCs subsequently bind to the transcripts and cause cleavage of 
mRNA leading to gene silencing. Adapted from www.sirna.com
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SiRNA kit was purchased from Santa Cruz Biotechnology and the transfection 
was performed according to manufacturers’ instructions. Confluent cells were 
grown in 12-well dishes in DMEM containing 10% FBS without antibiotics 
overnight to get results of 60-80% confluency. The transfection mixture was 
prepared in 0.5 pi sterile Eppendorf tubes. Mixture A was prepared as follows:
3.6 pi of the appropriate siRNA or the scrambled siRNA, which are non-specific 
sequence which does not interfere with any gene, was added to 40 pi of siRNA 
transfection medium, the mixture was then kept at room temperature for 5 
minutes. Mixture B was prepared by adding 2.4 pi of siRNA transfection reagent 
to 40 pi of siRNA transfection medium, and was kept at room temperature for 5 
minutes. Mixture A and B were then combined to form siRNA-siRNA 
transfection reagent complex, mixed gently and then incubated at room 
temperature for 20 minutes. After the incubation period, 0.32 ml of siRNA 
transfection medium was added to each tube containing the siRNA-siRNA 
transfection reagent complex. Just prior to transfection, the growing medium 
was aspirated and cells were washed once with 1 ml of siRNA transfection 
medium and then removed. The diluted siRNA-siRNA transfection reagent 
complex was then overlaid onto the washed cells and incubated at 37° C for 5-7 
hours. After incubation, 0.4 ml of normal growth medium containing twice the 
normal concentrations of FBS and antibiotics was added to each well containing 
transfected cells without removing the transfection mixture and incubated for an 
additional 24 hours. Once incubation was complete, transfection medium was 
replaced with fresh normal growth medium and the appropriate reagent was 
then added to incubate for the appropriate time point. Cells were then collected 
for Western blotting, other biochemical assay and ELISA.
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2.5.5 Western Blot Analysis
Total protein of each sample was calculated as described in section 2.4.1. 
Appropriate volumes of each sample were combined with loading buffer 
(Laemmli buffer, obtained from Bio-Rad Laboratories Ltd., containing 5% (v/v) 
p-mercaptoethanol) to a give a total volume 30 pi, so that the final concentration 
loaded onto each lane was equal to 30 pg. The HO-1 positive control (Bio- 
Quote Ltd., York, UK) was diluted to 1 pg/ml in loading buffer. Samples were 
pulsed for 20-30 sec on a bench-top microcentrifuge (MSE Microcentaur, Sanyo 
Gallenkamp Pic., Leicestershire, UK) followed by denaturing of the proteins for 
10 min at 90oC on a heating block (Techne DB2A, Techne GmBH, Germany). 
The molecular weight marker (MWM) (Invitrogen LifeTechnologies Ltd.) was not 
heated. After heating, the samples were re-pulsed and 30 pi of samples, 
positive control, and MWM (10 pi) was loaded carefully using gel loading tips 
(Fischer, UK) into the wells of a (12% tris-glycine Ready gel for HO-1, Nrf2 and 
NF-KB, or 7.5% for iNOS protein analysis) (Bio-Rad Laboratories Ltd.). 
Electrophoresis was carried out at room temperature in a tank containing 
running buffer (0.025 M Tris, 0.192 M glycine, 0.1% (v/v) SDS) (Fischer, UK) 
using the Mini-PROTEAN® II system and Power-Pac 300 power supply 
(Bio-Rad Laboratories Ltd.) at a constant voltage of 125 V until the loading 
buffer had migrated to, but not beyond the base of the gel. The subsequent 
procedures were carried out using the Mini Trans-Blot® electrophoretic transfer 
cell (Bio-Rad Laboratories Ltd.). While the gel was running appropriately sized 
sheets of nitrocellulose membrane (Amersham Biosciences UK Ltd., Little 
Chalfont, Buckinghamshire, UK) and 3MM Whatman™ blotting paper were cut 
and pre-soaked in dH20 and cold (4oC) transfer buffer (0.025 M Tris, 0.192 M
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glycine, 0.1% (v/v) SDS, 20% (v/v) methanol) for 10 and 5 min, respectively. 
After electrophoresis was completed a ‘gel sandwich’ (Figure 2.6) was prepared 
upon the clear (positive electrode) side of a gel cassette. After removing any air 
bubbles the cassette was closed securely via the latch and placed into the 
electrode module with the black (negative electrode) side facing the black panel 
of the module. This orientation ensures the proteins migrate from the gel onto 
the nitrocellulose membrane and not into the transfer buffer while transferring. 
Overnight transfer was carried out at 4°C with a constant voltage of 30 V using 
a transfer unit (Bio-Rad Laboratories Ltd).
Gel
Whatman paperNitrocellulose
Positive electrode Negative electrode
Foam pads
Figure 2.6: Arrangement of gel sandwich assembly
All subsequent procedures were performed at room temperature on an orbital 
shaker (Denley Instruments Ltd., Sussex, UK) at low speed. Non-specific 
binding of the antibodies was prevented by incubating the membrane in 
blocking solution (5% (w/v) non-fat dried milk in PBS (0.01 M phosphate buffer, 
pH 7.4, containing 0.2% Tween-20) for 2 h at room temperature, followed by a 
single 5 min wash with 10 ml of PBS (pH 7.4). The membrane was then 
incubated for 2 h with anti-HO-1 (Stressgen Biotechnologies Corporation, 
Victoria, BC, Canada) anti-Nrf2, or anti-NF-KB (Santa Cruz Biotechnology,
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Santa Cruz, CA, USA) and p-actin (Abeam) primary antibodies, in tris buffered 
saline (TBS) (0.05 M Tris-HCI, 0.0037 M KCI, 0.7137 M NaOH, pH 7.4). Next, 
the membrane was washed three times, once with PBS-T (PBS 0.01 M, pH 7.4, 
containing 0.05% (v/v) Tween 20), then twice with TBS (pH 7.4). Proteins were 
visualised using an ExtrAvidin® alkaline phosphatase staining kit (Sigma). The 
biotinylated anti-rabbit IgG antibody, diluted 1:1000 in TBS (pH 7.4), was 
incubated with the membrane for 1 h. The membrane was washed three times 
with TBS (pH 7.4) and the ExtrAvidin® alkaline phosphatase conjugate, diluted 
1:1000 in TBS (pH 7.4) applied for 1 h. The three washes with TBS (pH 7.4) 
were repeated. After the last wash, a freshly prepared substrate solution (9.8 ml 
of 0.1 M Tris buffer, pH 8.2, containing 200 pi of 1% (w/v) Napthol-AS-BI 
phosphate in N-N-N-dimethyl formamide and a 10 mg Fast Red DT salt tablet) 
was incubated with the membrane until red/pink bands, which indicates the 
location of the antigen-antibody complexes of the protein on the nitrocellulose 
membrane, were observed. After maximal colour change was attained (after 10 
minutes) any excess substrate solution was washed off with dH2 0  and the 
membrane stored in foil, until scanned using photoshop software.
2.5.6 Isolation and Determination of Total HO-1 mRNA
In order to maintain the integrity of the ribonucleic acid (RNA) and prevent 
contamination or degradation by RNases (enzymes that degrade RNA) a 
number of precautions were taken: all glassware were sterilised and the 
equipment and solutions were washed and prepared with dH2 0  which was pre­
treated with diethyl pyrocarbonate (DEPC). The latter was prepared by adding 
DEPC (0.5 ml/litre) to dH20, within pre-autoclaved glass bottles, shaking
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vigorously to mix, followed by baking at 40°C for 24 h. The water was cleaned 
of any remaining DPEC by autoclaving at 121°C for 25 min.
After being treated, cells were harvested as mentioned in section 2.2.3. Cells 
were then resuspended in 1X PBS, transferred into 1.5 ml Eppendorf tubes, and 
kept in the ‘80°C freezer until being used for RNA extraction. RNA isolation was 
performed using Purescript® RNA Isolation Kit (Gentra, Minneapolis, MN 55441 
USA). RNA isolation was performed according to the manufacturers’ 
instructions. Briefly, cells were centrifuged at 13,000-16,000 g for 5 seconds; 
the supernatant was removed with a pipette leaving behind a visible cell pellet 
and 10-20 pi of residual liquid. The pellets were then vortexed vigorously to 
resuspend the cells in the residual supernatant, 300 pi of the cell lysis solution 
was added, and pippetted up and down for 3 times to lyse the cells. 100 pi of 
the protein precipitation solution was then added to the cell lysates, the tubes 
containing the cell lysate were gently inverted 10 times and then placed into ice 
for 5 minutes before being centrifuged at 13,000 g for 3 minutes. The 
supernatant (containing the RNA) was poured into a clean 1.5 ml Eppendorf 
tube containing 300 pi 100% propan-2-ol. The samples were then gently 
inverted 50 times, after which they were centrifuged at 13,000 g for 3 minutes; 
the supernatant was discarded, leaving the RNA as a small pellet. The pellets 
were then washed using 300 pi of 70% ethanol, the samples were centrifuged 
at 13,000 g for 1 minute and the ethanol was poured off gently. The tubes 
containing the RNA pellets were then inverted to drain and air dry for 30 
minutes and the RNA was resuspended with15 pi of RNA hydration solution, 
samples were then kept in the '80°C freezer until needed.
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The RNA concentration was determined spectrophotometrically with 3 pi of 
each sample diluted in 97 pi of DEPC water. The absorbance was read at 260 
nm and 280 nm against a blank of DPEC water using a UV-visual 
spectrophotometer (Helios a, Unicam Ltd., Cambridge, UK). The total RNA 
concentration of the entire sample was derived from Equation 2-3. The quality of 
the extracted RNA was based on the ratio of the readings at OD26o/OD28o. A 
ratio of 1.6-1.8 indicates good quality while anything less that 1.6 signifies that 
the sample contains DNA instead of RNA.
OD260 x  4 = RNA(pg/pJ)
Equation 2-3 Calculation of total RNA concentration
2.5.7 Reverse Transcriptase-polymerase Chain Reaction (RT-PCR) 
Analysis of HO-1 mRNA
Having isolated and calculated the total RNA concentration as described above, 
sufficient DPEC water was added to each sample so that a final concentration 
of 500 ng RNA was obtained. The RT reaction was carried out in a 50 pi 
reaction volume using Ready-To-Go™ RT-PCR Beads (Amersham Biosciences 
UK Ltd., UK) in 0.2 ml tubes. Each bead contains all the reagents necessary for 
the reaction (i.e. Moloney murine leukaemia virus (M-MuLV) RT in 1.5 mM 
MgCI2, Taq DNA polymerase and RNase inhibitor) except primers. To each 
reaction tube 35 pi of DPEC water was added and left for 5-10 min to dissolve 
the beads. Next, 5 pi of first strand primer (pd (N) 6 random hexamer primers) 
and 2 pi of sample was added to each tube and mixed by gentle pipetting. A 50
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[j| aliquot of mineral oil was added onto the latter mixture to prevent exposure to 
air and RNAase. Then the tubes were placed in a UNO II thermal cycler 
(Biometra Ltd., Maidstone, Kent, UK) and underwent RT denaturation for a 
duration of 20 min (15 min at 42 °C and 5 min at 95°C). The RT reaction was 
amplified by PCR, for this 8 pi of primer mixture (2 pi) of the primers ( 
)•
Table 2-2: the sequence of the primers
HO-1 sense AGT ATC CTT GTT G AC AC G G C
HO-1 antisense GTTAGACCAAGGCCACAGTG
GAPDH sense GGAGTCAACGGATTTGGT
GAPDH antisense GT GAT G G G ATTT C C ATT G
The primers were placed in 152 pi of DPEC water added under the mineral oil, 
the second cycle parameters consisted of a 30 sec denaturing step at 94°C, a 
30 sec annealing step at 60°C and a 1 h 30 min extension step at 68°C. A total 
of 26 cycles were used per amplification and the annealing temperature for HO- 
1 and GAPDH was 65°C. In the mean time a 1.5% agarose gel (1.5 g of 
agarose in 100 ml of 0.5% TBE buffer (10 mM Tris-HCI, 1 mM EDTA), 
containing 0.5 pg/ml of ethidium bromide (EB) was prepared. The gel was 
poured into a gel casting mould and pre-run for 10 min at 120 V in a tank 
containing 0.5% TBE buffer. After completion of the PCR the samples were 
placed on ice while prepared for running on the gel. To a fresh set of Eppendorf
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tubes 3 pi of loading buffer and 10 pi of sample (taken from below the mineral 
oil layer) was added and mixed by gentle pipetting. A molecular weight marker 
(5 pi of 100 base pair PCR ladder, 5 pi of DPEC water and 3 pi of loading 
buffer) was prepared in parallel. Aliquots (13 pi) of samples and molecular 
weight marker were carefully loaded into their respective wells, their loading 
order recorded, and the gel was run at 120 V for about 1-1.5 h. The PCR 
products were visualised using a UV dual-intensity transilluminator TM 20 (UVP, 
Genetic Research Instrumentation Ltd., Dunmow, Essex, UK) and 
photographed using a Polaroid DS 34 camera with a DS H-8 hood (Polaroid UK 
Ltd., St Albans, Hertfordshire, UK) and Polaroid film (Type 667) with a No. 15, 
deep yellow filter.
2.6 Statistical Analysis
Statistical analysis was performed using one-way analysis of varience (ANOVA) 
combined with Bonferroni test. Data were presented as mean ± SEM and 
differences were considered significant at P < 0.05. All calculations were 
performed using a commercially available statistical package (GraphPad Prism 
version 4 for Windows, GraphPad Software, San Diego California USA, 
www.graphpad.com).
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3 THE SEARCH FOR INDUCERS OF HO-1 AMONGST 
PHYTOCHEMICALS
3.1 Introduction
Diets rich in fruit and vegetables are associated with lower risks of developing 
various diseases-mediated by oxidative stress, such as atherosclerosis (Talalay 
and Fahey, 2001). Several mechanisms are involved in the protective effects of 
fruit and vegetables, which undoubtedly include the endogenous cytoprotective 
mechanisms, such as endogenous detoxifying enzymes, i.e. phase II enzymes 
(Talalay and Fahey, 2001). Phase II enzymes protect against damage by 
electrophiles and therefore emerging as a very important component of cellular 
defenses against oxidants (Talalay, 2005). Indeed, ample studies support the 
view that induction of phase II enzymes is an important protective mechanism 
against ROS (Moskaug et al., 2005). It is therefore of great importance to 
search for different pharmacological agents, which possess intrinsic abilities to 
modulate the expression of these protective enzymes (Balogun et al., 2003b). 
Dietary phytochemicals are emerging as novel modulators of cellular functions, 
because of their intrinsic ability to selectively and potently induce phase II 
enzymes (Moskaug et al., 2005) namely, HO-1 (Xu et al., 2005). The induction 
of many antioxidants and phase II drug-metabolizing enzymes by phenolic 
antioxidants and electrophilic compounds is regulated at the transcriptional level 
(Talalay and Fahey, 2001). It has been demonstrated that MAPK are involved in 
the activation of the HO-1 expression by some phenolic compounds, for 
example, p38 pathway was involved in the mechanisms of HO-1 gene induction 
by quercetin in rat aortic smooth muscle cells (Lin et al., 2004), by carnosol in
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PC12 cells (Martin et al., 2004) and by curcumin in renal epithelial cells 
(Balogun et al., 2003b). In this chapter, we investigated a number of 
polyphenolic compounds, namely, phloretin, which is abundantly present in 
apples (Tsao et al., 2003) and possesses anti-oxidative properties, and 
accounts in part for the anti-oxidative capacity of apples (Lee et al., 2003). 
Another compound which belongs to the family of phytochemicals is baiclein, 
which has potent cytoprotective properties, including anti-oxidant properties; it 
prevented endothelial dysfunction in spontaneously hypertensive rat aorta 
(Machha and Mustafa, 2005) and prevented lipid peroxidation in mice (Im et al., 
2005). Epigallocatechin 3-O-gallate (EGCG) is one of the major polyphenols in 
green tea (Nakai et al., 2005), and was shown to be protective against 
oxidation-induced damage in erythrocytes (Rizvi et al., 2005). Another exciting 
group is the chalcones, which are emerging as potent modulators of 
endogenous cytoprotective enzymes (Alcaraz et al., 2004). Chalcones are a 
group of phenolic compounds which belong to the flavonoids family, and widely 
occur in nature as pigments, they are present in hops plants and liquorice 
(Ivanov and Ronai, 2000). Chalcones have been reported to possess a variety 
of beneficial biological properties (Anto et al., 1995) (Ban et al., 2004), including 
anti-inflammatory (Alcaraz et al., 2004), antioxidant and anti-bacterial activities 
(Haraguchi et al., 1998) (Yu et al., 1995). In the present study, we are interested 
in a particular derivative of chalcones, i.e. 2'-hydroxychalchone (2-HC) which 
exerts its cytoprotective actions through the activation of specific transcriptional 
factors, such as Nrf2 (Alcaraz et al., 2004) and by up-regulation of endogenous 
cytoprotective pathways (Foresti et al., 2005). It has been demonstrated that
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chalcones possess potent anti-oxidant properties; chalcones protected BAEC 
from H202-induced cellular damage (Foresti et al., 2005).
3.2 Objectives
To investigate if baiclein, phloretin, EGCG and 2-HC have the ability to induce 
haem oxygenase activity and HO-1 expression in BAEC and to elucidate the 
cellular mechanisms involved in the induction of HO-1.
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3.3 Materials and Methods
CHAPTER 3
3.3.1 Reagents
2-HC was purchased from INDOFINE chemical company INC (Belle Mead, NJ 
08502). All other reagents were purchased from Sigma unless otherwise 
specified.
3.3.2 Cell Culture
Bovine Aortic Endothelial cells (BAEC) were purchased from Coriell Cell 
Repositories (Camden, NJ, U.S.A.) and cultured in ISCOVES’ medium which 
contains: 2mM glutamine, 100 units/ml penicillin, 0.1 mg/ml streptomycin and 
supplemented with 10% FBS. Cells were grown in 75-cm2 flasks and maintained 
at 37°C in a humidified atmosphere of air and 5% CO2.
3.3.3 Experimental Protocol
BAEC were exposed to various concentrations (5, 15 and 30 pM) of 
polyphenolic compounds phloretin, baiclein, and EGCG (Table 3-1) for 6 h, 
haem oxygenase activity was then determined. Haem oxygenase activity and 
HO-1 protein expression were also measured in cells exposed for 6, 18, and 36 
h to 2-HC (Table 3-1). Cell viability was assessed using a metabolic assay 
(Alamar Blue) and LDH release after 24 and 36 h-incubation. To assess the 
potential anti-oxidant effects of 2-HC, cells were pretreated with 2-HC for 6 h 
followed by a 2-h exposure to various concentrations (0.75, 1.5 and 3 mM) of 
H2O2. The participation of the MAPK pathway in the increase of haem oxygenase 
activity by 2-HC was assessed using commercially avalailbe inhibtors of the three 
pathways; PD098059 (ERK inhibitor, 25 pM), SB203580 (p38 inhibitor, 5 pM) or 
SP600125 (JNK inhibitor, 10 pM). An inhibitor of the PI3K pathway (LY294002, 25
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|jM) was also tested. Furthermore, in order to investigate the effect of 2-HC on 
the translocation of the transcription factor Nrf2 to the nucleus, cells were pre­
incubated with 2-HC for 30 and 60 minutes. At the end of the experimental 
protocol, nuclear extraction was performed as mentioned previously.
Table 3-1: The chemical structure of baiclein, phloretin, EGCG and 2-HC
Compound Chemical structure Cytoprotective
properties
Ref.
Phloretin .OH
HO .OH
OH
Anti-oxidant [147]
Baiclein Anti-oxidant,
HO
HO
OH O
[114; 157]
EGCG OHHO
OH
OH
OHHO
OHOH
Anti-oxidant,
anti­
inflammatory
[68;233]
2-HC
OH
0
Anti-oxidant, 
anti­
inflammatory 
and anti-tumour
[165]
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3.3.4 Haem Oxygenase Activity Assay
Haem oxygenase activity was determined at the end of each treatment as 
described previously by our group (Foresti et al., 1997) (Motterlini et al., 2000a). 
Briefly, microsomes from harvested cells were added to a reaction mixture 
containing NADPH, glucose-6-phosphate dehydrogenase, rat liver cytosol as a 
source of biliverdin reductase, and the substrate haemin. The reaction mixture 
was incubated in the dark at 37°C for 1 h and was terminated by the addition of 
1 ml of chloroform. After vigorous vortex and centrifugation, the extracted 
bilirubin in the chloroform layer was measured by the difference in absorbance 
between 464 and 530 nm (e = 40 mM 1cm 1).
3.3.5 Western Blot Analysis for HO-1 and Nrf2
Cells were also analyzed by Western immunoblot technique as previously 
reported (Foresti et al., 1997). Briefly, an equal amount of proteins (30 pg) from 
each sample was separated by SDS-polyacrylamide gel electrophoresis, 
transferred overnight to nitrocellulose membranes, and the non-specific binding 
of antibodies was blocked with 3% non-fat dried milk in PBS. Membranes were
then probed with a polyclonal rabbit anti-HO-1 antibody (Stressgen, Victoria,
Canada) (1:1000, dilution in Tris-buffered saline, pH 7.4) Nrf2 (1:500 dilution) 
antibodies (Santa Cruz Biotechnology Inc.). After three washes with PBS 
containing 0.05% (v/v) Tween 20, blots were visualized using an amplified 
alkaline phosphatase kit from Sigma (Extra-3A).
3.3.6 Preparation of Nuclear Extract
Nuclear extraction was performed as mentioned previously (Balogun et al., 
2003b). Briefly, cells were washed twice with cold 1X PBS and harvested by
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centrifugation at 800 g for 3 minutes at 4°C. Cells were then carefully 
resuspended in a cold buffer (buffer A) which contains 10 mM HEPES, pH 7.9, 
10 mM KCI, 0.1 mM EDTA, and 0.1 EGTA, 10% NP-40 and protease inhibitor 
cocktail (Roche) and incubated on ice for 15 minutes. The homogenate was 
then centrifuged at 800 g for 3 minutes; the pellet was then resuspended and 
incubated for 15 minutes with buffer B, which contains 20 mM HEPES, pH 7.9, 
0.4 M NaCI, 1 mM EDTA, and 1 mM EGTA. Finally the samples were spun at 
15,000 g for 5 minutes and the supernatant was kept in the -80 freezer until 
needed.
3.3.7 Cell Viability/Alamar Blue Assay
Cell viability was determined using an Alamar Blue assay kit, it was carried out 
according to the manufacturer’s instructions (Serotec, U.K.) as previously 
reported (Motterlini et al., 2000b). The assay is based on the detection of 
metabolic activity of living cells using a redox indicator, which changes from an 
oxidized (blue) form to a reduced (red) form. The intensity of the red color is 
proportional to the metabolism of the cells, which is calculated as the difference 
in absorbance between 570 and 600 nm and expressed as a percentage of 
control.
3.3.8 LDH Assay
Extracellular, i.e., released, lactate dehydrogenase (LDH) activity was 
measured using cytotoxicity detection kit (Roche). At the end of the period of 
incubation, cell supernatant was collected, and then any cell residue was 
removed by centrifugation at (250xg). The reaction mixture (which is composed 
of the catalyst and the dye solution) was then added to the cell-free
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supernatant, incubated for 15 minutes, and then the absorbance was measured 
at 490 and 600 nm. Cellular LDH activity was determined after lysis of the cells 
with Triton X-100 (1% in DMEM at 25°C). Released LDH was expressed as 
percentage of total LDH activity.
3.4 Statistical Analysis
Differences among the groups were analyzed using one way ANOVA .Values 
were expressed as mean ± S.E.M., and differences between groups were 
considered to be significant at p < 0.05.
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3.5 Results
3.5.1 The Effect of Baiclein, Phloretin and EGCG on Haem Oxygenase 
Activity in Bovine Aortic Endothelial Cells
We wanted to examine whether baiclein, phloretin and EGCG have the ability to 
induce haem oxygenase activity in BAEC, for this purpose, cells were incubated 
with various concentrations (5-30 pM) of each of the compounds. As illustrated 
in Figure 3.1, exposure of cells for 6 h to various concentrations of baiclein 
(Figure 3.1 A), phloretin (Figure 3.1 B), or EGCG (Figure 3.1 C) did not have 
any significant effects on haem oxygenase activity.
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Figure 3.1: The effect of baiclein, phloretin and EGCG on haem oxygenase 
activity in BAEC
BAEC were exposed to various concentrations (5-30 pM) of baiclein(A) phloretin (B) 
and EGCG (C) for 6 h. Haem oxygenase activity was then determined at the end of the 
incubation. Cells treated with medium alone represented control (0). Bars represent the 
mean ± S.E.M. of 6 independent experiments per group.
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3.5.2 2-HC Induces Haem Oxygenase Activity and HO-1 Expression in 
BAEC
In order to establish the effect of 2-HC on haem oxygenase activity and HO-1 
protein expression, we measured the haem oxygenase activity and HO-1 
protein expression in BAEC exposed to 2-HC for three different time points. As 
shown in (Figure 3.2), exposure of BAEC to various concentrations (5, 15 and 
30 pM) of 2-HC, resulted in a concentration and time-dependent increase in 
haem oxygenase activity and HO-1 protein expression; at 6 h (Figure 3.2 A), 18 
h (Figure 3.2 B), however, after 36 h-incubation, there was a significant 
decrease in haem oxygenase activity and HO-1 protein expression (Figure 3.2 
C).
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Figure 3.2: The effect of 2-HC on haem oxygenase activity and HO-1 expression 
in BAEC
BAEC were exposed to various concentrations (5-30 pM) of 2-HC for 6 h (A) 18 h (B) 
and 36 h (C). Haem oxygenase activity and HO-1 protein expression were determined 
at the end of the incubation. Cells treated with medium alone represented control (0). 
Each Western Blot is a representative of three independent experiments. Bars 
represent the mean ± S.E.M. of 5-6 independent experiments per group.* P < 0.001 vs. 
control. HO-1: positive control recombinant HO-1 protein, MW: molecular weight 
marker.
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3.5.3 Effects of 2-HC on Cell Viability and Metabolism
We next examined the effect of increasing concentrations of 2-HC (5-30 |jM) on 
cell viability, at two time points, 24 h and 36 h. For this purpose, we used two 
different methods, assessment of cell metabolism using Alamar Blue (Figure 3.3 
A, and Figure 3.4 A) and measurements of LDH release (Figure 3.3 B and 
Figure 3.4 B). Our data showed that incubation of BAEC for 24 h with 2-HC (5- 
30 pM) did not cause cytotoxicity compared to control (Figure 3.3). However, 
(Figure 3.4 A) and (Figure 3.4 B) showed that incubation of BAEC for 36 h with 
increasing concentrations of 2-HC demonstrated a slight (but insignificant, 
P>0.05) increase in LDH release (5%) at 5-30 pM (Figure 3.4 B) and a mild (but 
insignificant, P> 0.05) decline in cell metabolism at 30 pM compared to control 
(Figure 3.4 A).
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Figure 3.3: Viability of cells exposed to 2-HC after 24 h incubation.
BAEC were exposed for 24 h in the presence of 2-HC (5-30 pM) and the viability was 
then determined using Alamar Blue (A). Cells were exposed to 2-HC (5-30 pM) for 24 h 
and damage was assessed by measuring LDH release (B). Bars represent the mean ± 
S.E.M. of 5-6 independent experiments.
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Figure 3.4: Viability of cells exposed to 2-HC after 36 h incubation
BAEC were exposed for 36 h in the presence of 2-HC (5-30 pM) and the viability was 
then determined using Alamar Blue (A). Cells were exposed to 2-HC (5-30 pM) for 36 h 
and damage was assessed by measuring LDH release (B). Bars represent the mean ± 
S.E.M. of 5-6 independent experiments.
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3.5.4 2-HC Attenuates H202-Mediated Oxidative Stress
Having established that 2-HC is a potent inducer of hame oxygenase activity 
and HO-1 expression, we then tested if 2-HC could counteract the oxidative 
stress caused by treatment with H2O2. Cells were initially pretreated with 2-HC 
(5-30 pM) for 6 h to allow HO-1 induction to take place. Treatment with 
increasing concentrations of H2O2 (0.75, 1.5, and 3 mM) for 2 h resulted in a 
concentration-dependent decline in cell metabolism (50, 40 and 35% 
respectively) compared to control group, pre-treatment of cells with 2-HC (5 pM) 
did not have any significant effect on H2 0 2 -mediated decrease in cell 
metabolism (Figure 3.5 A). However, at higher concentrations (15 and 30 pM), 
2-HC significantly attenuated the H202-mediated cytotoxicity evident by a 
significant increase (P<0.05) in cell metabolism in a concentration-dependent 
manner, (Figure 3.5 B and C).
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Figure 3.5: Effect of 2-HC the H202-mediated oxidative stress
Cells were pre-treated with of 2-HC 5 pM (A), 15 pM (B) and 30 pM (C) for 6 h and then 
exposed to different concentrations of H20 2 for 2 h. Viability was then determined using 
Alamar Blue assay. Bars represent the mean ± S.E.M. of 5-6 independent experiments, 
* P < 0.001 vs. control. t< 0.05 vs. H20 2.
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3.5.5 The Effect of Actinomycin-D on 2-HC-Mediated Induction of Haem 
Oxygenase Activity
In order to investigate the mechanisms involved in 2-HC-mediated induction of 
haem oxygenase activity. Actinomycin-D, a universal inhibitor of gene 
transcription (Hill-Kapturczak et al., 2001) was used. Cells were pre-treated with 
actinomycin-D for 30 minutes followed by 2-HC (15 pM) for 6 hours. The 
presence of actinomycin-D totally inhibited the 2-HC-mediated increase in the 
activity of haem oxygenase (Figure 3.6) suggesting that the induction of haem 
oxygenase activity by this chalcone occurs at the transcriptional level.
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Figure 3.6: The effect of actinomycin-D on the 2-HC-mediated stimulation of 
haem oxygenase activity in BAEC
BAEC were pre-incubated with actinomycin-D for 30 min. then various concentrations 
(5-30 pM) of 2-HC for were added for 6 h and haem oxygenase activity was determined 
at the end of the incubation. Cells treated with medium alone represented control (0). 
Bars represent the mean ± S.E.M. of 6 independent experiments per group.* P < 0.001 
vs. 2-HC alone, t  P < 0.001 vs control.
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3.5.6 The PI3K Pathway is required For the Induction of Haem 
Oxygenase Activity and HO-1 Expression Mediated by 2-HC
To investigate the signalling cascade mediating the increase in haem 
oxygenase activity by 2-HC, we employed pharmacological antagonists of 
different MAPK family and PI3K pathways. As observed previously with 
endothelial cells (Foresti et al., 2005), inhibition of the ERK, JNK (Figure 3.7 A) 
and p38 (Figure 3.7 B) did not affect the induction of haem oxygenase activity 
by 2-HC. However, blockade of PI3K completely abolished the 2-HC-mediated 
up-regulation of haem oxygenase activity (Figure 3.7 B).
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Figure 3.7: Effect of MAPK inhibitors on the on the increase of haem oxygenase 
activity mediated by 2-HC.
BAEC were pre-treated for 30 min. with PD 098,059 (ERK inhibitor, 25 pM) or SP 
600125 (JNK inhibitor, 10 pM), in serum free-medium prior to exposure to 15 pM 2-HC 
for 6 h (A). Haem oxygenase activity was determined at the end of the incubation. 
BAEC were pre-treated for 30 min. LY 294002 (PI3K pathway inhibitor, 25 pM) or SB 
203580 (p38 inhibitor, 5 pM) in serum free-medium prior to exposure to 15 pM 2-HC for 
6 h (B). Haem oxygenase activity was determined at the end of the incubation. Bars 
represent the mean ± S.E.M. of 6 independent experiments, *P < 0.001 vs. Control, f  
represents p<0.001 vs. 2-HC alone.
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3.5.7 Treatment with 2-HC Results in the Activation of Nrf2
Using Western blotting, we determined whether treatment of BAEC with 2-HC 
would result in the activation of Nrf2, i.e. the translocation of Nrf2 to the nucleus. 
For this purpose, cells were incubated with 2-HC for 30 min. As shown in 
(Figure 3.8), treatment with 2-HC resulted in the translocation of Nrf2 to the 
nucleus.
30 min 60 min
N r f 2  
p - a c t i n  
2-HC [15 [ i M ]
Figure 3.8: Treatment with 2-HC results in the activation of Nfr2
BAEC were pre-treated with 15 pM 2-HC for 30 min. and 60 min. The translocation of 
Nrf2 to the nucleus was determined in the nuclear extracts by Western Blot. Western 
Blot is a representative of three independent experiments, p-actin was used as an 
internal control for equal loading.
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3.6 Discussion
Fruit and vegetables contain thousands of structurally diverse phytochemicals,
of which a large fraction is polyphenols (Scalbert and Williamson, 2000).
Furthermore, phytochemicals increase the efficacy of endogenous antioxidant
defences and modulate the cellular redox state, a process which involves a
wide range of signaling pathways and transcription factors (Balogun et al.,
2003b) (Frigo et al., 2002). Therefore, the use of naturally-occurring compounds
that possess intrinsic anti-inflammatory and antioxidant properties which can
prompt the intracellular protective cascades offers a promising stratagem for
therapeutic applications (Foresti et al., 2005). Based on the ability of some
polyphenolic compounds to modulate phase II response enzymes (Talalay,
2005) we speculated that a number of polyphenolic compounds i.e. baiclein,
phloretin, EGCG and 2-HC would have the ability to induce HO-1, one of the
phase II response enzymes. Our data showed that baiclein, phloretin, EGCG
did not induce haem oxygenase activity, however, treatment of cells with 2-HC
induced haem oxygenase activity and HO-1 expression potently. Our results
showed that the differential pattern of the ability to induce haem oxygenase
activity amongst the four polyphenolic compounds tested could be explained on
the basis of structural differences between these compounds. The presence of
two structural elements was found to be required for high inducer potency: (i)
hydroxyl groups at ortho-position on the aromatic rings and (ii) the beta-
diketone functionality (Dinkova-Kostova and Talalay, 1999) (Dinkova-Kostova et
al., 2001). This observation is supported by other studies in the HO-1 induction
abilities of other phytochemicals (Scapagnini et al., 2002). However, based on
our data, there is not enough evidence to support this view. Our results showed
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that 2-HC is a potent inducer of haem oxygenase activity and HO-1 expression 
in BAEC, an effect which is observed after 6 and 18 h incubation, and to a 
lesser extent, after 36 h, the significant decrease in the haem oxygenase 
activity and the HO-1 expression after 36 h could be due to the fact that the 
compound have been metabolized by the cells, and it no longer presents in the 
medium to induce the expression of haem oxygenase activity. This is decidedly 
possible, because the decrease in the haem oxygenase activity and HO-1 
expression is not due to cytotoxicity, because cells were still viable after 36 h- 
incubation with 2-HC. Our data is in agreement with data in the literature which 
recently documented that 2-HC and its derivatives are potent inducers of HO-1 
expression, in endothelial cells (Foresti et al., 2005) and in RAW 264.7 murine 
macrophages (Alcaraz et al., 2004). Since the other 3 phytochemicals involved 
in this study (baiclein, phloretin and EGCG) did not have the ability to induce 
haem oxygenase activity, we did not study them further. Conversely, having 
established that 2-HC is a potent inducer of HO-1 expression, we wanted to 
study the mechanisms involved in the effect of 2-HC on HO-1, and examine the 
potential cytoprotective properties of this chalcone, in addition to the 
contribution of the HO-1 in these protective effects. Our data showed that 
actinomycin-D totally inhibited the 2-HC-mediated increase in the activity of 
haem oxygenase, suggesting that the induction of haem oxygenase activity by 
this chalcone occurs at the transcriptional level. Investigation into the 
involvement of MAPK in the mechanism involved in the 2-HC-mediated 
induction of HO-1, indicated that the three MAPK pathways are not necessary 
for activation of haem oxygenase by 2-HC, our data is in agreement with data 
provided in the literature (Foresti et al., 2005). Furthermore, we established the
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novel finding that the activation of the PI3K pathway is essential for the 
activation of haem oxygenase by 2-HC. It is worth mentioning that there was no 
positive control that demonstrates the effectiveness of MAPK inhibitors, and 
therefore this should be borne in mind when interpreting these results. 
Moreover, pre-treatment of cells with 2-HC protected BAEC from the oxidative 
damage-mediated by H202, this is in accordance of data in the literature 
(Foresti et al., 2005). Furthermore, 2-HC activated Nrf2, which resulted in the 
translocation of Nrf2 into the nucleus, this data is agreement with the previous 
data obtained by Al-caraz and co-workers (Alcaraz et al., 2004), furthermore, 
our group which showed that other plant-derived phytochemicals, induced HO-1 
expression and resulted in the activation of Nrf2 (Balogun et al., 2003b),(Foresti 
et al., 2005). This further emphasizes the potent cytoprotective properties of this 
chalcone, having anti-oxidant properties per se as well as having inherent ability 
to strongly activate the endogenous cytoprotective pathways; this chalcone 
appears to possess antioxidant and free radical-scavenging characteristics. 
Thus, it is plausible that 2-HC could be used as a pharmacological 
preconditioning agent to modulate the expression of endogenous protective 
intracellular pathways in tissues exposed to oxidant-mediated injury.
In conclusion, our data show that chalcone is a potent inducer of HO-1 in 
BAEC, and it has beneficial effects in protection against oxidative stress. In 
addition, our data provided a mechanistic insight onto the effect of 2-HC on 
haem oxygenase. In view of these results, it is tempting to speculate that some 
beneficial effects of 2-HC might take place because of the intrinsic ability of this 
chalcone to up-regulate HO-1 and possibly other intracellular protective 
pathways.
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4 HO-1 MEDIATES THE ANTI-INFLAMMATORY ACTIONS OF 2- 
HC IN RAW 264.7 MURINE MACROPHAGES
4.1 Introduction
The use of naturally-occurring compounds that possess intrinsic anti­
inflammatory, and antioxidant properties and which can trigger the intracellular 
protective cascades offers a promising stratagem for therapeutic applications 
(Woodman and Chan, 2004). An interesting class of agents that might fill these 
criteria are the phytochemicals chalcones. 2-HC derivatives showed potent anti­
inflammatory activity in various models of inflammation, including LPS-induced 
inflammatory response in macrophages (Ban et al., 2004) (Batt et al., 1993). 
Inflammation plays a role in cardiovascular pathological conditions (Schiffrin, 
2002), upon stimulation by LPS, macrophages produce NO and pro- 
inflammatory cytokines such as IL-1 and TNF-a (Zembowicz and Vane, 1992). 
NO is generated by NO synthases and induces tissue injury at the inflammatory 
site (MacMicking et al., 1997). 2-HC derivatives have been shown to suppress 
the LPS-induced production of NO and TNF-a in the macrophage cell line RAW 
264.7(Ban et al., 2004). It is postulated that chalcones exert their anti­
inflammatory action by inhibiting the production of various inflammatory 
mediators such as cytokines and iNOS (Herencia et al., 2002), either by a direct 
inhibitory action on these mediators or inhibition of the transcription factors (NF- 
KB, AP-1) that regulate the production of the various mediators that are involved 
in the inflammatory response (Madan et al., 2000) (Ban et al., 2004). 
Furthermore, chalcones exert their cytoprotective actions via activation of a 
variety of transcriptional factors and by up-regulation of endogenous
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cytoprotective pathways, such as phase-11 enzymes, among them is the HO-1 
(Alcaraz et al., 2004), as it was shown in different cell lines, in RAW 264.7 
macrophages (Alcaraz et al., 2004) and in endothelial cells (Foresti et al., 
2005). The HO-1 system plays a crucial role in the control of the inflammatory 
process (Alcaraz et al., 2003), this role is supported by several models of 
inflammation, in which HO-1 up regulation results in a significant reduction in 
inflammatory response (Zampetaki, 2003) (Berberat, 2005) (Wang, 2004) 
including oedema, leukocyte adhesion and migration, and production of 
cytokines (Alcaraz et al., 2003). HO-1 down regulates the pro-inflammatory 
cytokines (Otterbein et al., 2000) and the adhesion molecules (Wagener, 2001), 
furthermore, HO-1 up-regulates the anti-inflammatory cytokine IL-10 (Lee and 
Chau, 2002). On the other hand, pro-inflammatory cytokines and LPS have 
been shown to activate HO-1, in an adaptive response to inflammatory stress 
(Camhi et al., 1998), HO-1 end products biliverdin/bilirubin and CO have also 
been implicated in the modulation of a range of signalling pathways, including 
MAPK pathways by which they may modulate inflammatory processes (Morse 
et al., 2003) (Otterbein et al., 2000).
In the present study, the anti-inflammatory action of 2-HC was investigated in 
an LPS-induced model of inflammation in RAW 264.7 macrophages, and the 
role of HO-1 in this process was investigated.
4.2 Objectives
In this study, the potential anti-inflammatory action of 2-HC was investigated in 
an LPS-induced model of inflammation in RAW 264.7 macrophages; 
furthermore, the role of HO-1 in this process was elucidated. In addition, the 
signalling mechanisms involved in this process were investigated
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4.3 Material and Methods 
4.3.1 Reagents
All reagents were purchased from Sigma, unless otherwise specified. LPS is E- 
coli: serotype 026:B6 (Sigma). Tin Protoporphyrin IX (SnPPIX) was obtained 
from Porphyrin Products INC (Logan, Utah, USA). HO-1 and PI3K small 
interfering RNA (siRNA) were purchased from Santa Cruz Biotechnology.
4.3.2 Cell Culture
RAW 264.7 murine macrophages were purchased from the European Collection 
of Cell Cultures (ECACC, Salisbury, Wiltshire, UK) and cultured in DMEM 
containing, 2 mM glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin 
and supplemented with 10% FBS. Cells were grown in 75-cm2 flasks and 
maintained at 37°C in a humidified atmosphere of air and 5% CO2.
4.3.3 Experimental Protocol
RAW 264.7 macrophages were treated with 2-HC (5, 15 and 30 pM) for 6 h, 
haem oxygenase activity and HO-1 protein expression were then determined. 
Haem oxygenase activity was also measured in cells exposed to 2-HC for 6 h, 
and the medium was then removed and replaced by fresh medium, cells were 
then incuabted for further 12 h. Furthermore, haem oxygenase activity was 
determined in cells treated for 24 h with LPS in the presence or absence of 2- 
HC. Cell viability was then assessed using LDH release and Alamar Blue Assay 
after 24 h-incubation with 2-HC alone, or following incubation of cells with the 
combination of 2-HC and LPS. In order to examine the potential anti­
inflammatory action of 2-HC, macrophages were exposed for 24 h to LPS
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(1 |jg/ml) in the presence or absence of 2-HC (5, 15 and 30 pM), nitrite levels 
and iNOS protein expression were then determined at the end of the incubation. 
SiRNA for HO-1 were used to determine the involvement of HO-1. In a similar 
set of experiments, cells were treated with 2-HC for 6 h prior to incubation with 
LPS and nitrite production was measured after 24 h. The levels of TNF-a were 
also determined in cells exposed for 12 h to LPS (0.1 pg/ml) in the presence or 
absence of 2-HC. Similarly, TNF-a was measured in experiments conducted 
with SnPPIX (10 pM) and HO-1 siRNA. The participation of the MAPK pathway in 
the increase of haem oxygenase activity and HO-1 expression by 2-HC was 
assessed using PD098059 (ERK inhibitor, 25 pM), SB203580 (p38 inhibitor, 5 
pM) and SP600125 (JNK inhibitor, 10 pM). An inhibitor of the PI3K pathway 
(LY294002, 25 pM) was also tested, in addition to PI3K siRNA. Furthermore, to 
investigate the effect of 2-HC on the translocation of the transcription factor NF- 
KB to the nucleus, cells were pre-incubated with 2-HC for 30 min, followed by 
treatment with LPS 1 pg/ml for 30 and 60 min. At the end of the experimental 
protocol, the nuclear extraction was performed.
4.3.4 Cell Viability/Alamar Blue Assay
Cell viability was determined using an Alamar Blue assay kit, it was carried out 
as previously described in Section 2.3.1.
4.3.5 LDH Assay
LDH release was measured using cytotoxicity detection kit (Roche) as 
previously described in section 2.3.2.
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4.3.6 Haem Oxygenase Activity Assay
Haem oxygenase activity was determined at the end of each treatment as 
described previously in Section 2.4.3.
4.3.7 Western Blot Analysis for HO-1, iNOS and NF-KB
Cells were also analyzed for the determination of the protein expression for HO- 
1, iNOS and NF-KB by Western immunoblot technique as previously described 
in Section 2.5.5.
4.3.8 Determination of Nitrite
Nitrite levels were determined using the Griess method as previously described 
by our group (Chan and Kan, 1999). The measurement of this parameter is 
widely accepted as indicative of NO production. Briefly, the medium from 
treated cells cultured in 24-well plates was removed and placed into a 96-well 
plate (50 pi per well). The Griess reagent was added to each well to begin the 
reaction, the plate was shaken for 10 min and the absorbance read at 550 nm 
on a Molecular Devices VERSAmax plate reader. The nitrite level in each 
sample was calculated from a standard curve generated with sodium nitrite 
(0-300 pM in cell culture medium).
4.3.9 Measurement of TNF-a Production
TNF-a present in each sample was determined using a commercially available 
kit from R&D Systems (Abingdon, U.K.). The assay was performed according to 
the manufacturers' instructions, as prevoiusly described in Section 2.5.1.
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4.3.10 Transfection of RAW 264.7 Macrophages with Small Interfering 
RNA for HO-1 and PI3K
RAW 264.7 macrophages were grown in twelve-well plates and transiently 
transfected with HO-1 or PI3K siRNA mixed with the appropriate transfection 
reagent (Santa Cruz Biotechnology) according to the manufacturer’s 
instructions, as previously described in Section 2.5.4. After incubation at 37 °C 
for 30 h, cells were exposed to different reagents according to the Experimental 
Protocol.
4.4 Statistical Analysis
Differences among the groups were analyzed using one way ANOVA. Values 
were expressed as mean ± S.E.M., and differences between groups were 
considered to be significant at p < 0.05.
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4.5 Results
4.5.1 2-HC Induces Haem Oxygenase Activity and HO-1 Expression in 
RAW 264.7 Macrophages
Firstly, we wanted to verify that 2-HC at the concentrations used in the present 
study are not toxic to the cells, for this purpose, LDH release was measured as 
an index of cell damage. Figure 4.4 A showed that incubation of macrophages 
for 24 h with increasing concentrations of 2-HC (5-30 pM) did not cause 
cytotoxicity. We have previously reported that 2-HC induces haem oxygenase 
activity and HO-1 expression in BAEC (Foresti et al., 2005). We wanted to 
establish the effect of 2-HC on HO-1 expression in RAW264.7 macrophages. 
As shown in (Figure 4.1), exposure of macrophages to 2-HC for 6 h resulted in 
a concentration-dependent increase in haem oxygenase activity (Figure 4.1 A) 
and HO-1 protein expression (Figure 4.1 B). We also assessed whether the 
effect on haem oxygenase activity was a long-lasting effect, for this purpose, 
haem oxygenase activity was measured in macrophages incubated with 2-HC 
for 6 h followed by 12 h to medium alone (Figure 4.1 C). Interestingly, haem 
oxygenase activity remained elevated even after removal of the chalcone, 
suggesting that macrophages need a long time to metabolize the compound. 
This possibility was further sustained by the fact that the extent of haem 
oxygenase activity was similar between cells incubated for 6 h with 2-HC and 
cells exposed to 6 h to 2-HC followed by 12 h incubation in medium (Figure 4.1 
C).
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Figure 4.1: The effect of 2-HC on haem oxygenase activity and HO-1 expression 
in RAW264.7 macrophages
RAW 264.7 macrophages were exposed to various concentrations (5-30 pM) of 2-HC 
for 6 h. Haem oxygenase activity (A) and HO-1 protein expression (B) were determined 
at the end of the incubation. Cells treated with medium alone represented control (0). 
Western Blot is a representative of three independent experiments. Cells were exposed 
to various concentrations (5-30 pM) of 2-HC for 6 h followed by 12 h incubation in fresh 
medium alone (C). Haem oxygenase activity was measured at the end of the 
incubation (6+12 h). Cells treated with medium alone represented control (0). Bars 
represent the mean ± S.E.M. of 5-6 independent experiments per group.* P < 0.001 vs. 
control. (3-actin was used as an internal control for equal loading HO-1: positive control 
recombinant HO-1 protein, MW: molecular weight marker.
127
_________________________________________________  CHAPTER 4
4.5.2 2-HC Reduces LPS-Stimulated Nitrite Production and iNOS 
Expression
We next assessed the potential anti-inflammatory action of 2-HC by measuring 
nitrite produced by macrophages challenged with LPS, in the presence or 
absence of the 2-HC. As shown in (Figure 4.2 B), treatment of macrophages 
with 2-HC (15-30 pM) resulted in a concentration-dependent decrease in nitrite 
production-elicited by LPS. In addition, 2-HC decreased the LPS-stimulated 
iNOS expression in a concentration-dependent manner (Figure 4.2 B). Similarly, 
but less potently, nitrite generation was decreased in macrophages pre­
incubated with 2-HC for 6 h, followed by 24 h exposure to LPS alone (Figure 4.3 
B). Treatment of cells with the combination of LPS and 2-HC resulted in a 
significant cytotoxicity as indicated by LDH release (Figure 4.4 A); therefore, the 
reduction in the nitrite production and iNOS expression could be explained due 
to the cytotoxic effects of LPS and 2-HC. Furthermore, exposure of cells to LPS 
resulted in increased cell injury, the presence of 2-HC markedly reversed this 
effect (Figure 4.4 A). Intriguingly, cell viability assessed using Alamar Blue 
indicated that 2-HC at 30 pM, but not 5 or 15 pM, decreased the cellular 
metabolic activity (Figure 4.4 B). Co-incubation of cells with LPS and 2-HC at 30 
pM further decreased cell viability by more than 50 %. Exposure of cells to LPS 
results in up-regulation HO-1 (Sawle et al., 2005), we determined the activity of 
haem oxygenase in macrophages exposed to LPS or to a combination of LPS 
and 2-HC for 24 h. Our results showed that cells incubated with LPS alone 
exhibited a significant increase in haem oxygenase activity (Figure 4.3 A), this 
effect was significantly increased in the presence of 2-HC in a concentration- 
dependent manner.
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Figure 4.2: 2-HC modulates LPS-stimulated nitrite production and iNOS 
expression
RAW264.7 macrophages were exposed to LPS (1 pg/ml) in the presence or absence of 
2-HC and nitrite production was determined after 24 h (A). Bars represent the mean ± 
S.E.M. of 5-6 independent experiments, * P < 0.001 vs. control, f  P< 0.001 vs. LPS. 
RAW264.7 macrophages were exposed to LPS (1 pg/ml) in the presence or absence of 
2-HC and iNOS expression was determined at 24 h (B). Western Blots are 
representatives of three independent experiments, p-actin was used as an internal 
control for equal loading.
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Figure 4.3: Effect of pre-incubation with 2-HC on the LPS-mediated nitrite 
production
RAW 264.7 macrophages were exposed to various concentrations (5-30 pM) of 2-HC 
in the presence of LPS 1 pg/ml for 24 h and haem oxygenase activity was measured at 
the end of the incubation (A). RAW 264.7 macrophages were exposed to 2-HC (5-30 
pM) for 6 h followed by 24 h incubation in medium containing of LPS (1 pg/ml). Nitrite 
production was measured at the end of the incubation (6+24h) (B). Cells treated with 
medium alone represented control (0). Bars represent the mean ± S.E.M. of 5-6 
independent experiments per group.* P < 0.001 vs. control, t  P < 0.001 vs. LPS.
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Figure 4.4: Viability of cells exposed to 2-HC and LPS
RAW 264.7 macrophages were exposed to LPS (1 pg/ml) for 24 h in the presence of 2- 
HC (5-30 pM) and cytotoxicity was determined using LDH release (A) and Alamar blue 
(B). Bars represent the mean ± S.E.M. of 5-6 independent experiments, * P < 0.001 vs. 
control, t  P < 0.001 vs. LPS.
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4.5.3 2-HC Attenuates LPS-Stimulated TNF-a Production
Since TNF-a is a major cytokine involved in the inflammatory response 
triggered by LPS (Tracey, 1994), we tested the effect of 2-HC on LPS-induced 
TNF-a production. Treatment of macrophages with LPS resulted in a significant 
increase in TNF-a, 2-HC significantly decreased LPS-mediated TNF-a 
production in a concentration-dependent manner (Figure 4-5 A), inhibition of the 
haem oxygenase pathway with SnPPIX significantly prevented this effect 
(Figure 4-5 B).
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Figure 4.5 : 2-HC modulates LPS-stimulated TNF-a production.
RAW 264.7 macrophages were exposed to LPS (0.1 pg/ml) for 12 h in the presence or 
absence of 2-HC (5-30 pM) and TNF-a production was determined (A). Cells were 
exposed to LPS for 12 h in the presence or absence of 2-HC and SnPPIX (10 pM) and 
TNF-a production was determined (B). Bars represent the mean ± S.E.M. of 5-6 
independent experiments, * P < 0.001 vs. Control.
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4.5.4 HO-1 Mediates the 2-HC Elicited Attenuation of Nitrite, iNOS 
Expression and TNF-a
Having established the anti-inflammatory effects of 2-HC, the involvement of the 
haem oxygenase pathway in the 2-HC-mediated reduction of nitrite production 
and TNF-alpha was then tested using siRNA for HO-1. In cells transfected with 
HO-1 siRNA, the effect of 2-HC on LPS-mediated increase in nitrite production 
(Figure 4.6 A), iNOS expression (Figure 4.8 B) and TNF-a (Figure 4.6 B) was 
abolished. This indicates that the activation of the HO-1 pathway is essential to 
2-HC-mediated anti-inflammatory effects. It is interesting to note that in 
macrophages treated with HO-1 siRNA, the levels of nitrite and TNF-a 
production following treatment with LPS was 4-5 times higher than in cells with 
normal HO-1 expression, compare (Figure 4.6 A) with (Figure 4.2 A), and 
(Figure 4.6 B) with (Figure 4.5 A).
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Figure 4.6: HO-1 expression is required for the anti-inflammatory actions of 2-HC.
RAW 264.7 macrophages transfected with HO-1 siRNA were exposed to LPS (1 pg/ml) 
in the presence or absence of 2-HC and nitrite production was determined after 24 h 
(A). Cells transfected with HO-1 siRNA were exposed to LPS (0.1 pg/ml) for 12 h in the 
presence or absence of 2-HC and TNF-a production was determined (B). Cells treated 
with medium alone represent the control group (0 pM). Bars represent the mean ± 
S.E.M. of 5-6 independent experiments per group* P < 0.001 vs. 0 pM (Control). Scr = 
scrambled siRNA.
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4.5.5 The PI3K Pathway is Required for the Induction of Haem 
Oxygenase Activity and HO-1 Expression Mediated by 2-HC
To investigate the signalling cascade mediating the increase in haem 
oxygenase activity and HO-1 expression by 2-HC, we employed 
pharmacological antagonists of the MAPK and PI3K pathways. As observed 
previously with endothelial cells (Itoh et al.t 1999), inhibition of ERK, JNK 
(Figure 4.7 A) or p38 (Figure 4.7 B) did not result in any significant effect on the 
2-HC-mediated induction of haem oxygenase activity and HO-1 expression. 
However, blockade of the PI3K pathway completely prevented the 2-HC 
mediated up-regulation of HO-1 (Figure 4.7 B). To further support the role of 
PI3K-mediated induction of HO-1 by 2-HC, we used siRNA for the PI3K 
pathway; as shown in (Figure 4.8 A), 2-HC failed to induce HO-1 expression in 
macrophages treated with either HO-1 or PI3K siRNA.
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Figure 4.7: Effect of MAPK inhibitors on the on the increase of haem oxygenase 
activity and HO-1 expression mediated by 2-HC
RAW 264.7 macrophages were pre-treated for 30 min with PD 098,059 (ERK inhibitor, 
25 pM) or SP 600125 (JNK inhibitor, 10 pM) in serum free-medium prior to exposure to 
15 pM 2-HC for 6 h. Haem oxygenase activity and HO-1 expression were determined 
at the end of the incubation (A). Cells were pre-treated for 30 min LY 294002 (PI3K 
pathway inhibitor, 25 pM) or SB 203580 (p38 inhibitor, 5 pM) in serum free-medium 
prior to exposure to 15 pM 2-HC for 6 h (B). Haem oxygenase activity and HO-1 
expression were determined at the end of the incubation. Bars represent the mean ± 
S.E.M. of 5-6 independent experiments, *P < 0.001 vs. Control, f  P <0.001 vs. 2-HC 
alone. Western blot is representative of three independent experiments, p-actin was 
used as an internal control for equal loading. HO-1: positive control recombinant HO-1 
protein, MW: molecular weight marker.
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Figure 4.8: Effect of HO-1 and PI3K siRNA on HO-1 expression and iNOS 
expression
RAW 264.7 macrophages were transfected with HO-1 or PI3K siRNA and exposed to 
various concentrations (5-30 pM) of 2-HC for 6 h and HO-1 protein expression was 
determined (A). Cells transfected with HO-1 siRNA were also exposed to LPS in the 
presence or absence of 2-HC for 24 h and iNOS expression determined (B). Cells 
treated with medium alone represent the control group (0 pM). Western blots are 
representative of three independent experiments. Scr = scrambled siRNA.
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4.5.6 Effect of 2-HC on the Nuclear Translocation of NF-KB
NF-KB is a transcriptional factor playing a central role in the regulation of many 
immune and inflammatory responses (Yamamoto and Gaynor, 2004). 
Therefore, we determined by Western blotting of nuclear extracts whether 2-HC 
could modulate the translocation of the P65 subunit of NF-KB elicited by LPS. 
Treatment of macrophages with LPS caused a marked increase of NF-KB after 
30 and 60 minute-incubation (Figure 4.9), however, 2-HC did not have any 
significant effect on the LPS-mediated activation of NF-KB.
P65 
p-actin
2-HC f r i M ] - - + - - +
LPS [ng/ml] + + + +
30min. 60 min.
Figure 4.9 Effect of 2-HC on the nuclear translocation of NF-KB elicited by LPS
RAW 264.7 macrophages were pre-treated with 15 pM 2-HC for 30 min. followed by an 
additional 30 or 60 min. incubation with LPS (1 pg/ml). The translocation of the P65 
subunit of NF-KB to the nucleus was determined in nuclear extracts by Western Blot. 
Western blots are representatives of three independent experiments. |3-actin was used 
as an internal control for equal loading.
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4.6 Discussion
In the present study, the anti-inflammatory properties of 2-HC were studied in 
an LPS-induced model of inflammation in RAW 264.7 macrophages. Recently, 
it was shown that many phytochemicals found in fruit and vegetables have the 
intrinsic ability to modulate endogenous cytoprotective pathways, including 
phase II response enzymes (Talalay and Fahey, 2001) among those is the HO- 
1 enzyme, which was found to be modulated by different phytochemicals, such 
as curcumin in renal epithelial cells (Balogun et al., 2003b) and in astrocytes 
(Scapagnini et al., 2002), Caffeic acid phenethyl ester in astrocytes (Scapagnini 
et al., 2002) and by carnosol in rat pheochromocytoma PC12 cells (Martin et al., 
2004). Our results showed that 2-HC is a potent inducer of haem oxygenase 
activity and HO-1 protein expression in RAW 264.7 macrophages, this data is in 
agreement with the literature which showed that 2-HC is a potent inducer of 
HO-1 expression in RAW 264.7 macrophages (Alcaraz et al., 2004) and BAEC 
(Foresti et al., 2005). It is also worth noting that 2-HC caused toxicity in 
macrophages at 30 pM, while it did not cause any evident toxicity in BAEC after 
24 hours incubation, as shown by our group (Foresti et al., 2005), which might 
indicates that macrophages are less resistant to damage by this chalcone. 2-HC 
derivatives were shown to suppress the LPS-induced production of nitrite and 
TNF-a in RAW 264.7 macrophage (Ban et al., 2004). Our results showed that 2- 
HC markedly the LPS-induced production of nitrite and iNOS expression in a 
concentration-dependent manner; these results are similar to the results 
obtained using 2-HC derivatives (Alcaraz et al., 2004) (Ban et al., 2004). 
However, cell viability tests showed that the co-incubation of LPS and 2-HC at 
30 pM caused a marked toxicity in the cells after 24 h-incubation, so the
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decrease in the nitrite production and iNOS protein expression at this particular 
concentration might be to toxicity in the cells. It is also interesting to note that 
pre-incubation with 2-HC prior to addition of LPS elicited a reduction in nitrite 
production, suggesting that 2-HC can exert delayed effects, even if is not 
present in the culture medium. Moreover, the effect of 2-HC on TNF-a, a crucial 
cytokine that is involved in the inflammatory response elicited by LPS 
(Anderson, 2004) (Tracey, 1994) was assessed. Our results showed that 2-HC 
inhibited the production of TNF-a in the cells challenged with LPS in a 
concentration-dependent manner, these results are similar to the results 
obtained using different derivatives of 2-HC (Alcaraz et al., 2004) (Ban et al., 
2004), which indicates that this chalcone is a potent inhibitor of the key 
mediators of the pro-inflammatory cascade caused by LPS. We also 
demonstrated the novel finding that the anti-inflammatory effects of this 
chalcone are mediated by HO-1, since these effects were totally abolished in 
the presence of SnPPIX, a potent inhibitor of haem oxygenase activity, and HO- 
1 knockout cells using siRNA. To elucidate the transcriptional mechanisms 
involved in the inhibitory actions of 2-HC on LPS-induced production of nitrite 
and TNF-a, the effect of 2-HC on the activation of NF-KB, an essential 
transcription factor for the different inflammatory cytokines and iNOS expression 
(Yamamoto and Gaynor, 2004), was examined. Our results showed that 2-HC 
did not inhibit the LPS-induced translocation of the p65 subunit of NF-KB; these 
findings point out that the inhibition of nitrite production and iNOS expression by 
this compound is not mediated through the p65 subunit of NF-KB pathway. This 
is in disagreement with data in the literature, which showed that one of 2-HC 
derivatives inhibited the activation of NF-KB (Alcaraz et al., 2004). However, in
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order to elucidate the effect of 2-HC on the activation of NF-KB further studies 
are needed, such as electrophoretic mobility shift assay (EMSA), and the 
assessment of the integrity of I KB (Ranjan et al., 2004).
To investigate the mechanisms of induction of HO-1 by 2-HC, we studied 
involvement of MAPK pathways (p38, ERK and JNK), in addition to the PI3K 
pathway. Data in the literature showed evidence of the involvement of MAPK 
pathways in the biological actions of the chalcones (Lee et al., 2002) (Frigo et 
al., 2002), for example, Butein (3,4,2',4-tetrahydroxychalcone) inhibitory effects 
on NF-KB was mediated through the phosphorylation of ERK pathway (Lee, 
2004). Our data suggest that the MAPKs pathway play a minor role in 2-HC- 
mediated induction of haem oxygenase activity and HO-1 expression. PI3K 
pathway is involved in a wide range of signaling pathways, mainly cell 
proliferation, cell death and apoptosis (Song et al., 2005), furthermore, it has 
been shown that PI3K is involved in the activation of phase II response 
enzymes (Lee et al., 2001), based on these findings and the diverse effects of 
PI3K, we examined whether this pathway is involved in the effect of 2-HC on 
haem oxygenase activity and HO-1 expression. In cells treated with LY294002 
(a pharmacological inhibitor of the PI3K pathway) or PI3K siRNA, 2-HC-induced 
haem oxygenase activity and HO-1 protein expression were decreased 
significantly. Our data demonstrated, for the first time, the involvement of the 
PI3K pathway in the 2-HC-mediated induction of haem oxygenase activity and 
HO-1 protein expression. In conclusion, this study demonstrated that 2-HC is an 
anti-inflammatory compound that down regulates the inflammatory response in 
the LPS-macrophages model, in a mechanism which involves the haem 
oxygenase system.
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5 CARBON MONOXIDE-RELEASING MOLECULES MODULATE 
LPS-INDUCED INFLAMMATORY RESPONSE IN RAW 264.7 
MURINE MACROPHAGES
5.1 Introduction
CO has emerged in the last decade as a novel modulatory gas which exhibits a 
wide range of cellular functions including anti-inflammatory (Otterbein et al., 
2000), and anti-apoptotic (Zhang et al., 2003) and has been shown to be 
beneficial in many models of inflammation (Morse, 2003) and l/R injury (Nakao 
et al., 2003) (Nakao et al., 2005). Furthermore, it has been demonstrated that 
CO exhibited inhibitory effects on the LPS-induced inflammatory response in 
vivo (Sarady et al., 2004), and in vitro (Morse et al., 2003). Recently, transitional 
metal carbonyls have been identified as potential CO-releasing molecules (CO- 
RMs) to facilitate the delivery of CO into biological systems (Motterlini, 2005). 
These compounds can release CO at controllable levels, which facilitate their 
use in therapeutic applications. In the present study, the effect of two novel 
water soluble CO-RMs, i.e. CORM-43 and CORM-319 on the inflammatory 
response in a model of inflammation in murine macrophages was examined. 
Previously, other CO-RMs have been studied in various experimental models 
and showed potent vaso-dilatory effects in isolated rat aortic rings (Foresti, 
2004) and protective actions in vitro and in vivo models of cardiac l/R injury 
(Clark, 2003) as well as exhibiting anti-inflammatory effects (Sawle et al., 2005). 
LPS, a constituent of the gram negative bacterial cell wall, is a potent activator 
of macrophages, and induces a cascade of inflammatory responses which 
leads to the production of pro-inflammatory cytokines like TNF-a and IL-1
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(Raetz et al., 1991). This is accompanied by increased expression and activity 
of iNOS, with a concomitant rise in NO generation production released during 
phagocytosis (Nathan, 1997). However, excessive production of NO can result 
in adverse effects, like tissue damage and hypotension, which could lead to 
endotoxic shock and death (Boscp, 2005). NO levels in cells must therefore be 
tightly-regulated (Yamamoto and Gaynor, 2004). The inflammatory response to 
LPS is orchestrated by a group of transcriptional factors, including, NF-KB 
(Guha and Mackman, 2001). Activation of l-KB (which anchors the NF-KB in 
the cytoplasm in un-stimulated cells) by different stimuli such as ROS, cytokines 
and LPS leads to the phosphorylation and proteolysis of l-KB, which leads in 
turn to the translocation of NF-KB into the nucleus (Verma and Stevenson, 
1997). NF-KB has been implicated in the pathogenesis of a number of 
inflammatory diseases including rheumatoid arthritis, inflammatory bowel 
disease and atherosclerosis (Yamamoto and Gaynor, 2004). It has been shown 
that NF-KB plays a critical role in the regulation of iNOS (Surh et al., 2001). It 
was shown previously that CO blocked the LPS-induced NF-KB activation 
(Sarady et al., 2002).
In the present study, two new CO-RMs, CORM-43 and CORM-319 were 
investigated in vitro model of inflammation using LPS-induced inflammation in 
RAW 264.7 murine macrophages, and the different mechanisms involved in this 
process were investigated.
5.2 Objectives
The purpose of this study is to investigate the potential anti-inflammatory effects 
of CORM-43 and CORM-319 in vitro using the LPS-induced responses of 
inflammation in RAW 264.7 murine macrophages.
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5.3 Material and Methods
5.3.1 Preparation of Reagents
CORM-43 and CORM-319 (Table 5-1) were freshly prepared as a 10 mM stock 
solution in dH20. Inactive forms of each CO-RM (negative controls) were also 
used in some experiments and they were prepared as follows: CORM-43 and 
CORM-319 were inactivated by adding cell culture medium to the compound 
and leaving it for 24 h at 37°C in a 5% CO2 humidified atmosphere to liberate 
CO. The iCORM-43 and iCORM-319 solutions were finally bubbled with 
nitrogen to remove the residual CO present in the solution. All other chemicals 
were reagent obtained from Sigma unless otherwise stated.
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Table 5-1: Characteristics of CORM-43 and CORM-319
Code Structure/formula Transition
metal
CORM-43
CORM-319
CO
OC, I H
\ \
Ru'
a / \ \  
____
NH
(CH2)3
\
N NH2 
H
Ru(CO)3CI-arginine
co
CO
[Fe(n-C3H5)(CO)4][BF4]
[BF4]
Ruthenium
Fe
Kinetics 
of CO 
release
Instant
Steady, 
plateau 
At 40 
minutes
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5.3.2 Cell Culture
Murine RAW264.7 macrophages were purchased from the European Collection 
of Cell Cultures (Salisbury, Wiltshire, U.K.) and cultured in DMEM 
supplemented with 10% FBS, 2 mM L-glutamine, penicillin and streptomycin. 
Cultures were maintained at 37°C in a 5% CO2 humidified atmosphere and 
experiments were conducted on cells at approximately 80-90% confluence
5.3.3 Experimental Protocol
RAW 264.7 macrophages were exposed to various concentrations of CORM-43 
or CORM-319 (10, 50 and 100 pM) for 24 h and cell viability was assessed by 
Alamar Blue, Trypan Blue and LDH release at the end of the experiments. To 
examine the potential anti-inflammatory action of these CO-RMs, macrophages 
were exposed for 24 h to LPS (1 pg/ml) in the presence or absence of CORM- 
43 or CORM-319 (10, 50 and 100 pM), nitrite levels and iNOS protein 
expression were then determined at the end of the incubation. Cytotoxicity was 
also determined in cells exposed to LPS (1 pg/ml) and CORM-43 or CORM-319 
at 24 h. Experiments were repeated with the negative controls iCORM-43 and 
iCORM-319 to assess whether the effects observed were due to the CO 
liberated by the CO-RMs or caused by other components of the molecules. The 
effect of CO-RMs and their inactive forms on the haem oxygenase pathway was 
also investigated. Specifically, cells were treated for 6 h or 18 h in the presence 
of 10, 50 and 100 pM CO-RMs and haem oxygenase activity was then 
determined. The levels of TNF-a and IL-10 were also determined in cells 
exposed for 24 h to LPS (0.1 pg/ml) in the presence or absence of CO-RMs or 
their inactive forms. Furthermore, to investigate the effect of CO-RMs on the 
translocation of the transcription factor NF-KB to the nucleus, cells were pre­
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incubated with CORM-43 or its inactive forms for 30 min, followed by treatment 
with LPS 1 pg/ml for 30 and 60 min. at the end of the experimental protocol.
5.3.4 Detection of CO Release
The release of CO from CORM-43 and CORM-319 or iCORM-43 and iCORM- 
319 was assessed spectrophotometrically by measuring the conversion of 
deoxymyoglobin (deoxy-Mb) to carbonmonoxy myoglobin (MbCO) as previously 
described (Motterlini et al., 2002a). The release of CO from metal carbonyl 
complexes was assessed spectrophotometrically by measuring the conversion 
of deoxymyoglobin (deoxy-Mb) to carbonmonoxy myoglobin (MbCO). The 
amount of MbCO formed was quantified by measuring the absorbance at 540 
nm (extinction coefficients 5.4 mmol/L-1 • cm-1). Myoglobin solutions (66 
pmol/L final concentration) were prepared fresh by dissolving the protein in 0.04 
mol/L phosphate buffer (pH 6.8). Sodium dithionite (0.1%) was added to convert 
myoglobin to deoxy-Mb prior to each reading. In contrast, CO released from 
CORM-43 was quantified by adding aliquots of stock solutions (10 pL) of the 
carbonyl complex in water directly to the myoglobin solution. All the spectra 
were measured using a Helios a-spectrophotometer.
5.3.5 Cell Viability/Alamar Blue Assay
Cell viability was determined using an Alamar Blue assay kit, it was carried out 
as previously described in Section 2.3.1.
5.3.6 LDH Assay
Extracellular, i.e., released, LDH activity was measured using cytotoxicity 
detection kit (Roche) as previously described in section 2.3.2.
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5.3.7 Trypan Blue Assay
Trypan Blue exclusion was performed as previously described in section 2.3.3.
5.3.8 Haem Oxygenase Activity Assay
Haem oxygenase activity was determined at the end of each treatment as 
described previously in Section 2.4.3.
5.3.9 Western Blot Analysis for iNOS and NF-KB
Cells were also analyzed for the determination of the protein expression for 
iNOS and NF-KB by Western immunoblot technique as previously described in 
Section 2.5.5.
5.3.10 Determination of Nitrite
Nitrite levels were determined using the Griess method as previously described 
in Section 2.4.4.
5.3.11 Measurement of TNF-a Production
TNF-a present in each sample was determined using a commercially available 
kit from R&D Systems as previously described in Section 2.5.1.
5.3.12 Determination of IL-10 Levels
IL-10 present in each sample was determined using commercially available kit 
from R&D Systems in Section 2.5.2.
5.4 Statistical Analysis
Statistical analysis was performed using one-way ANOVA combined with the 
Bonferroni test. Differences were considered to be significant at P<0.05.
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5.5 Results
5.5.1 Detection of CO Release from CORM-43
The rate and amount of CO liberated from CORM-43 were measured in the cell 
culture medium (DMEM), which was used for cell incubation. In this study, we 
tested the ability of CORM-43 to release CO at 37 °C in DMEM and then we 
measured the kinetic of CO release from CORM-43 as described in the 
Materials and Methods (Section 2.4.5). As shown in Figure 5.1 A, we found that 
the addition of the inactive form (iCORM-43) to deoxymyoglobin dissolved in 
DMEM at 37 °C did not produce any detectable MbCO over a 60 min period. 
However, the addition of CORM-43 (20, 40, and 60 pM) rapidly increased 
MbCO formation and reached a maximal level within minutes of release. For 
instance, after 60 min incubation with CORM-43, MbCO concentration was 14, 
31, and 40 pM at 20, 40, and 60 pM CORM-43 (Figure 5.1 A), which indicates 
that CORM-43 liberate approximately 0.75 mole of CO per 1 mole of compound. 
Absorption spectrum of MbCO after interaction of myoglobin with CO released 
from 20, 40, and 60 pM CORM-43, and 60 pM CORM-43 were compared to 
saturated MbCO (Figure 5.1 B).
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Figure 5.1: Detection of CO released from CORM-43 in DMEM medium
(A) Time course of CO released from 20, 40, and 60 |j M  CORM-43 after incubation in 
DMEM medium (pH=7.4) at 37°C. The amount of CO released was assessed 
spectrophotometrically by measuring the conversion of deoxymyoglobin to 
carbonmonoxy myoglobin (MbCO). (B) Spectra of MbCO formation at 60 min after 
addition of CORM-43 to myoglobin solution. Each line represents the mean ± SEM of 2 
independent experiments. The rate of CO release was calculated from the fitted 
curves. iCORM-43, which does not release CO, was used as negative control.
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5.5.2 Effects of CORM-43 on Cell Viability
Incubation of RAW 264.7 macrophages for 24 h with increasing concentrations 
(10, 50 and 100 pM ) of CORM-43 did not cause cytotoxicity as measured by 
LDH release compared to control (Figure 5.2A). However, exposure of cells to 
the inactive form (iCORM-43) at 100 pM resulted in increased cytotoxicity 
evident by approximately 75% increase in LDH release compared to control 
(Figure 5.2A). A similar effect was observed using Trypan Blue exclusion 
(Figure 5.2B). Cellular metabolism was not affected by the treatment with 
CORM-43 or its inactive form (Figure 5.2 C). It is worth mentioning that the 
discrepancy in the results of the three assays should be borne in mind, the 
alarm blue assay results should be considered with caution, as the results of the 
Alamar blue showed no cytotoxicity in cells treated with iCORM-43, while LDH 
release and trypan blue showed 75% cytotoxicity.
152
UCL- CHAPTER 5
100n
4)(/>Boo
Xo
□  Control 
■  CORM-43
□  iC0RM43
100 100
B 100i
£
o
’5
5o
o
75-
50-
25
□  Control 
■  CORM43
□  ICORM43
10 50
[HM]
100 100
□  Control 
■  CORM-43
□  iCORM-43
0 10 50 100 100
[m-M]
Figure 5.2: Viability of cells exposed to CORM-43.
RAW 264.7 macrophages were exposed for 24 h in the presence of CORM-43 (10-100 
pM). Cell viability was then determined using a LDH release (A) Trypan Blue exclusion 
(B) and Alamar Blue (C). Bars represent the mean ± S.E.M. of 6 independent 
experiments, * P < 0.001 vs. control.
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5.5.3 Viability Data of Cells Exposed to CORM-43 and LPS
Exposure of RAW 264.7 macrophages to LPS 1 pg/ml resulted in increased cell 
injury as indicated by a significant increase by 60% in LDH release (Figure 5.3 
A). However, the presence of CORM-43 (10-100 pM) markedly reversed this 
effect (Figure 5.3 A). Interestingly, cell viability assessed with Alamar Blue 
assay indicated that co-incubation of cells with CORM-43 at (100 pM) or 
iCORM-43 and LPS resulted in reduction in cellular metabolic activity (80% of 
the control) (Figure 5.3 B).
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Figure 5.3 : Viability of cells exposed to CORM-43 and LPS
RAW 264.7 macrophages were treated with CORM-43 (10-100 pM) and LPS 1pg/ml 
for 24 h, cell viability was then determined using a LDH release (A) Trypan Blue 
exclusion (B) and Alamar Blue (C). Bars represent the mean ± S.E.M. of 6 independent 
experiments, * P < 0.001 vs. control, f  P < 0.001 vs. LPS.
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5.5.4 Effect of CORM-43 on LPS-Stimulated Nitrite Production and iNOS 
Expression
Recently, the important anti-inflammatory actions exerted by CO gas have been 
highlighted, these findings incited us to assess whether CORM-43 could inhibit 
the inflammatory response in LPS-activated macrophages (Otterbein, 2002). As 
shown in (Figure 5.4) CORM-43 significantly attenuated LPS-induced nitrite 
production and iNOS protein expression in a concentration-dependent manner. 
This effect appeared to be dependent on the CO released by the compounds, 
since iCORM-43, which does not liberate CO, did not have any significant effect 
on nitrite levels. It is important to note that cell viability was not affected by the 
concentrations of CORM-43 (Figure 5.3). However, iCORM-43 caused 
significant cytotoxicity as detected by 75% increase in LDH release (Figure 5.3 
A) indicating that the results observed are not related to cytotoxicity of the 
compounds.
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Figure 5.4: CORM-43 modulates LPS-stimulated nitrite production and iNOS 
expression.
RAW264.7 macrophages were exposed to various concentrations (10-100 pM) of 
CORM-43 or iCORM-43 (100 pM) in the presence of LPS 1 pg/ml for 24 h. Nitrite 
production (A) and iNOS expression (B) were then determined at 24 h. Cells treated 
with medium alone represented control (0). Bars represent the mean ± S.E.M. of 5-6 
independent experiments, * P < 0.001 vs. control, t  P < 0.001 vs. LPS. Western Blot is 
a representative of three independent experiments. (3-actin was used as an internal 
control for equal loading.
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5.5.5 CORM-43 Attenuates LPS-Stimulated TNF-a Production.
We then tested the effect of CORM-43 on LPS-induced TNF-a production, 
treatment of macrophages with LPS resulted in a significant increase in the 
production of TNF-a (Figure 5.5 A), however, the addition of CORM-43 at 10 
pM did not affect TNF-a production (Figure 5.5 A). CORM-43 at 50 and 100 pM 
aggravated the LPS-induced TNF-a production. Similarly, co-incubation of cells 
with LPS and iCORM-43 increased TNF-a levels suggesting that the CO 
released from CORM-43 at high concentrations as well as the iCORM-43 act as 
pro-inflammatory agents. As shown in (Figure 5.5 B) treatment of macrophages 
with LPS resulted in a significant increase in the production of IL-10. 
Furthermore, CORM-43 increased the production of IL-10, Figure 5.5 B), 
suggesting that CORM-43 increases the anti-inflammatory response in 
macrophages.
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Figure 5.5: CORM-43 attenuates LPS-stimulated TNF-a production and increases 
the production of IL-10.
RAW 264.7 macrophages were exposed to LPS (0.1 pg/ml) for 24 h in the presence or 
absence of CORM-43 (10-100 pM), TNF-a (A) and IL-10 production (B) were 
determined. Bars represent the mean ± S.E.M. of 6 independent experiments, * P < 
0.001 vs. Control.
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5.5.6 The Effect of CORM-43 on Haem Oxygenase Activity
Recently, it was suggested that other water soluble CO-RMs have the ability to 
induce haem oxygenase activity and HO-1 expression (Sawle et al., 2005). 
Therefore, the effect of CORM-43 on haem oxygenase activity was measured. 
RAW 264.7 macrophages were incubated for 6 or 18 h with different 
concentrations of CORM-43 or its inactive form for 6 h. Treatment of cells with 
CORM-43 resulted a minor (insignificant) increase in haem oxygenase activity 
after 6 h (Figure 5.6 A) at (50 and 100 pM), and to a lesser extent after 18 h 
incubation (Figure 5.6 B). Furthermore, the effect of iCORM-43 on haem 
oxygenase activity was comparable to the effect of CORM-43, which could be 
related to the cytotoxicity of iCORM-43.
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Figure 5.6: The effect of CORM-43 on haem oxygenase activity in RAW 264.7  
m acrophages.
RAW 264.7 macrophages were exposed to various concentrations (10-100 pM) of 
CORM-43 for 6 h (A) or 18 h (B) and haem oxygenase activity was determined at the 
end of the incubation. Cells treated with medium alone represented control (0). Bars 
represent the mean ± S.E.M. of 5-6 independent experiments per group.* P < 0.05 vs. 
OpM.
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5.5.7 Effect of CORM-43 on the Nuclear Translocation of NF-KB
The activation of NF-KB in cells exposed to LPS and CORM-43 was determined 
by Western blotting of nuclear extracts; LPS caused translocation of NF-KB to 
the nucleus after 30 min. CORM-43 at 50 and 100 pm partially inhibited the 
translocation of the p65 subunit of NF-KB elicited by LPS (Figure 5.7).
P65
P-Actin
r n mut
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100 pM
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Figure 5.7: Effect of CORM-43 on NF-KB
RAW 264.7 macrophages were pre-treated with various concentrations of CORM-43 
(10-100 pM) and iCORM-43 (100 pM) for 30 min. followed by an additional 30 min. 
incubation with LPS (1 pg/ml). The translocation of the P65 subunit of NF-KB to the 
nucleus was determined in nuclear extracts by Western Blot. Western blot is a 
representative of three independent experiments. (B-actin was used as an internal 
control for equal loading.
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5.5.8 The effect of CORM-43 on the phosphorylation of the AKT 
pathway
It was demonstared that CO targets the AKT pathway (Fujimoto et al., 2004), 
RAW 264.7 macrophages were pre-treated with various concentrations of 
CORM-43 (10-100 pM) and iCORM-43 (100 pM) for 30 min. The 
phosphorylation of AKT was then determined by Western Blot, Our results 
showed that treatment of RAW 167.4 macrophages with various concentrations 
(10-100) of CORM-43 resulted in the phosphorylation of the AKT pathway; 
however, this effect was not observed when cells were exposed to iCORM-43 
(100 pM).
Phos A K T------------ ►
Total A K T--------------►
P-Actin ------------ ►
CORM-43 [pM]
Figure 5.8: Effect of CORM-43 on the phosphorylation of AKT
RAW 264.7 macrophages were pre-treated with various concentrations of CORM-43 
(10-100 pM) and iCORM-43 (100 pM) for 30 min. The phosphorylation of AKT was 
then determined by Western Blot. Western blot is a representative of three independent 
experiments. (3-actin was used as an internal control for equal loading.
iCORM 10
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5.5.9 Detection of CO Release from CORM-319
Using the myoglobin assay to detect the formation of MbCO as described in 
Chapter 2 (Section 2.4.5), we tested the ability of 10, 20, 40, and 60 pM CORM- 
319 to release CO at 37 °C in the cell culture medium (DMEM). Here, we found 
that the rate of CO release by CORM-319 in DMEM at 37 °C directly correlates 
with the concentrations used (Figure 5.9). Specifically, the calculated rates of 
CO release were 0.14, 0.31, 0.43, and 0.60 nmol/min for 10, 20, 40 and 60 pM 
CORM-319, respectively. Predictably, the inactive compound (iCORM-319) did 
not release any detectable CO in the DMEM at 37 °C (Figure 5.9A). 
Interestingly, the increase in MbCO formation after addition of 60 pM CORM- 
319 to DMEM reached almost a maximal level after 40 min.
Absorption spectrum of MbCO after interaction of myoglobin with CO released 
from 10, 20, 40, and 60 pM CORM-319 and 60 pM iCORM-319 were compared 
to saturated MbCO (Figure 5.9 B).
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Figure 5.9: Detection of CO released from CORM-319 in DMEM
(A) Time course of CO released from 10, 20, 40, and 60 pM CORM-319 after 
incubation in DMEM medium (pH=7.4) at 37 °C. The amount of CO released was 
assessed spectrophotometrically by measuring the conversion of deoxymyoglobin to 
carbonmonoxy myoglobin (MbCO). (B) Spectra of MbCO formation at 60 min after 
addition of CORM-319 to myoglobin solution. Each line represents the mean ± SEM of 
2 independent experiments. The rate of CO release was calculated from the fitted 
curves. iCORM-319, which does not release CO, was used as negative control.
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5.5.10 Effects of CORM-319 on Cell Viability
We next examined the other CO-RM, i.e. CORM-319, measurements of LDH 
release as an index of cell damage showed that incubation of RAW 264.7 
macrophages for 24 h with increasing concentrations (10 and 50 pM ) of 
CORM-319, did not cause cytotoxicity compared to control (Figure 5.10 A). 
However, exposure of cells to 100 pM and the inactive form (iCORM-319) at 
100 pM concentration resulted in increased cell death evident by an 
approximately 75% increase in LDH release compared to control (Figure 5.10 
A). A similar effect was observed using Trypan Blue exclusion (Figure 5.10 B). 
Cellular metabolism was not affected by the treatment with CORM-319; 
however, there was a mild decrease in cellular metabolism in cells treated with 
iCORM-319 (Figure 5.10 C). These results should be borne in mind when 
interpreting the data, the discrepancy between the cytotoxicity data obtained 
from Trypan Blue and LDH release, and Alamar Blue could be due to the fact 
that Alamar Blue has a low sensitivity in detection of cytotoxicity in RAW 2647 
macrophages. Therefore, it is tempting to speculate that Trypan Blue and LDH 
release are more sensitive cytotoxicity assays than Alamar Blue in these 
particular experimental settings.
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Figure 5.10: Viability of cells exposed to CORM-319
RAW 264.7 macrophages were exposed for 24 h to CORM-319 (10-100 pM) or 
iCORM-319 and cell viability was determined using LDH release (A) Trypan Blue 
exclusion (B) and Alamar Blue (C). Bars represent the mean ± S.E.M. of 6 independent 
experiments, * P < 0.001 vs. control.
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5.5.11 Effect of CORM-319 on LPS-stimulated Nitrite Production and 
iNOS Expression
We then examined the potential anti-inflammatory properties of CORM-319. As 
shown in (Figure 5.11), CORM-319 significantly attenuated LPS-induced nitrite 
production and iNOS protein expression in a concentration-dependent manner; 
iCORM-319 exhibited a significant inhibitory effect on nitrite levels (Figure 5.11 
A) and iNOS expression (Figure 5.11 B), which could be explained by the fact 
that co-incubation of cells with LPS and iCORM-319 resulted in a significant 
cytotoxicity (Figure 5.12 A). It is important to note that cell viability was not 
affected by lower concentrations of CORM4-319; (i.e. 10 and 50 pM). However, 
CORM-319 at 100 pM caused significant cytotoxicity as detected by 45% 
increase in LDH release (Figure 5.12 A), indicating that the reduction in nitrite 
and iNOS expression (Figure 5.11 A) resulted from cytotoxicity of this 
compound at high concentrations.
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Figure 5.11: CORM-319 modulates LPS-stimulated nitrite production and iNOS 
expression.
RAW264.7 macrophages were exposed to various concentrations (10-100 pM) of 
CORM-319 or iCORM-319 (100 pM) in the presence of LPS 1 pg/ml for 24 h, nitrite 
production (A) and iNOS expression (B) were determined at 24 h. Cells treated with 
medium alone represented control (0). Bars represent the mean ± S.E.M. of 5-6 
independent experiments, * P<  0.001 vs. control, f  P < 0.001 vs. LPS. Western blot is 
a representative of three independent experiments, p-actin was used as an internal 
control for equal loading.
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5.5.12 Viability of Cells Exposed to CORM-319 and LPS
Exposure of RAW 264.7 macrophages to LPS 1 pg/ml resulted in increased 
cytotoxicity as indicated by a significant increase in LDH release (30%) (Figure
5.12 A), however, the presence of CORM-319 at 10 and 50 pM significantly 
reduced the cytotoxicity exhibited by LPS. CORM-319 at 100 pM, however, 
caused significant cytotoxicity as detected by a 45% increase in LDH release 
(Figure 5.12 A). This toxic effect was not reflected in the cellular metabolism 
assay (Figure 5.12 B). Interestingly, cell viability assessed with Alamar Blue 
indicated that co-incubation of cells with CORM-319 at 100 pM or iCORM-319 
and LPS resulted in a significant reduction in cellular metabolic activity (80% of 
the control) (Figure 5.12 B).
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Figure 5.12: Viability data in macrophages exposed to CORM-319 and LPS
RAW264.7 macrophages were exposed to various concentrations (10-100 pM) of 
CORM-319 or iCORM-319 (100 pM) in the presence of LPS 1 pg/ml for 24 h. Cell 
viablity was then determined using LDH release (A) and Alamar Blue (B). Cells treated 
with medium alone represented control (0). Bars represent the mean ± S.E.M. of 5-6 
independent experiments, * P < 0.001 vs. control, f  P < 0.001 vs. LPS. Western Blot is 
a representative of three independent experiments. (3-actin was used as an internal 
control for equal loading.
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5.5.13 CORM-319 Attenuates LPS-Stimulated TNF-a Production and 
Increases IL-10 Production.
LPS caused a significant production of TNF-a in macrophages and the addition 
of CORM-319 at (10, 50 and 100 pM) significantly decreased this effect (Figure
5.13 A). However, the addition of iCORM-319 to the LPS-stimulated 
macrophages did not affect the TNF-a level. As shown in (Figure 5.13 B), 
treatment of cells with LPS resulted in a significant increase in the production of 
IL-10. Furthermore, CORM-319 significantly increased the production of IL-10. 
Co-incubation of cells with LPS and CORM-319 did not have any significant 
effect on IL-10 levels compared to cells treated with LPS alone (Figure 5.13 B) 
as the levels of IL-10 are comparable between cells treated with LPS alone or 
the combination of LPS and CORM-319, which might indicate that both LPS 
and CORM-319 may be acting via similar pathways. It is intriguing to note that 
iCORM-319 did not affect the LPS-induced TNF-a levels, however, this 
compound significantly reduced the LPS-induced IL-10 production.
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Figure 5.13: CORM-319 attenuates LPS-stimulated TNF-a production and 
increases the production of IL-10.
RAW264.7 macrophages were exposed to LPS (0.1 pg/nil) for 24 h in the presence or 
absence of CORM-319 (10-100 pM) or iCORM-319. TNF-a production (A) and IL-10
(B) were then determined. Bars represent the mean ± S.E.M. of 6 independent 
experiments, * P < 0.001 vs. control, f  < 0.05 vs. LPS.
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5.5.14 The Effect of CORM-319 on Haem Oxygenase Activity
RAW 264.7 macrophages were incubated for 6 or 18 h with different 
concentrations of CORM-319 or iCORM-319. Treatment of cells with CORM- 
319 and its inactive form did not affect the level of haem oxygenase activity 
after 6 h (Figure 5.14 A) or 18 h (Figure 5.14 B).
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Figure 5.14: The effect of CORM-319 on haem oxygenase activity in RAW264.7 
macrophages.
RAW 264.7 macrophages were exposed to various concentrations (10-100 pM) of 
CORM-319 or iCORM-319 for 6 h (A) or 18 h (B). Haem oxygenase activity was then 
determined at the end of the incubation. Cells treated with medium alone represented 
control (0). Bars represent the mean ± S.E.M. of 5-6 independent experiments per 
group.* P < 0.001 vs. 0 pM.
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5.5.15 The effect of biliverdin on the LPS-induced nitrite and TNF-a 
production
In this section, we utilised biliverdin, one of the products of the HO-1 pathway, 
to test the ability of this compound to combat the LPS-mediated nitrite and TNF- 
a production, treatment of RAW264.7 macrophages with various concentrations 
of biliverdin did not result in any effect on the LPS-mediated nitrite and TNF-a 
production see (Figure 5.15).
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Figure 5.15 The effect of biliverdin on the LPS-induced nitrite and TNF-a 
production
(A) RAW264.7 macrophages were exposed to various concentrations (5-15 pM) of 
biliverdin in the presence of LPS 1 pg/ml for 24 h. Nitrite production was then 
determined. (B) RAW264.7 macrophages were exposed to LPS (0.1 pg/ml) for 24 h in 
the presence or absence of biliverdin (5-15 pM) TNF-a production were then 
determined. Bars represent the mean ± S.E.M. of 6 independent experiments, * P < 
0.001 vs. control.
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5.6 Discussion
There is a growing interest in the role of CO in cytoprotection, CO administered 
as a gas was shown to exhibit protective effects in l/R injury in rat intestinal 
grafts (Nakao et al., 2003), in lung hyperoxic injury (Otterbein et al., 1999) and 
suppressed the acute hypertensive response in vivo (Motterlini et al., 1998). In 
many experimental approaches, the inhalation or administration of exogenous 
CO gas in therapeutic applications showed beneficial results (Otterbein et al., 
1999). However, these methods of delivering CO have limitations, including 
handling and storage of CO gas (Motterlini et al., 2005a). The need for a more 
practical and reliable method of delivering CO into the tissue in a controllable 
fashion lead to the development of new compounds, which have the ability to 
release CO in biological milieu (Motterlini et al., 2005b). Recently, our group 
developed a group of transitional metal carbonyls which have the intrinsic ability 
to liberate CO in biological systems (Clark et al., 2003). These groups have 
been identified generically as CO-releasing molecules (CO-RMs). Our initial 
studies showed that these compounds have important beneficial effects in 
biological systems, with versatile chemical properties that could facilitate the 
delivery of CO into the biological milieu (Foresti, 2004) and could be considered 
as a potential therapeutic approach in many pathological states (Clark et al., 
2003). CO-RMs have similar beneficial pharmacological effects characteristics 
of CO gas, which include: vaso-relaxation of pre-contracted isolated aortic rings 
(Motterlini, 2005) (Foresti, 2004), CO-RMs attenuated the LPS-induced 
inflammatory response in RAW 264.7 murine macrophages (Sawle et al., 2005) 
and reduced the infarct size in vivo (Guo et al., 2004).
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In the present study, two new water soluble CO-RMs (CORM-43 and CORM- 
319) were investigated in an in vitro model of inflammation using LPS-induced 
inflammation in RAW 264.7 murine macrophages. In the present study, we 
found that CORM-43 and CORM-319 exhibited inhibitory effects on the LPS- 
induced nitrite production and iNOS expression. Incubation of RAW 264.7 
macrophages with CORM-43 for 24 h of did not cause cytotoxicity as measured 
by LDH release and Trypan Blue, however, iCORM-43 at 100 pM resulted in 
increased cytotoxicity evident by approximately 75% increase in LDH release 
and Trypan Blue, while cellular metabolism was normal. It is worth mentioning 
that the discrepancy in the results of the three assays should be borne in mind, 
the Alamar blue assay results should be considered with caution, as the results 
of the Alamar blue showed no cytotoxicity in cells treated with iCORM-43, while 
LDH release and trypan blue showed 75% cytotoxicity. This could be due to 
interference of iCORM-43 and the Alamar Blue dye. It is worth mentioning that 
the treatment of macrophages with the combination of LPS and either CORM- 
43 or CORM-319 did not result in any cytotoxicity, therefore, the reduction in 
the nitrite production and iNOS expression was solely due to the effects of 
these CO-RMs. However, co-incubation of CORM-319 at a concentration of 100 
pM and LPS resulted in a significant cytotoxicity as measured by LDH release, 
and therefore, we conclude that the inhibitory effect of CORM-319 at 100 pM on 
nitrite and iNOS expression is due to cytotoxicity. These results are in 
disagreement with the findings obtained by our group previously, in which two 
other water soluble CO-RMs (CORM-3 and CORM-2) did not affect iNOS 
expression in murine macrophages (Sawle et al., 2005). It is interesting to note 
that different CO-RMs exert differential effects on iNOS expression, which might
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be due to the different chemical structures of these compounds. To further 
elucidate the different aspects of the anti-inflammatory properties of CORM-43 
and CORM-319, the effects of these compounds on the production of the pro- 
inflammatory (TNF-a) and the anti-inflammatory (IL-10) cytokines were studied. 
Our data showed that CORM-43 did not affect the LPS-induced TNF-a 
production, while at higher concentrations (50-100 pM) CORM-43 increased the 
production of this pro-inflammatory cytokine, it is possible that CORM-43 at 
higher concentrations acts as a pro-inflammatory agent. However, it is 
interesting to note that both CORM-43 and CORM-319 caused a significant 
increase in the production of IL-10 in un-stimulated cells, in LPS-stimulated 
cells, CORM-43 and CORM-319 did not have any significant effect on the 
production of IL-10. This is in a strong support of the anti-inflammatory 
properties of CO-RMs (Sawle et al., 2005). It is tempting to speculate that the 
CO released from both CORM-43 and CORM-319 exert their anti-inflammatory 
properties by up-regulation of anti-inflammatory cytokine, while not affecting the 
production of the pro-inflammatory cytokines, it has been shown that CO 
augmented the production of the ant-inflammatory IL-10 and mediated anti­
inflammatory effects of IL-10 in mice (Lee and Chau, 2002).
The NF-KB family of transcription factors controls the expression of many 
genes, including genes encoding cytokines (Sarady et al., 2004). We 
speculated that CO exerts its anti-inflammatory effects by inhibiting the LPS- 
mediated activation of NF-KB pathway (Sarady et al., 2002). We therefore 
investigated the effect of CO released from CORM-43 on the activation of NF- 
KB. Our data demonstrated that CORM-43 did not have any significant effect on 
LPS-mediated translocation of the p65 of NF-KB to the nucleus. Therefore, it is
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plausible to conclude that this CORM-43 does not exert inhibitory effects on the 
NF-KB pathway, and probably activates or deactivates other cellular pathways 
that mediate its inhibitory effects on the cytokines and on nitrite production. 
However, one cannot make a conclusion without undertaking further detailed 
studies to elucidate the effect of CORM-43 on the activation of NF-KB, such as 
measuring the activation of NF-KB using EMSA as well as the assessment of 
the integrity of IKB. Our data is in disagreement with data in the literature that 
showed that CO inhibited the activation of NF-KB (Sarady et al., 2002). 
Furthermore, our data showed that CORM-43 results in the activation of the 
AKT pathway, our data is in agreement with previous data in the literature which 
showed that CO gas targets the AKT pathway (Fujimoto et al., 2004). We then 
investigated the mechanisms by which CORM-43 and CORM-319 exert their 
anti-inflammatory effects; one possible pathway is the haem oxygenase system. 
It was shown that other CO-RMs are potent inducers of haem oxygenase 
activity and HO-1 expression (Sawle et al., 2005). Treatment of cells with 
CORM-43 resulted in a minor (insignificant) increase in haem oxygenase 
activity after 6 h and to a lesser extent after 18 h incubation. Furthermore, the 
effect of iCORM-43 on haem oxygenase activity was comparable to the effect of 
CORM-43, and therefore, this effect is not CO-dependent. In addition, treatment 
of cells with iCORM-43 resulted in cytotoxicity, which indicates that the 
insignificant effect of iCORM-43 on haem oxygenase activity might be due the 
effect on the cells. We conclude that CORM-43 and CORM-319 are targeting 
cellular pathways that do not involve the haem oxygenase system. Our results 
showed that biliverdin, one of the products of the HO-1 pathway, was unable to 
reduce the LPS-mediated nitrite and TNF-a production, treatment of RAW264.7
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macrophages with various concentrations of biliverdin did not result in any effect 
on the LPS-mediated nitrite and TNF-a production. This data is in agreement 
with data provided by our group (Swale et al., 2005).
In conclusion, the present study identified two new water soluble CO-RMs, and 
explored their anti-inflammatory effects, furthermore, it supports the anti­
inflammatory action of CO-RMs in an in vitro model of LPS-mediated 
inflammation and supports the further testing of CO-RMs.
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6  CURCUMIN ATTENUATES THE OXIDANT-DAMAGE 
STIMULATED BY H20 2 IN HUMAN CARDIAC MYOBLASTS
6.1 Introduction
Curcumin is a naturally-occurring yellow pigment presents in the plant Curcuma 
longa (turmeric) (Ammon and Wahl, 1991). The significance of this compound in 
health and nutrition has changed considerably since the discovery of the 
antioxidant properties of naturally occurring phenolic compounds 
(Balasubramanyam et al., 2003). The dried rhizome of C. longa (used as a 
spice, food preservative and a colouring agent) is a rich source of beneficial 
phenolic compounds; the curcuminoids, which are a group of phenolics present 
in turmeric (Chainani-Wu, 2003). Three major curcuminoids have been isolated 
from turmeric namely: curcumin (diferuloylmethane) which makes up 
approximately 90% of the curcuminoids content, followed by 
demethoxycurcumin, and bisdemethoxycurcumin (Ruby et al., 1995). In this 
study we have tested curcumin (
), which possesses intrinsic anti-inflammatory, antioxidant and anti-tumour 
actions (Song et al., 2001) (Lim et al., 2001) (Huang et al., 1991) (Menon et al., 
1999).
It has been suggested that oxidative stress play a major role in the 
pathogenesis of cardiovascular diseases (Hamilton et al., 2004). Oxidative 
stress is the result of excessive production of ROS and or depletion of 
intracellular antioxidant defenses, leading to an imbalance in the redox status of 
the cell (Miquel et al., 2002). Due largely to the detrimental nature of ROS and 
electrophilic species, mammalian cells have evolved a number of anti- oxidative
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and phase II detoxifying enzymes to protect against oxidative and electrophilic 
cell damage (Talalay, 2005). In recent years, much attention has been focused 
on HO-1, one of the phase II enzyme responses (Owuor and Kong, 2002). It 
has been suggested that it functions primarily as an effective system to 
counteract oxidative stress (Maines, 1997). HO-1 is the rate-limiting enzyme in 
the conversion of haem into biliverdin, releasing free iron and carbon monoxide 
(Maines, 1997). Biliverdin is rapidly metabolized to bilirubin, which is a potent 
antioxidant (Otterbein and Choi, 2000). The proposed antioxidant role for HO-1 
is based on some crucial experimental observations: HO-1 gene expression is 
extremely sensitive to up-regulation by oxidative stress in a variety of 
mammalian tissues (Ryter et al., 2002), induction of HO-1 protein protects 
tissues against oxidant-mediated injury (Llesuy and Tomaro, 1994), and HO-1 
knockout mice exhibited reduced stress defenses when exposed to oxidative 
challenge (Agarwal and Nick, 2000). Since biliverdin and bilirubin have been 
shown to possess potent antioxidant properties (Ryter et al., 2002) and up- 
regulation of HO-1 is usually accompanied by increased levels of ferritin, a 
protein which sequesters intracellular catalytic iron (Balia et al., 1992), HO-1 
appears to be an excellent candidate for cytoprotection. Therefore, HO-1 can be 
regarded as a potential therapeutic target in a variety of oxidant-mediated 
diseases. In this respect, the search for novel and more potent inducers of this 
pathway will facilitate the development of pharmacological strategies to 
increase the intrinsic capacity of cells to maximize HO-1 expression and, 
ultimately, cytoprotection (Motterlini et al., 2000b).
There has been mounting evidence in the literature which showed that curcumin 
is a strong inducer of HO-1 in various cell types. It was demonstrated that
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curcumin induces HO-1 and protects endothelial cells, astrocytes and renal 
epithelial cells (Scapagnini et al., 2002) (Balogun et al., 2003a) against 
oxidative stress. It is suggested that some beneficial effects of curcumin might 
be mediated by its inherent ability to increase HO-1 and possibly other 
intracellular protective pathways such as activation of the endogenous 
detoxifying enzymes (e.g. phase II enzymes) for (Motterlini et al., 2000b). 
Recently, curcumin has been shown to exhibit anti-inflammatory (Chainani-Wu, 
2003), and anti-atherogenic activities due to its ability to scavenge superoxide 
anions (Sugiyama, 1996). In the present study, we aimed to investigate the 
protective effect of curcumin against H2 0 2 -induced cell damage in human 
cardiac myoblasts (Girardi cells). In this study we attempted to explore the 
possible mechanisms underlying the antioxidant effects of curcumin, with focus 
on the role of HO-1.
6.2 Objectives
To study the effects of curcumin on haem oxygenase activity and HO-1 protein 
expression in Girardi cells, in addition to examining the effects of curcumin on 
H202-mediated oxidative stress in Girardi cells.
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6.3 Materials and Methods 
6.3.1 Reagents
Curcumin and all other reagents were purchased from Sigma. Haemin and Tin 
Protoporphyrin were obtained from Porphyrin Products INC (Logan, Utah, 
USA). Alamar Blue reagent was obtained from Serotec; (Oxford, UK).
6.3.2 Cell Culture
Girardi (Human cardiac myoblasts) were purchased from the European 
Collection of Cell Cultures (ECACC, Salisbury, Wiltshire, UK) and cultured in 
Dulbecco's modified Eagle's medium containing, 3.5 mM glutamine, 100 units/ml 
penicillin, and 0.1 mg/ml streptomycin and supplemented with 10% FBS, in 
addition to 1 % Non-essential amino acids. Cells were grown in 75-cm2 flasks 
and maintained at 37°C in a humidified atmosphere of air and 5% CO2. 
Confluent cells were exposed to various reagents, haem oxygenase activity, 
HO-1 protein expression and cell viability assays were employed after each 
treatment.
6.3.3 Experimental Protocol
Confluent cells were exposed to curcumin (15 pM) for 2, 4, and 6 h, haem 
oxygenase activity was then determined at the end of the incubation. Haem 
oxygenase activity and HO-1 protein expression were also measured in cells 
exposed for 6 to various concentrations (5, 15 and 30 pM) of curcumin or 
haemin (5-20 pM). Cell viability was assessed using a metabolic assay (Alamar 
Blue) and LDH release after 24. To assess the range of cytotoxicity induced by
186
A ._________________________________________________ CHAPTER 6
H2O2 in the cells, Girardi cells were treated with increasing concentrations of 
H2O2 (0.75, 1.5, and 3 mM) for 2, 4 and 6 h; cell viability was then assessed 
using Alamar Blue. The potential anti-oxidant effects of curcumin was also 
examined; for this purpose, cells were pre-treated with this compound for 6 h, 
the culture medium was then removed and cells were then exposed for 2, 4 or 6 
h to various concentrations (0.75, 1.5 and 3 mM) of H2O2. In a similar set of 
experiments, haemin (5 or 10 pM) was added to examine the possibility of 
synergism between haemin (a known inducer of HO-1) and curcumin. To 
assess the range of cytotoxicity induced by H2O2 in the cells, for this purpose, 
cells were treated with increasing concentrations of H2O2 (0.75, 1.5, and 3 mM) 
for 2, 4 and 6 h; cell viability was then assessed by measuring the LDH release. 
Similar experiments were performed using higher concentrations of H2O2 (3, 6 
and 9 mM) for 2, 4 and 6 h. In order to examine the involvement of HO-1 in the 
anti-oxidant effects of curcumin, cells were pre-treated with of curcumin 15 pM 
for 6 h and then exposed to different concentrations of H2O2 (3, and 6 mM) for 6 
h in the presence or absence of SnPPIX 10 pM. Viability was then determined 
using Alamar Blue assay and LDH release.
6.3.4 Cell Viability/Alamar Blue Assay
Cell viability was determined using an Alamar Blue assay kit, it was carried out 
as previously described in Section 2.3.1.
6.3.5 LDH Assay
Extracellular, i.e., released, LDH activity was measured using cytotoxicity 
detection kit (Roche) as previously described in section 2.3.2.
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6.3.6 Trypan Blue Assay
Trypan Blue exclusion was performed as previously described in section 2.3.3.
6.3.7 Haem Oxygenase Activity Assay
Haem oxygenase activity was determined at the end of each treatment as 
described previously in Section 2.4.3.
6.3.8 Western Blot Analysis for HO-1
Cells were also analyzed for the determination of the protein expression for HO- 
1by Western immunoblot technique as previously described in Section 2.5.5.
6.4 Statistical Analysis
Statistical analysis was performed using one-way ANOVA combined with the 
Bonferroni test. Differences were considered to be significant at P<0.05.
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6.5 Results
6.5.1 The Effect of Curcumin on Haem Oxygenase Activity and HO-1 
Expression in Girardi Cells
It was reported previously that curcumin induces haem oxygenase activity and 
HO-1 expression in renal epithelial cells (Balogun et al., 2003b). In order to 
establish the effect of curcumin on haem oxygenase activity and HO-1 in Girardi 
cells, cells were exposed to curcumin (15 pM) for 2, 4 and 6 h. As shown in 
(Figure 6.1 A), treatment of cells with curcumin (15 pM) resulted in a time- 
dependent increase in haem oxygenase activity. When cells were exposed to 
increasing concentrations of curcumin (5-30 pM), a concentration-dependent 
increase in haem  oxygenase activity HO-1 protein expression as shown in 
(Figure 6.1 B) w as observed.
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Figure 6.1: The effect of curcumin on haem oxygenase activity and HO-1 
expression in Girardi cells
Girardi cells were exposed to curcumin 15 pM for 2, 4 and 6 h (A), and to curcumin (5- 
30 pM) for 6 h (B). Haem oxygenase activity and HO-1 protein expression were then 
determined at the end of the incubation. Cells treated with medium alone represented 
control (0). Western Blot is a representative of three independent experiments. Bars 
represent the mean ± S.E.M. of 5-6 independent experiments per group.* P < 0.001 vs. 
control. (3-actin was used as an internal control for equal loading. . HO-1: positive 
control recombinant HO-1 protein, MW: molecular weight marker.
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6.5.2 The Effect of Haemin on Haem Oxygenase Activity and HO-1 
Expression in Girardi Cells
Haemin is the substrate for the haem oxygenase enzymatic reaction (Maines, 
1988) and it was reported previously that it induces haem oxygenase activity 
and HO-1 expression in different cell lines (Foresti et al., 2003). As shown in 
(Figure 6.2), exposure of Girardi cells for 6 h to haemin resulted in a dramatic 
and concentration-dependent increase in haem oxygenase activity and HO-1 
protein expression at 6 h with a maximal expression at concentration (20 pM).
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Figure 6.2: The effect of haemin on haem oxygenase activity and HO-1 
expression in Girardi cells
Girardi cells were exposed to various concentrations (5-20 pM) of haemin for 6 h. 
Haem oxygenase activity and HO-1 protein expression were determined at the end of 
the incubation. Cells treated with medium alone represented control (0). Western Blot 
is a representative of three independent experiments. Bars represent the mean ± 
S.E.M. of 5-6 independent experiments per group.* P < 0.001 vs. 0 pM. |3-actin was 
used as an internal control for equal loading. HO-1: positive control recombinant HO-1 
protein, MW: molecular weight marker.
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6.5.3 Cytotoxicity in Ceils Treated with Curcumin
Measurements of LDH release as an index of cell damage showed that 
incubation of Girardi cells for 24 h with increasing concentrations (5, 15) of 
curcumin did not cause cytotoxicity compared to control (Figure 6.3 A). While 
exposure of cells to (30 pM) concentration, resulted in increased cell evident by 
approximately 50% increase in LDH release compared to control. A similar 
effect was also observed using Trypan Blue exclusion, in cells treated with 30 
pM curcumin, but not with 5 or 15 pM (Figure 6.3 B).
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Figure 6.3: Viability of cells exposed to curcumin.
Girardi cells were exposed to for 24 h in the presence of curcumin (5-30 pM). Cell 
viability was determined using LDH release (A) and Trypan Blue exclusion (B). Bars 
represent the mean ± S.E.M. of 5-6 independent experiments, * P < 0.001 vs. control.
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6.5.4 Effect of H2O2 on Cell Metabolism
Oxidative stress has been suggested to play a critical role in a number of 
cardiovascular pathologies, such as atherosclerosis and l/R injury, in which 
ROS including superoxide, H2O2 and hydroxyl radicals are found in the 
myocardium (Chen et al., 2000). Therefore, it is of importance to investigate the 
effects and the potential therapeutic approaches to the H2 0 2 -mediated cardiac 
injury. First, we wanted to identify the cytotoxicity range of H2O2, for this 
purpose, Girardi cells were treated with increasing concentrations of H2O2 (0.75, 
1.5, and 3 mM) for 2, 4 and 6 h (Figure 6.4). Exposure of cells to this protocol 
resulted in a concentration and time-dependent decline in cell metabolism 
(50%) (Figure 6.4 A), 40% (Figure 6.4 B) and 35% (Figure 6.4 C). Treatment of 
cells with H2O2 caused cytotoxicity evident by a significant decrease in cell 
metabolism in a concentration-dependent manner. Therefore, for subsequent 
protection experiments, we used this range of concentrations (1.5, and 3 mM) 
for 2 and 4 h-incubation.
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Figure 6.4 : Effect of H2O2 on cell metabolism in Girardi cells
Girardi cells were exposed to different concentrations of H20 2 (0.75, 1.5 and 3 mM) for 
2 h (A) 4 h (B) or 6 h (C). Cell viability was then determined using Alamar Blue assay. 
Bars represent the mean ± S.E.M. of 5-6 independent experiments, * P < 0.001 vs. 
control.
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6.5.5 Effect of Curcumin on the h^Or-Mediated Oxidative Stress
We then tested if curcumin could counteract oxidative stress caused by 
treatment with H2O2. For this purpose, Girardi cells were initially pre-treated with 
curcumin (15 pM) for 6 h to allow HO-1 induction to take place, and then the 
growing medium was removed, and H2O2 (1.5, or 3 mM) was added to the cells 
grown in fresh medium. Treatment with increasing concentrations of H2O2 (1.5, 
or 3 mM) for 2, or 4 h resulted in a concentration-dependent decrease in cell 
metabolism 50% (Figure 6.5 A) and 40% (Figure 6.5 B) respectively, however, 
pre-treatment of cells with curcumin did not exert any significant effect on the 
H2 0 2 -mediated cytotoxicity.
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Figure 6.5: Effect of curcumin on the H202-mediated oxidative stress
Girardi cells were pre-treated with of curcumin 15 pM for 6 h, the culture medium was 
then removed and cells were exposed to different concentrations of H20 2 (1.5 and 3 
mM) for 2 h (A) or 4 h (B). Cell viability was then determined using Alamar Blue assay. 
Bars represent the mean ± S.E.M. of 5-6 independent experiments. * P < 0.001 vs. 
control.
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6.5.6 Effect of Curcumin and Haemin on the H202-Mediated Oxidative 
Stress
Since pre-treatment with curcumin (15 pM) did not attenuate the H2O2-  
mediated cytotoxicity, we tested if the combination of curcumin and haemin 
could counteract the cytotoxicity induced by H2O2. Having established that 
haemin at (5 pM) concentration has the ability to induce haem oxygenase 
activity and HO-1 expression in Girardi cells (Figure 6.2). Cells were initially pre­
treated with curcumin (15 pM) and haemin (5 pM) for 6 h to allow for a possible 
synergism for HO-1 induction to take place. Treatment with increasing 
concentrations of H2O2 (1.5, and 3 mM) for 2 h or 4 h resulted in a 
concentration-dependent decline in cell metabolism (40% Figure 6.6 A) and 
35% (Figure 6.6 B) respectively; pre-treatment of cells with curcumin and 
haemin however, did not have any significant effect on the H202-induced 
cytotoxicity (Figure 6.6).
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Figure 6.6: Effect of curcumin and haemin (5 pM) on the H202-mediated oxidative 
stress
Girardi cells were pre-treated with of curcumin 15 pM and haemin 5 pM for 6 h, the 
medium was then removed and cells were exposed to different concentrations of H20 2 
(1.5 and 3 mM) for 2 h (A), 4 h (B). Viability was then determined using Alamar Blue 
assay. Bars represent the mean ± S.E.M. of 5-6 independent experiments. * P < 0.001 
vs. control.
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6.5.7 Effect of Curcumin and Haemin (10 pM) on the H202-Mediated 
Oxidative Stress
Since the combination of curcumin and haemin at (5 pM) was not protective 
against H2 0 2 -mediated damage, we then tested if the combination of curcumin 
and haemin at a higher concentration (10 pM) could counteract the oxidative 
stress caused by treatment with H2O2. Girardi cells were initially pre-treated with 
curcumin (15 pM) and haemin (10 pM) for 6 h to allow HO-1 induction to take 
place; cells were then exposed to H2O2. Treatment with increasing 
concentrations of H2O2 (1.5, and 3 mM) for 2 h or 4 h resulted in a 
concentration-dependent decline in cell metabolism (40 and 35% respectively), 
pre-treatment of cells with curcumin (15 pM) and haemin (10 pM) did not have 
any significant effect on the H202-induced cytotoxicity after 2 h (Figure 6.7 A). 
However, in cells exposed to H2O2 for longer time point (4 h), the combination of 
curcumin and haemin exhibited a further decrease in cellular metabolism 
(Figure 6.7 B), which indicates that pre-exposure to curcumin and haemin at 
higher concentration (10 pM), rendered the cells more susceptible to cellular 
damage by H2O2.
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Figure 6.7: Effect of curcumin and haemin (10 pM) on the H202-mediated 
oxidative stress
Girardi cells were pre-treated with of curcumin (15 pM) and haemin (10 pM) for 6 h the 
medium was then removed and cells were exposed to different concentrations of H20 2 
(1.5 and 3 mM) for 2 h (A), 4 h (B). Cell viability was then determined using Alamar 
Blue assay. Bars represent the mean ± S.E.M. of 5-6 independent experiments. * P < 
0.001 vs. control
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6.5.8 Effect of H2O2 on LDH Release in Girardi Cells
Treatment of cells with increasing concentrations of H202(0.75, 1.5, and 3 mM) 
for 2 (Figure 6.8 A) and 4 h (Figure 6.8 B) did not cause any detectable 
cytotoxicity, with the percentage of LDH release similar to the level in the control 
group (3-5%). Therefore, we tested if higher concentrations of H2O2 would 
cause ant detectable damage, as shown in (Figure 6.9), treatment with 
increasing concentrations of H2O2 (3, 6 or 9 mM) for 2 h did not cause any 
detectable cytotoxicity measured by LDH release. However, exposure of cells to 
H2O2 for 4 h resulted in a concentration-dependent increase in LDH release 
(7.5, 7.8 and 11 % respectively), (Figure 6.9 B). Treatment of cells with higher 
concentrations of H2O2 (3, 6 and 9 mM) for longer time points, i.e. 6 and 8 h, 
resulted in a time and concentration-dependent increase in LDH release, i.e. 12, 
18 and 20% (Figure 6.10 A), and 35, 45, and 55% (Figure 6.10 B) following 6 
and 8 h exposure, respectively.
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Figure 6.8: Effect of H20 2 on the LDH release in Girardi cells
Girardi cells were exposed to different concentrations of H20 2 (0.75, 1.5 and 3 mM) for 
2 h (A) and 4 h (B). Cell viability was then determined using LDH release. Bars 
represent the mean ± S.E.M. of 5-6 independent experiments. * P < 0.001 vs. control
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Figure 6.9: Effect of H20 2 on the LDH release in Girardi cells
Girardi cells were exposed to different concentrations of H20 2 (3, 6 and 9 mM) for 2 h 
(A) and 4 h (B). Cell viability was then determined using LDH release. Bars represent 
the mean ± S.E.M. of 5-6 independent experiments, * P < 0.05 vs. control.
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Figure 6.10: Effect of H2O2 on the LDH release in Girardi cells
Girardi cells were exposed to different concentrations of H20 2 (3, 6 and 9 mM) for 6 h 
(A) and 8 h (B). Cell viability was then determined using LDH release. Bars represent 
the mean ± S.E.M. of 5-6 independent experiments, * P < 0.001 vs. control
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6.5.9 Effect of Curcumin on HhOr-Mediated Oxidative Stress
Having established that exposure of cells to H2O2 at 3 and 6 mM for 6 h caused 
significant cytotoxicity detectable by LDH release; this protocol was employed to 
study the potential beneficial effects of curcumin on cells exposed to H2O2 for 6 
h. For this purpose, Girardi cells were initially pre-treated with curcumin (15 pM) 
for 6 h to allow HO-1 induction to take place, cells were then exposed to H2O2 
(3 or 6 mM) for 6 h. Pre-treatment of cells with curcumin (15 pm) significantly 
attenuated the H202-mediated cytotoxicity evident by a significant improvement 
in cellular metabolism (Figure 6.11 A). Furthermore, exposure of cells to H2O2 
resulted in a concentration-dependent increase in LDH release; 12, 18 and 20% 
respectively after 6 h exposure (Figure 6.11 B). Furthermore, pre-treatment of 
cells with curcumin (15 pM) resulted in a significant reduction in cytotoxicity 
evident by a decrease in LDH release (Figure 6.11 B). This effect was abolished 
in the presence of SnPPIX, the inhibitor of haem oxygenase enzymatic activity.
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Figure 6.11: Effect of curcumin on the H202-mediated oxidative stress.
Girardi cells were pre-treated with of curcumin 15 pM for 6 h and then exposed to 
different concentrations of H20 2 (3, and 6 mM) for 6 h in the presence or absence of 
SnPPIX 10 pM. Cell viability was then determined using Alamar Blue assay (A) and 
LDH release (B). Bars represent the mean ± S.E.M. of 5-6 independent experiments, * 
P < 0.05 vs. control, t  represents P < 0.05 vs. H20 2.
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6.6 Discussion
ROS from both endogenous and exogenous sources play an important role in 
the pathogenesis of cardiovascular diseases, such as IHD (Talalay and Talalay,
2001), in which ROS including superoxide, H2O2 and hydroxyl radicals are 
found in the myocardium (Dhalla et al., 1999). In the present study, we chose 
H2O2 to induce oxidative cell damage in our cultures because it is a precursor of 
highly oxidizing, tissue-damaging radicals such as hydroxyl radicals 
(Mahakunakom et al., 2003), furthermore, H2O2 is a major player in the 
pathogenesis of oxidative stress, since it is generated from nearly all sources of 
oxidative stress (Chen et al., 2000). Furthermore, exogenous H2O2 can enter 
the cells and induce cytotoxicity due to its high membrane permeability 
(Halliwell et al., 1992). It has been suggested that diets rich in fruits and 
vegetables are associated with a reduced risk for various cardiovascular 
diseases, which are mediated by oxidative stress (Morton et al., 2000). These 
protective effects have been attributed to antioxidant micronutrients such as 
vitamin C, p-carotene, and vitamin E (Weisburger, 1999). However, scientific 
attention has also been focused recently on the significance of other minor 
dietary components, such as natural polyphenolic compounds, as protective 
agents against diseases (Frusciante et al., 2000). In recent years, several 
studies emphasized the intrinsic cytoprotective properties of curcumin (Nirmala 
and Puvanakrishnan, 1996) (Venkatesan, 1998), a polyphenolic phytochemical 
which possesses antioxidant and free radical-scavenging characteristics (Bonte 
et al., 1997). Curcumin neutralized ROS including superoxide and hydroxyl 
radical (Sreejayan and Rao, 1996), it inhibited lipid peroxidation and protected 
against H202-induced cytotoxicity in renal epithelial cells (Cohly et al., 1998).
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Curcumin was found to inhibit lipid peroxidation and lysis in mouse red blood 
cells challenged with H2O2 (Toda et al., 1988). Recently, a protective effect of 
curcumin on H2 0 2 -induced cell damage in human keratinocytes and human 
fibroblasts was reported (Phan et al., 2001). In the present study, we evaluated 
the protective effects of curcumin on H202-induced cell damage in Girardi cells 
and investigated the possible mechanisms underlying the antioxidant effects of 
curcumin, with focus on the role of HO-1. Our data demonstrated, for the first 
time, that curcumin is a potent inducer of haem oxygenase activity and HO-1 
protein in Girardi cells, it has been shown before that curcumin is a potent 
inducer of haem oxygenase activity and HO-1 protein expression in other cell 
lines such as endothelial cells (Motterlini et al., 2000b) and astrocytes 
(Scapagnini et al., 2002). Experiments performed to assess cell viability showed 
no apparent damage after incubation with (5, 15 pM) curcumin for 24 h, 
however, curcumin at (30 pM) produced a significant increase in cytotoxicity. 
Our data are in agreement with previous reports showing that curcumin at (1 to 
15 pM) does not cause cytotoxicity in vascular smooth muscle cells (Phan et 
al., 2001). But concentrations of (30-100 pM) appear to mediate pro-oxidant 
effects and also apoptosis in various cell types (Ahsan et al., 1999). When 
curcumin at (15 pM) was added simultaneously with various concentrations (3, 
6 mM) of H2O2, it significantly protected Girardi cells against ^(Vinduced cell 
damage compared to treatment with H2O2 alone. This is in line with data in the 
literature which demonstrated that curcumin protected cells against H2O2- 
induced cell damage (Cohly et al., 1998). Incubation of cells for 6 h with 
curcumin resulted in enhanced resistance to oxidative damage; this effect was 
attributable to induction of HO-1 as the inhibitor of haem oxygenase activity
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(SnPPIX) markedly reduced cytoprotection by curcumin treatment. The 
antioxidant properties of this phytochemical are in essence related to its ability 
to stimulate a defensive intracellular enzymatic pathway, namely HO- 
1(Moskaug et al., 2005). In addition, it is possible that the protective effect of 
curcumin against the H2 0 2 -induced cytotoxicity may partly result from its 
intrinsic antioxidant and free radical scavenging properties; since pre-treatment 
with curcumin (removal of the medium which contains curcumin) was unable to 
protect Girardi cells from H202-induced oxidative damage. The addition of 
haemin to the experimental protocol was aimed at investigating any possible 
synergism between curcumin and haemin to protect cardiac cells against 
cytotoxicity induced by H2O2. In contrast, pre-treatment with curcumin and 
haemin (which is known pro-oxidant perse) rendered the cells more susceptible 
to cytotoxicity. It is possible that both curcumin and haemin are taken up by 
cells and then elicit changes that increase the susceptibility of cells to oxidative 
stress induced by H2O2. The dual actions of curcumin suggest that pretreatment 
with curcumin sensitizes them to oxidative damage induced by H2O2. Curcumin 
shows antioxidant and free radical scavenging activities, which are usually 
considered to protect cells from oxidative stress (Bonte et al., 1997). However, 
this polyphenolic compound has been reported to induce significant DNA 
damage by free radical generation (Ahsan et al., 1999). H2O2 is believed to 
cause cytotoxicity by reacting with the cell membrane and producing lipid 
peroxidation (Salahudeen, 1995), since cellular membranes are the richest 
source of lipids; plasma membranes are important targets for cell injury in H2O2 
(Salahudeen et al., 2000). Therefore LDH release assay was chosen in this 
study to assess cytotoxicity, because LDH release usually correlates to cellular
211
^ __________________________________________________ CHAPTER 6
membrane damage (Venkatesan, 1998), and therefore; LDH release is 
suggested to be a reliable method of assessing cytotoxicity (Bartels-Stringer et 
al., 2003). However, while H2O2 at low concentrations (1.5 and 3 mM) for 2, 4 
and 6 h incubation caused significant decrease in the metabolism in cells 
(assessed by Alamar Blue) (40 and 35 % compared to control group Figure 
6.4), H2O2 at these concentrations (1.5 and 3 mM) did not result in any LDH 
release in the cells. Therefore higher concentrations of H2O2 (6 and 9 mM) 
incubated for longer incubation times (6 and 8 h) (Figure 6.10) were needed to 
induce detectable cytotoxicity using the LDH release. It is tempting to speculate 
that in our experimental approach, Alamar Blue is a more sensitive assay in the 
detection of cellular derangements induced by H2O2 than LDH release. 
However; cells exposed to H2O2 are more subjected to damage to the cell 
membrane, rendering the membrane more permeable to LDH, which is 
reflected by an increase in the LDH release by cells. So it is tempting to 
speculate that LDH is a reliable assay for determination of H202-mediated 
cytotoxicity when higher concentrations of H2O2 are used, i.e. (3-6 mM).
In this study, we suggest that the use of curcumin as a therapeutic agent to 
mitigate cardiovascular disease and other vascular dysfunction-mediated by 
oxidative stress. This cytoprotective action is related to the ability of curcumin to 
act as a scavenger of ROS, and to a lesser extent, up-regulate HO-1 
expression.
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7 CURCUMIN MODULATES THE EXPRESSION OF HO-1 
UNDER HYPOTHERMIC CONDITIONS
7.1 Introduction
Heart transplantation is the treatment of choice for end stage cardiac disease 
(Jahania et al., 1999). Currently, a greater availability of harvested human 
hearts is precluded by the short period of cold ischaemia tolerated by this organ 
(Jahania et al., 1999). To make organs tolerant to hypothermia, blood is 
removed and replaced with an appropriate hypothermic preservation solution 
(Muhlbacher et al., 1999). The strategy commonly used to reduce ischaemic 
injury during cold storage is the rapid flushing, and cooling of the organs to 4°C 
using preservation solutions (Southard and Belzer, 1995). The methods used to 
preserve organs are based on suppression of metabolism by hypothermia; cold 
storage slows the cellular metabolism and extends cellular viability (Muhlbacher 
et al., 1999). However, prolonged storage is still associated with cold-induced 
cell and tissue injury (Kuznetsov et al., 2004). Several mechanisms mediate 
cold storage-associated injury, for example, reduced ATP levels which lead to 
cell swelling, and anaerobic metabolism, resulting in intracellular lactic acidosis 
(McLaren and Friend, 2003) (Kuznetsov et al., 2004). For both cold storage and 
reperfusion, ROS play an important pathogenetic role, mainly by provoking lipid 
peroxidation by incorporating into membrane lipid bilayers (Bartels-Stringer et 
al., 2003). Preservation solutions have been designed to slow down the rate at 
which reactions leading to l/R injury take place (Southard and Belzer, 1995). 
For the latter reason, most preservation solutions are high in potassium (to 
prevent loss of cellular K in the absence of Na, K-ATPase activity) and include a
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colloid to prevent cell swelling (Michel et al., 2002). However, these solutions 
are only poorly protective against l/R injury. This is entirely explicable, if one 
considers all the complex mechanisms of cold-induced injury. The antioxidants 
present in some of the solutions, such as glutathione, are not directed against 
the mechanism involved and cannot be expected to be present where the 
antioxidant would be required (Muhlbacher et al., 1999). Glutathione (oxidized 
after storage of the solution) remains largely extracellular and is thus not able to 
protect against the species generated intracellularly (Salahudeen et al., 2000). 
Similarly, mannitol, which is known to be a hydroxyl radical scavenger, cannot 
protect against intracellularly generated hydroxyl radicals because of its lack of 
membrane permeability, and because hydroxyl radical scavenging requires 
excessively high concentrations (>100mM) (Muhlbacher et al., 1999). 
Therefore, the composition of the preservative appears to be a critical 
determinant of the tolerance of the organ to hypothermic storage (Salahudeen 
et al., 2000). Thus, it is of importance to add agents which protect the organs 
from the damage which occurs during cold storage. Celsior solution, a new 
preservation solution was introduced in heart transplantation (Michel et al.,
2002). Preliminary data for Celsior solution in the preservation of thoracic 
organs showed an improved graft function after ischaemia, and reperfusion in 
comparison to other preservation solutions (Michel et al., 2002) (Jahania et al.,
1999). Treatment with the polyphenolic compounds was associated attenuation 
of renal inflammation in a rat model of transplantation (Jones and Shoskes,
2000). In endothelial cells Fuller et al. showed that addition of curcumin 
abrogated expression of adhesion molecules (E-selectin and ICAM- 1 
(intercellular adhesion molecule 1) (Fuller et al., 2003). Renal epithelial cells
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pre-treated with curcumin were more resistant to oxidative damage during a 
programmed change in temperature under hypoxia (Balogun et al., 2003a). 
Based on the hypothesis that curcumin would provide a defense mechanism 
against cardiac l/R injury, this study examined the efficacy of curcumin in 
protection of cardiac cells against prolonged cold preservation.
7.2 Objectives
To determine whether curcumin, a plant-derived polyphenolic compound and a 
potent inducer of HO-1 could up-regulate haem oxygenase activity and HO-1 
mRNA expression under hypothermic conditions, and to investigate whether the 
addition of curcumin to a commercial preservation solution (Celsior) improved 
and extended cardiac preservation.
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7.3 Material and Methods
CHAPTER 7
7.3.1 Reagents
Haemin (ferriprotoporphyrin IX chloride) and tin protoporphyrin (SnPPIX) were 
obtained from Porphyrin Products INC (Logan, Utah, USA). Curcumin and all 
other reagents were purchased from Sigma. Alamar Blue reagent was obtained 
from Serotec (Oxford, UK). Polyclonal antibodies were purchased from Bio- 
Quote Ltd. PCR primers were purchased from Amersham. Celsior solution 
(Table 7-1) was obtained from IMTIX SANGSTAT, Lyon, France.
T a b le  7-1: C o m p o s itio n  o f C e ls io r  s o lu tio n
C o m p o s it io n W e ig h t
(g)
C o n c e n tra tio n
(m M )
M a n n ito l 10.930 60
L a c to b io n ic  ac id 28.664 80
G lu ta m ic  ac id 2.942 20
S o d iu m  h y d ro x id e 4.00 100
C a lc iu m  c h lo r id e 0.037 0.25
P o ta s s iu m  c h lo rid e 1.118 15
M a g n e s iu m  c h lo rid e 2.642 13
H is tid in e 4.650 30
G lu ta th io n e 0.921 3
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7.3.2 Cell Culture
Girardi cells (human cardiac myoblasts) were purchased from the European 
Collection of Cell Cultures (ECACC, Salisbury, Wiltshire, UK) and cultured in 
Dulbecco's modified Eagle's medium containing, 3.5 mM glutamine, 100 units/ml 
penicillin, and 0.1 mg/ml streptomycin and supplemented with 10% fetal bovine 
serum and 1% non-essential amino acids. Cells were grown in 75-cm2 flasks 
and maintained at 37°C in a humidified atmosphere of air and 5% CO2. 
Confluent cells were exposed to various concentrations of curcumin and 
haemin, and haem oxygenase activity and HO-1 protein expression and mRNA 
were determined at different times after treatment. Cells were also incubated 
with different concentrations of curcumin in conditions of programmed changes 
in temperature using a cooled incubator (Sanyo, Model MIR-153), where a 
temperature controller allowed setting and programming the temperature of the 
interior of the cabinet. Within the incubator, cells were placed in an air-tight 
Plexiglas chamber (Billups-Rothenberg, Del Mar, CA) and flushed with a 
mixture of 21% 02/5% C02/74% N2 to simulate "normoxic" incubation.
7.3.3 Experimental Protocol
The cells were studied upon confluence, in 24-well plates. The groups included 
parallel control cells kept in Dulbecco’s modified Eagle’s medium (DMEM), and 
cells subjected to cold storage in CS solution over 4, 6, 8 and 12 h. Cytotoxicity 
was determined using LDH release, Trypan Blue exclusion was used to 
determine cell membrane integrity and Alamar Blue to determine the effect of 
cold storage on cellular metabolism. Before cold storage, the prevailing cell 
culture medium was replaced by Celsior solution; cells were then placed in a 
temperature monitored refrigerator at 4°C. To determine the effect of rewarming
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on cold storage-induced cell injury, cells cold-stored for 6 h were subjected to 0,
1 and 2 h of rewarming in the incubator at 37°C before cytotoxicity was 
assessed using LDH release, Trypan Blue and Alamar Blue. To determine the 
effect of curcumin on the cold-induced cellular injury, similar sets of 
experiments were performed, in which cells were exposed to cold storage in 
Celsior solution over 6 h in the presence of curcumin 15 pM. Furthermore, cells 
exposed to 6 h cold storage were then rewarmed for 1 h. To investigate the 
involvement of haem oxygenase, similar sets of experiments were conducted in 
the presence of SnPPIX (10 pM), an inhibitor of haem oxygenase activity. In a 
different set of experiments, cells were incubated with curcumin (5-30 pM) 
under a programmed change in temperature which included exposure for 3 
hours at 37°C followed by 3 hours at 4°C in Celsior solution for an additional 3 
h. After these treatments, cells were harvested for the determination of haem 
oxygenase activity and HO-1 mRNA expression. Additional experiments were 
performed to simulate the oxidative stress which concurs during the rewarming. 
For this purpose, cells exposed to the programmed change in temperature were 
further incubated with paraquat, a known generator of free radicals (1, 1.5 mM) 
for 18 h; cellular damage was assessed by using the Alamar Blue assay. To 
address the contribution of HO-1, a parallel set of experiments was performed 
using siRNA for HO-1.
7.3.4 Cell Viability/Alamar Blue Assay
Cell viability was determined using an Alamar Blue assay kit, it was carried out 
as previously described in Section 2.3.1.
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7.3.5 LDH Assay
Extracellular, i.e., released, LDH activity was measured using cytotoxicity 
detection kit (Roche) as previously described in section 2.3.2.
7.3.6 Trypan Blue Assay
Trypan Blue exclusion was performed as previously described in section 2.3.3.
7.3.7 Haem Oxygenase Activity Assay
Haem oxygenase activity was determined at the end of each treatment as 
described previously in Section 2.4.3.
7.3.8 RNA Isolation
RNA isolation was performed using Purescript® RNA Isolation Kit (Gentra, 
Minneapolis, MN 55441 USA). RNA isolation was performed according to the 
manufacturer instruction, as previously described in (section 2.5.6).
7.3.9 Measurement of HO-1 mRNA by RT-PCR
PCR was performed as previously described in (section 2.5.7).
7.3.10 Transfection of Girardi cells with HO-1 siRNA
Girardi cells were grown in twelve-well plates and transiently transfected with 
HO-1 siRNA mixed with the appropriate transfection reagent (Santa Cruz 
Biotechnology) according to the manufacturer’s instructions and as previously 
described in Section 2.5.4. After incubation at 37°C for 30 h, cells were exposed 
to hypothermia for 4, 6, 8, 12, and 24 h in the presence or absence of curcumin 
(15 pM) as described in the Experimental Protocol. Samples were then 
collected and analyzed for LDH release.
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7.4 Statistical Analysis
Differences among the groups were analyzed using one-way analysis of 
variance combined with the Bonferroni test. Values were expressed as mean ± 
S.E.M., and differences between groups were considered to be significant at p < 
0.05.
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7.5 Results
7.5.1 Time Course for Cold Storage-Induced Cytotoxicity
Exposure of Girardi cells at 4°C in Celsior solution resulted in a time-dependent 
increase in LDH release compared with warm control cells, i.e. cells kept in cell 
culture medium at 37°C. The increase of LDH release in hypothermia was 
strikingly higher than the spontaneous release found in cells kept in cell culture 
medium at 37°C. For example, the LDH release in cells after 6 h of cold storage 
was over 65%, whereas in a similar time period the LDH release at 37°C was 
close to 5% (Figure 7.1 A). This was accompanied by an increase in the uptake 
of Trypan Blue dye by the cells. As can be seen in (Figure 7.1 B) there was a 
time-dependent increase in the uptake of the dye, reaching the maximum 
uptake, i.e. cytotoxicity (100%) after 8 and 12 h incubation at 4°C. Furthermore, 
there was a time-dependent decrease in cellular metabolism, 50 %, 45%, and 
20 % after 4, 6 and 8 h cold storage respectively. Interestingly, cells exposed to 
12 h cold storage did not exhibit any detectable metabolic activity by the Alamar 
Blue Assay (Figure 7.1 C).
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Figure 7.1: Time course for the cold storage-induced cytotoxicity
Girardi cells were exposed to 4°C for 4, 6, 8 and 12 h in Celsior solution. Cytotoxicity 
was then assessed using LDH release (A) Trypan Blue exclusion (B) and Alamar Blue 
(C). The control group (warm control) is represented by cells kept in cell culture 
medium at 37°C. Each bar represents mean ± S.E.M. of 6 independent experiments. * 
P < 0.001 vs. warm control.
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7.5.2 Cytotoxicity in Girardi Cells Exposed to 6 h Cold Storage and then 
Rewarming
Having established that cold storage after 6 h results in significant cytotoxicity 
without reaching irreversible (100% cytotoxicity), this time point was chosen to 
study the effect of rewarming on cellular damage. Rewarming for 1 or 2 h, i.e., 
replacement of Celsior solution after a 6 h cold storage with a regular cell 
culture medium and re-incubating the cells at 37°C. Exposure of cells to this 
protocol caused additional marked increase in LDH release (Figure7.2 A), 
increased cytotoxicity detected by Trypan Blue (Figure7.2 B) and decreased 
metabolism as assessed by Alamar Blue (Figure7.2 C). Cellular damage was 
further aggravated during rewarming, reaching maximal levels as detected by 
Trypan Blue uptake after 2 h rewarming (Figure7.2 C).
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Figure7.2: Time course for rewarming-induced cytotoxicity
Girardi cells were exposed to 4 °C for 6 h in Celsior solution followed by rewarming 
(replacement of Celsior solution after a 6-h cold storage with cell culture medium and 
re-incubating the cells at 37°C). Cytotoxicity was then assessed using LDH release (A) 
Trypan Blue exclusion (B) and Alamar Blue (C). The control group is represented by 
cells kept in cell culture medium at 37°C. Each bar represents mean ± S.E.M. of 6 
independent experiments. * P < 0.001 vs. warm control.
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7.5.3 The Effect of Curcumin on Hypothermia and Rewarming-Induced 
Cytotoxicity in Girardi Cells
Curcumin at (15 pM) concentration completely suppressed the 6-h cold-induced 
LDH release (Figure 7.3 A), decreased Trypan blue uptake by the cells (Figure
7.3 B) and normalized the cellular metabolism (Figure 7.3 C). When SnPPIX 
was added, the protective effects of curcumin on LDH release were not 
diminished (Figure 7.3 A). However, there was a mild attenuation of this effect 
as observed by Trypan Blue exclusion (Figure 7.3 B) and cellular metabolism 
(Figure 7.3 C). Similarly, curcumin completely reversed the 1 h rewarming- 
induced increase in LDH release (Figure 7.4 A), decreased Trypan blue uptake 
by Girardi cells (Figure 7.4 B) and normalized the cellular metabolism (Figure
7.4 C). The protective effects of curcumin on LDH release was not diminished in 
the presence of SnPPIX, however, there was a mild attenuation of this effect as 
observed by Trypan blue exclusion (Figure 7.4 B) and cellular metabolism 
(Figure 7.4 C).
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Figure 7.3: The effect of curcumin on the cold storage cytotoxicity in Girardi cells
Girardi cells were exposed to 4°C for 6 h in Celsior solution in the presence or absence 
of curcumin (15 pm). Cytotoxicity was then assessed using LDH release (A) Trypan 
Blue exclusion (B) and Alamar Blue (C). The control group is represented by cells kept 
in cell culture medium at 37°C. Each bar represents mean ± S.E.M. of 6 independent 
experiments, t  represents P < 0.001 vs. warm control, * P < 0.001 vs. cold control.
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Figure 7.4: The effect of curcumin on the cold storage cytotoxicity in Girardi cells
Girardi cells were exposed to 4oC for 6 h in Celsior solution, followed by rewarming at 
37°C for 1 h in the presence or absence of curcumin 15 pm and SnPPIX (10 pM). 
Cytotoxicity was then assessed using LDH release Trypan Blue exclusion (B). The 
control group is represented by cells kept in cell culture medium at 37°C. Each bar 
represents mean ± S.E.M. of 6 independent experiments. |  represents P < 0.001 vs. 
warm control, * P < 0.001 vs. cold control.
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7.5.4 HO-1 Partially Mediates the Cytoprotective Effects of Curcumin
LDH release was measured in Girardi cells subjected to cold storage for 
different times points (4-24 h), in the presence or absence of curcumin (15 pM), 
and in cells incubated with curcumin and siRNA for HO-1. Figure 7.5 illustrates 
that cold storage resulted in a time-dependent cytotoxicity which was maximum 
at 12 h, after which it reached a plateau, which was significantly (P< 0.001) 
decreased by curcumin. Consistent with the results obtained with SnPPIX, 
siRNA for HO-did not have a significant effect on the protective action of 
curcumin, suggesting that the protective effects of curcumin are predominantly 
HO-1 independent.
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Figure 7.5: HO-1 mediates the protective effects of curcumin
Girardi cells were transfected with HO-1 siRNA; (CS): represents cells exposed to 4°C 
h (4-24 h) in Celsior solution, cells exposed to this protocol in the presence of curcumin 
15 pM is represented by (cur.). Cytotoxicity was then assessed using LDH release. The 
warm control (Control) is represented by cells kept in cell culture medium at 37°C. 
Each bar represents mean ± S.E.M. of 6 independent experiments. ** P < 0.001 vs. 
warm control, f  P < 0.001 vs. cold control. * P < 0.05 vs. curcumin.
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7.5.5 The Effect of Curcumin on Girardi Cells Exposed to Programmed 
Change in Temperature
Girardi cells were treated with curcumin (5, 15 and 30 pM) and exposed to a 
programmed change in temperature which involved exposure of cells for 3 h at 
37°C in medium to allow the induction of HO-1 expression to take place, 
followed by 3h exposure at 4°C in Celsior solution. Exposure of cells to this did 
not result in any evident cytotoxicity, as measured by LDH release (Figure 7.6
A), and cellular metabolism (Figure 7.6 C). However, cells exposed to this 
programmed change in temperature showed signs of toxicity evident by a 
significant increase (30% compared to warm control) in the uptake of the 
Trypan Blue dye (Figure 7.6 B). Preconditioning of cells with increasing 
concentrations of curcumin significantly reduced the cold storage-induced 
cellular membrane derangement detected by Trypan Blue uptake (Figure 7.6
B).
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Figure 7.6: The effect of curcumin on cell viability in Girardi cells exposed to a 
programmed change in temperature
Girardi cells were exposed to various concentrations of curcumin (5, 15 or 30 pM), 
initially for 3 h at 37°C, followed by 3 h-incubation at 4°C. LDH release (A) Trypan Blue 
(B) and Alamar Blue assays (C) were performed. The control group is represented by 
cells incubated with medium alone (0 pM). Each bar represents mean ± S.E.M. of 6 
independent experiments. * P < 0.05 vs. cold control, f  P < 0.001 vs. warm control.
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7.5.6 The Effect of Curcumin and Haemin on Cold Storage and 
Rewarming-Mediated Cytotoxicity in Girardi Cells
Girardi cells were treated with curcumin 15 |jM and haemin 5 |jM or the 
combination of both agents for 3 hours at 37°C in complete medium to allow for 
the induction of HO-1 expression to take place, then at 4°C for 3h in Celsior 
solution. Exposure of cells to this protocol did not result in any evident 
cytotoxicity, as measured by LDH release (Figure7.7 A) and cellular metabolism 
(Figure7.7 C). However, cells exposed to this programmed change in 
temperature showed signs of toxicity evident by a significant increase (30% 
compared to warm control) in the uptake of the Trypan Blue dye (Figure7.7 B). 
Preconditioning of cells with curcumin and haemin significantly reduced the cold 
storage-induced cellular membrane derangement detected by Trypan Blue 
uptake (Figure7.7 B).
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Figure7.7 The effect of curcumin and haemin on cell viability in Girardi cells 
exposed to a programmed change in temperature
Girardi cells were exposed to curcumin 15 pM in the presence or absence of haemin 5 
pM (B), initially for 3 hours at 37oC, then 3 hours at 4oC. LDH release (A) Trypan blue 
(B) and Alamar Blue (C) assays were performed. The control group is represented by 
cells incubated with medium alone (0 pM). Each bar represents mean ± S.E.M. of 6 
independent experiments. * P < 0.001 vs. cold control, t  P < 0.001 vs. warm control.
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7.5.7 The Effect of Curcumin and Haemin on Haem Oxygenase Activity 
and HO-1 mRNA Expression in Girardi Cells
(Figure 7.8 A) represents the haem oxygenase activity in Girardi cells treated 
with various concentration of curcumin (5, 15 and 30 pM) for 3 hours at 37°C in 
complete medium, then for 3 hours at 4°C in Celsior solution. Curcumin 
significantly increased the level of haem oxygenase activity with a maximal 
value being observed at 30 pM. (Figure 7.8 B) represents the haem oxygenase 
activity and HO-1 mRNA in Girardi cells treated with curcumin (15 pM), haemin 
(5 pM) or the combination of both agents added for 3 h at 37°C in complete 
medium, then at 4°C for 3h in Celsior solution. Individually, curcumin (15 pM) 
and haemin (5 pM) resulted in a significant increase in haem oxygenase 
activity, however, when both agents were combined, further increase in haem 
oxygenase activity and HO-1 mRNA was observed.
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Figure 7.8: Effect of change in temperature on curcumin-mediated induction of 
haem oxygenase activity and HO-1 mRNA expression
Girardi cells were exposed to various concentrations of curcumin (5, 15 and 30 pM) (A) 
or curcumin 15 pM in the presence or absence of haemin 5 pM (B). Cells were 
exposed initially for 3 h at 37oC, then 3 h at 4oC. Haem oxygenase activity and HO-1 
mRNA expression were determined. Each bar represents mean ± S.E.M. of 6 
independent experiments. * P < 0.001 vs. Control.
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7.6 Discussion
An important and potentially amendable determinant of shortened graft survival 
and post-transplant morbidity is the cold storage-associated organ injury 
(Salahudeen et al., 2000). Therefore, the composition of the preservation 
solution appears to be a critical determinant of the tolerance of the organ to 
hypothermic storage (Redaelli et al., 2002a). In the present study with a cell 
culture model, we investigated whether the addition of curcumin to Celsior 
solution could ameliorate the cold-associated injury in cardiac myoblasts, and 
therefore allow longer cold preservation of these cells; furthermore, the 
involvement of HO-1 was also studied.
The present study demonstrated that cold storage of human cardiac myoblasts 
(Girardi cells) caused a marked increase in cytotoxicity, primarily due to loss of 
cell membrane integrity and necrotic cell death (Clerk et al., 2003) (Bartels- 
Stringer et al., 2003). It is well established that cold-induced organ injury is 
generally considered necrotic, recent experimental observations suggest that 
cold per se, that is, without reperfusion results in necrotic but not apoptotic cell 
death (Nakao et al., 2003). Apoptotic cell death was found to be an important 
component of cell injury after reperfusion and rewarming but not during cold 
storage (Nakao et al., 2003). In the present study, alterations to membrane 
integrity as a result of necrotic cell death were well depicted by the release of 
intracellular LDH, and increase in the uptake of the Trypan Blue dye. The injury 
observed at 6 hours may be attributable to the well-described mechanism of cell 
injury caused by cold storage: mitochondrial ATP synthesis decreases, tissue 
acidosis occurs, and acidic proteases are activated, which leads to degradation 
of proteins and undermining of cell membrane integrity (Salahudeen et al.,
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2000). Additional cell injury may be caused by increased storage time and lipid 
peroxidation of cell membranes (Nakao et al., 2005). Therefore, the 
maintenance of membrane integrity during ischaemia and reperfusion is one 
hallmark of good protection of organ-preservation solutions (Southard and 
Belzer, 1995). Interestingly, the addition of curcumin to Celsior solution resulted 
in preservation of cellular membrane integrity as well as cellular metabolism in 
cells exposed to cold storage and rewarming. These protective effects of 
curcumin are not mediated by the haem oxygenase system, since the 
employment of siRNA for HO-1 and SnPPIX did not inhibit the cytoprotective 
actions of curcumin, which indicates that the cytoprotective effects of curcumin 
are predominantly HO-1 independent. It is possible that other endogenous 
phase II enzymes are involved in the cytoprotective actions of curcumin, 
furthermore, curcumin-induced gene and protein expression of HO-1 is not 
epitomized at the enzymatic level due to the reduction in metabolic and 
enzymatic activity associated with cold temperature (McLaren and Friend,
2003). These findings support the strategy of adding antioxidants to 
preservation solutions to further boost their antioxidant capacity, and endorse 
the hypothesis that preconditioning of organs to oxidative stress before harvest 
might limit cold storage- associated organ injury.
It should be noted that the cell culture model used here might not be fully 
reflective of the actual cellular conditions in preserved whole organs, because 
cells in the cultured settings are not disrupted as they go into cold storage. 
Furthermore, this model is also unable to separate between cold storage and 
rewarming, because the assays used to assess cytotoxicity do not provide 
information to differentiate between necrotic cell death observed in cold storage
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and apoptotic cell death cell that occur during rewarming. However, the model 
used here partially simulates the cold storage situation, and provides valuable 
information that can not be readily obtained from in vivo.
One of the most promising strategies that lengthen the time of cold ischaemia 
without risking reperfusion injury is preconditioning, in which the graft is 
subjected to a modifying agent for a limited period of time before harvesting 
(Tsuchihashi et al., 2003) (Redaelli et al., 2002a). This preconditioning confers 
resistance to subsequent lethal stress by inducing the expression of the HSPs, 
which protect the cellular machinery of many organs from a wide variety of 
insults such as anoxia, ischaemia, and oxidative stress (Calabrese et al., 2003), 
HSP 32, better known as HO-1 is one of the most important of these (Maines 
and Gibbs, 2005). Many of the protective effects of HSPs have been attributed 
to HO-1 (Maines, 1997). The expression of HO-1 is amenable to pharmacologic 
manipulations (Hill-Kapturczak et al., 2001). Its pharmacologic induction 
attenuated oxidative injury in a rat kidney ischaemia-reperfusion model (Maines 
et al., 1999) and improved survival after transplantation of fatty livers in rats 
(Amersi et al., 1999).
Therefore, pharmacologic induction of HO-1 might be of clinical value to permit 
longer cold storage of harvested organs before transplantation, and is an 
attractive approach to minimize preservation injury in organs (Balogun et al., 
2003a) (Shibahara et al., 2002). From the perspective of the present study, it 
would be of interest to determine whether preconditioning of Girardi cells with 
curcumin, an inducer of HO-1 would reduce cold storage. It is interesting to 
observe that under these conditions curcumin induced HO-1 mRNA expression, 
suggesting that curcumin is a potent inducer of HO-1 and that Girardi cells are
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still responsive even after a prolonged cold storage period, under these 
conditions, curcumin up-regulated haem oxygenase activity, and no sign of 
toxicity was detected in cell viability assays. The addition of haemin in the 
protocol was based on the idea that it would synergize with curcumin to up- 
regulate HO-1 mRNA and at the same time, provide the substrate for haem 
oxygenase enzymatic activity. It is worth noting that the increase in activity 
detected under the programmed change in temperature was lower than that 
observed during normothermia, since cold temperature is associated with 
reduced metabolic and enzymatic activity (Southard and Belzer, 1995). The 
results obtained in Girardi cells are similar to those obtained in renal epithelial 
cells, where the experiments examining the effect of curcumin on HO-1 mRNA 
during hypothermia were performed (Balogun et al., 2003a).
The findings in the present study suggest that experimental strategies using a 
programmed change in temperature could be used to protect organs prior to 
transplantation.
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8 GENERAL DISCUSSION
8.1 Analysis of Methodology
8.1.1 Cell Culture Methodology
In this thesis, established commercial cell lines were used instead of primary 
cell lines because of their convenience. Primary cultures are of mixed nature, 
with limited culture lifespan and potential contamination problems. In contrast, 
the cell lines are more stable and less labour intensive to maintain. Admittedly, 
the advantages of primary cultures are that the cells have not been modified in 
any way (other than by enzymatic or physical dissociation). The following cell 
lines were used: Bovine Aortic Endothelial Cells (BAEC), RAW 264.7murine 
macrophages, and human cardiac myoblasts (Girardi cells). In this thesis, three 
in vitro models of cardiovascular tissue dysfunction were used; a model of 
H202-mediated by oxidative stress, a model of inflammation, and a model of 
hypothermic ischaemic injury. These models were used to study the major 
aspects of the pathophysiology of cardiovascular dysfunction, and to study the 
potential cytoprotective effects of HO-1 up-regulation in these models. In the 
present study, the three major cellular components which are involved in the 
pathogenesis of cardiovascular diseases were studied, i.e. endothelial cells 
(represented by BAEC), macrophages, which are involved in the pathogenesis 
of the inflammatory response associated with cardiovascular dysfunction 
(Schiffrin, 2002), and cardiac cells. BAEC were used before to establish the 
effect of 2-HC on haem oxygenase activity and HO-1 expression (Foresti et al., 
2005), in addition to studying the potential anti-oxidant effects of 2-HC; since 
the endothelium plays a major role in tissue response to oxidative stress (Singh
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et al., 2005). RAW 264.7 macrophages are established cell line and they have 
been extensively used to study the inflammatory response (Alcaraz et al.,
2004). An LPS-mediated inflammatory response in RAW 264.7 macrophages 
was used because it is an established in vitro model of inflammation (Vicente et 
al., 2001). In the present study, this model was used to explore the different 
aspects of the anti-inflammatory response and the role of HO-1 in and CO was 
also elucidated. It is important to note that inflammation is considered as a 
major player in the patho-physiology of cardiovascular disease (Schiffrin, 2002). 
Therefore, we examined the effect of 2-HC on LPS-elicited inflammatory 
response, in addition, the role of HO-1 in this action was also examined. 
Furthermore, we used CO-RMs, to study the effect of CO, one of the products 
of HO-1 pathway, on the inflammatory response elicited by LPS.
Girardi cells (human atrial myoblasts) are established cell line (Harwood et al., 
2003). In the present study, Girardi cells were used to establish the effect of 
curcumin on haem oxygenase activity and HO-1 expression, and we also used 
them to examine the potential cytoprotective effects of curcumin against 
oxidative and hypothermic damage on cardiac cells. Data obtained using Girardi 
cells is supported by a number of reports, for example, the response of these 
cells to H2O2 was documented in other studies (McDonald et al., 2000). 
However, so far, no data in the literature was provided about the expression of 
HO-1 in these cells. Data presented in this thesis provided a novel insight to the 
biological properties of Girardi cells, and therefore facilitated further studies to 
understand the patho-physiology of cardiac cells.
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8.1.2 Biochemical Assays
GENERAL DISCUSSION
8.1.2.1 Haem Oxygenase Assay
The haem oxygenase activity assay was first described by Tenhunen et al. in 
1968 and has been used extensively by our laboratory to measure intracellular 
and tissue haem oxygenase activity (Foresti et al., 1997). The assay used in 
this thesis reflects the relative haem oxygenase activity in the sample as “pmol. 
bilirubin/mg prot./h”. Although the value obtained is not directly comparable to 
the amount of bilirubin measured in the culture medium after stimulation of the 
HO-1 pathway, the fact that the substrate (haemin) and the cofactors NADPH, 
glucose-6-phosphate, glucose-6-phosphate-1 -dehydrogenase and biliverdin 
reductase were all added in excess and the procedure was carried out in 
controlled conditions must be considered when interpreting the data.
8.1.3 Molecular Biology Techniques
8.1.3.1 Western Blot Assay
Western Blot is an established molecular biology technique, which is used for 
measuring relative protein expression in cells and tissue, therefore every assay 
was run with both negative and positive controls (untreated cells/tissue and 
recombinant HO-1 for protein respectively) and (3-Actin for equal loading. Since 
Western Blot analysis of HO-1 expression is only used in conjunction with haem 
oxygenase activity in this study, the actual levels (pg, pmoles etc) of HO-1 
protein are not necessary; each experiment is presented by a representative 
blot which has been scanned into a microcomputer, cropped to the right size 
and printed.
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8.1.3.2 TNF-a and IL-10 Detection by ELISA
For the determination of TNF-a and IL-10 production in cells stimulated with 
LPS, commercially available ELISA kits were used because of their high 
sensitivity and specificity for detection of TNF-a and IL-10 in murine cells 
(Abuarqoub et al., 2005). Data obtained using these kits are similar to the data 
obtained by other studies in the literature (Sawle et al., 2005).
8.1.3.3 SiRNA
RNA interference is the biological mechanism by which double-stranded RNA 
(dsRNA) induces gene silencing by targeting mRNA, resulting in a reduction in 
the expression of a particular gene in mammalian cells (Shan et al., 2004). In 
the present study, siRNA specific for HO-1 were used to determine the 
involvement of HO-1 in various cytoprotective effects of 2-HC and curcumin. 
SnPPIX was also used to test the involvement of HO-1 in different processes, 
however, SnPPIX is not a specific inhibitor for haem oxygenase enzymatic 
activity, it also inhibits other haem containing enzymes (Serfass and Burstyn, 
1998). So a more clean and specific approach was needed to verify the role of 
HO-1, therefore, siRNA technology was used in this thesis. In addition, siRNA 
for the PI3K pathway were also used to determine the involvement of this 
pathway in 2-HC-mediated induction of HO-1. Furthermore, in this thesis, 
commercially available inhibitor for the PI3K was also used, however, there are 
limitations to this inhibitor, including a possible interaction with the components 
of growth medium (FBS) (Martin et al., 2004). Therefore, we used siRNA for the 
PI3K pathway as a more specific approach.
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8.1.4 Cell Viability Assays
To assess cell viability three methods were used in parallel, LDH release, 
Trypan Blue exclusion and Alamar Blue assay.
8.1.4.1 LDH
LDH is a cytosolic enzyme present within all mammalian cells, the normal 
plasma membrane is impermeable to LDH, but damage to the cell membrane 
results in a change in the membrane permeability and subsequent leakage of 
LDH into the extracellular fluid (Luss et al., 2002). LDH release is suggested to 
be a reliable method of assessing cytotoxicity because in vitro release of LDH 
from cells provides a reliable method for measuring cell membrane integrity and 
cell viability (Salahudeen et al., 2000) (Venkatesan, 1998).
8.1.4.2 Trypan Blue
Trypan Blue is a vital dye; all cells which exclude the dye are viable. It is 
considered as a reliable method of assessing cell death (Byler et al., 1994). It 
has been used in numerous studies to assess cell damage and in particular cell 
membrane integrity (Kuramochi et al., 2004) (Fukuta et al., 1984) (Pinsky et al., 
1995).
8.1.4.3 Alamar Blue
This dye presents numerous advantages over other cytotoxicity or proliferation
tests. First, it is simple to use, it is added directly to cells in culture towards the
end of the incubation period (Nakayama et al., 1997). No additional reagents or
manipulations are required. Second, Alamar Blue is non-toxic to the cells and
user (Ahmed et al., 1994). Third, the Alamar Blue assay does not require any
special handling or disposal methods since no radioactive or toxic materials are
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used (O’Brien et al., 2000). Thus, it is less costly than traditional assays. Each 
cell line has unique metabolic properties and must be individually characterized 
to determine the experimental parameters (e.g., incubation time, Alamar Blue 
dilution) for optimal conversion from the oxidized to reduced forms of Alamar 
Blue. Recently, the dye has gained popularity as a very simple and versatile 
way of measuring cell proliferation and cytotoxicity.
245
4 ________________________________________ GENERAL DISCUSSION
8.2 Thesis Discussion
HO-1 is an inducible stress protein, the expression of which can be markedly 
augmented in eukaryotes by a wide range of substances that cause a transient 
change in the cellular redox state (Motterlini et al., 2002b). Induction of HO-1 
plays an important role in the patho-physiology of several diseases involving the 
heart (Motterlini et al., 1998). Studies aimed at the development of novel 
inducers of the endogenous HO-1 gene or targeted gene over-expression of 
HO-1 serve as a therapeutic and preventive modality in patho-physiologic states 
(Scapagnini et al., 2002). Therefore, strategies to target and achieve regulated 
expression of HO-1 will have significant therapeutic implications in several 
pathological conditions of the cardiovascular system (Agarwal and Nick, 2000). 
The hypothesis behind the work carried out in this thesis is: up-regulation of the 
haem oxygenase activity and HO-1 expression by plant-derived phytochemicals 
offers protection to cardiovascular tissue against oxidative and inflammatory 
damage.
In Chapter 3, we established that 2-HC is a potent inducer of haem oxygenase 
activity and HO-1 protein expression in endothelial cells, both in a time and a 
concentration-dependent manner. This induction occurs at the transcriptional 
level as actinomycin D completely eliminated 2-HC-mediated activation of haem 
oxygenase. Furthermore, the results related to the transcription factor Nrf2 
suggest that the latter is a potential transcriptional target for 2-HC. Furthermore, 
our data showed that 2-HC was well tolerated by cells as tested by LDH release 
and Alamar Blue assays. Our results are in agreement with data in the 
literature, Alcaraz and co-workers demonstrated that a synthetic chalcone 3', 4’, 
5’, 3, 4, 5-hexamethoxy-chalcone was a potent inducer of HO-1 and it resulted
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in the activation of Nrf2 expression (Alcaraz et al., 2004). Furthermore, our 
group showed that 2-HC was a potent inducer of haem oxygenase activity and 
HO-1 protein expression in BAEC (Foresti et al., 2005). In addition, we 
demonstrated for the first time that 2-HC-mediated induction of haem 
oxygenase activity and HO-1 protein expression is mediated by the PI3K 
pathway. However, our results showed MAPK pathways play a minor role in the 
2-HC-mediated induction of HO-1. Few studies have demonstrated the cellular 
signalling mechanisms that mediate the 2-HC-elicited HO-1 induction (Alcaraz et 
al., 2004). However, several studies demonstrated the ability of chalcones to 
regulate MAPK-responsive pathways (Frigo et al., 2002). These results are in 
agreement with data obtained by our group in which the authors concluded that 
MAPK play a minor role in the 2HC-mediated HO-1 expression (Foresti et al.,
2005). However, more studies are needed to elucidate the molecular and 
cellular targets of 2-HC. Our data also showed that 2-HC protected endothelial 
cells against H202-medated cytotoxicity. These findings support the data in the 
literature (Foresti et al., 2005) in which the potent cytoprotective properties of 
chalcone were demonstrated, mainly through its ability to strongly activate the 
endogenous cytoprotective pathways (Alcaraz et al., 2004). By virtue of its 
polyphenolic chemical structure (Batt et al., 1993) (Dinkova-Kostova et al., 
2001) 2-HC possesses antioxidant and free radical-scavenging characteristics 
(Herencia et al., 2002). Having established that 2-HC is a potent inducer of 
haem oxygenase activity and HO-1 protein expression; 2-HC was used in 
chapter 4 in vitro model of inflammation. Inflammation plays an important role in 
cardiovascular diseases (Davi and Falco, 2005). The present study 
demonstrated that 2-HC is an anti-inflammatory compound that inhibited the
247
4 ________________________________________ GENERAL DISCUSSION
inflammatory response in LPS-macrophages model. 2-HC reduced the LPS- 
mediated increase in nitrite, TNF-a production and iNOS expression; these 
effects were mediated by HO-1. Therefore, 2-HC can be used as a potential 
therapeutic agent to mitigate cardiovascular pathologies which are mediated by 
oxidative and inflammatory stress. Our data is in agreement with data in the 
literature, in which 2-HC and other derivatives showed potent anti-inflammatory 
(Ban et al., 2004) (Batt et al., 1993) and anti-oxidant properties (Nakamura et 
al., 2003). Results in chapter 3 and 4 emphasized this data, and provided a 
mechanistic insight to the cytoprotective properties of 2-HC, which mainly 
involve the intrinsic ability of this compound to activate the endogenous 
cytoprotective enzymes, i.e. HO-1. Furthermore, this study identified some of 
the intracellular signaling pathways involved in the 2-HC-mediated induction of 
HO-1, in particular PI3K.
In chapter 5, we investigated the role CO, one of HO-1 pathway end products, 
in combating the inflammatory response elicited by LPS. For this purpose we 
used CO-RMs as a method of delivering CO. In chapter 5, we described a 
series of experiments designed to test the ability of novel water soluble CO- 
RMs to release biologically active CO. The CO-RMs tested were able to release 
CO in a time-dependent and controlled manner. In addition, the two new water 
soluble CO-RMs (CORM-43 and CORM-319) were investigated in an in vitro 
model of inflammation, using LPS-induced inflammation in RAW 264.7 
macrophages. Our results showed that CORM-43 and CORM-319 exhibited 
inhibitory effects on the LPS-induced iNOS expression, nitrite and TNF-a 
production. Furthermore, treatment with iCO-RMs, the inactive form of CO-RMs 
that does not release any CO as confirmed by the myoglobin assay, did not
248
 4 ________________________________________ GENERAL DISCUSSION
affect the nitrite or TNF-a production and iNOS expression, which further 
emphasizes our conclusion that the anti-inflammatory effects of CORM-43 and 
CORM-319 are not caused by the metal carbonyl, but are due to CO. 
Furthermore, our findings showed that CO released from CORM-43 and 
CORM-319 ameliorated inflammation in LPS-induced model of inflammation. 
Our results emphasized data obtained in the literature, which demonstrated the 
ability of CO gas to suppress pro-inflammatory responses in macrophage 
activation (Otterbein et al., 2000) (Otterbein, 2002). Furthermore, our group 
recently provided evidence that CO released from CO-RMs attenuated the LPS- 
mediated inflammatory response (Sawle et al., 2005). However, data in chapter
5 provide a mechanistic insight into the anti-inflammatory properties of CO- 
RMs; in this study, we investigated the cellular and molecular targets of CORM- 
43, our results showed that this compound targets the AKT pathway. We also 
studied the effect of CORM-43 on the LPS-mediated activation of NF-KB, our 
data was inconclusive, one cannot conclude the effects on NF-KB without 
undergoing a more specific method for determining the effect on NF-KB, for 
examples, EMSA scan (Ranjan et al., 2004) (Alcaraz et al., 2004).
In chapter 6, we aimed at establishing that curcumin, a polyphenolic compound 
which has intrinsic cytoprotective properties (Scapagnini et al., 2002) 
(Balasubramanyam et al., 2003) (Balogun et al., 2003b) (Ghoneim et al., 2002), 
was able to induce haem oxygenase activity and HO-1 protein expression in 
cardiac myoblasts (Girardi cells). In addition, we determined the cytotoxicity 
profile of curcumin in Girardi cells. Furthermore, we demonstrated that curcumin 
can be used as a preconditioning agent to protect cardiac myoblasts against 
oxidative (explored in chapter 6) and hypothermic (chapter 7) stresses. Our
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data showed that curcumin in the range of (5-15 |jM) was not toxic to Girardi 
cells, and it markedly up-regulated haem oxygenase activity and HO-1 
expression. Therefore, in chapter 6 and 7, curcumin at 15 pM was used as a 
preconditioning agent. Our data showed that curcumin exhibited antioxidant 
activities and protected Girardi cells against H202-mediated oxidative stress. 
Preconditioning of cardiac myoblasts with curcumin resulted in enhanced 
resistance to H2 0 2 -mediated oxidative damage; this effect was mediated by 
HO-1, since the inhibitor of haem oxygenase activity (SnPPIX) markedly 
reduced cytoprotection by curcumin treatment. It is tempting to conclude that 
the antioxidant properties of curcumin are in essence related to its ability to 
stimulate HO-1. However, it is possible that the protective effects of curcumin 
against the H202-induced cytotoxicity also result from its antioxidant and free 
radical scavenging properties (Patro et al., 2002); since pre-treatment with 
curcumin (removal of the medium which contains curcumin) was unable to 
protect Girardi cells from H202-induced oxidative damage. Our results are in line 
with data in the literature, (Cohly et al., 1998) (Balogun et al., 2003b). Having 
established the anti-oxidant effects of curcumin and its ability to induce haem 
oxygenase activity and HO-1 in Girardi cells, curcumin was used as a 
preconditioning agent in chapter 7; in which we examined the ability of curcumin 
to protect Girardi cells against prolonged cold preservation. Using a cell culture 
model of hypothermia and reperfusion, we investigated whether the addition of 
curcumin to Celsior solution would ameliorate the cold-associated injury in 
cardiac myoblasts and therefore, allow longer cold preservation of these cells. 
Our study demonstrated that cold storage of Girardi cells causes a marked 
increase in cytotoxicity primarily due to loss of cell membrane integrity. The
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addition of curcumin to Celsior solution resulted in preservation of cellular 
membrane integrity as well as cellular metabolism in cells exposed to cold 
storage and rewarming. Using HO-1 siRNA, we found that the protective effects 
of curcumin were partially mediated by HO-1. up-to date, only two studies 
demonstrated the protective role of curcumin on hypothermic-damage (Balogun 
et al., 2003a) (Fuller et al., 2003). It is possible that the cytoprotective properties 
of curcumin are related to the intrinsic ability of curcumin to scavenge oxygen 
free radicals (Balasubramanyam et al., 2003). Similar data was obtained using 
inducers of HO-1 (Redaelli et al., 2002a) (Akamatsu et al., 2004) (Tsuchihashi 
et al., 2003) or the end products of the HO-1 pathway (Amersi et al., 2002). 
However, this study provided a novel approach to improving preservation of 
cardiac cells by using naturally occurring compounds. We suggest that using 
naturally-occurring compounds which have the intrinsic ability to enhance the 
activity of endogenous protective pathways can be used as potential therapeutic 
intervention (Balogun et al., 2003a). However, more studies are needed to 
clarify the mechanisms that mediate the protective effects of curcumin, possible 
mechanisms include: the induction of other endogenous cytoprotective 
enzymes and other cellular pathways, such as, MAPK, PI3K. Furthermore, this 
study did not provide data about the cellular events that mediate cell death 
during hypothermia, for example, the role of ROS and apoptosis, which have 
been associated with cold-induced cell death (Bartels-Stringer et al., 2003), 
(Burns et al., 1998). Numerous studies have highlighted the role of mitochondria 
in the cold-induced injury (Kuznetsov et al., 2004). However, the role of 
mitochondria in the cold-induced cell injury was not studied. Furthermore, this
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study only tested one aspect of cell damage, i.e., cell membrane damage; 
however, more studies to test the role of adhesion molecules.
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8.3 Conclusion
Up-regulation of HO-1 system offers promising new approaches to experimental 
work in cell biology. The use of pharmacological and genetic interventions for 
up-regulation of HO-1 in the managements of cardiovascular diseases appears 
to be especially promising. These pharmacologic strategies to regulate the HO- 
1 system could open up new therapeutic approaches for the effective 
management for a number of clinical disorders. This thesis has described the 
potential of 2-HC to activate the haem oxygenase pathway, explored and 
identified the possible molecular mechanisms involved for this response. 
Furthermore, in this study we have identified 2-HC as a potent anti-inflammatory 
and anti-oxidant compound. In addition, this study identified curcumin as a 
preconditioning agent, which can be used to protect cardiac cells against 
oxidative stress and hypothermia induced injury. And finally, we identified two 
novel CO-RMs (CORM-43 and CORM-319) and established the anti­
inflammatory effects of these compounds; and explored the potential molecular 
mechanisms that mediate the anti-inflammatory effects of CORM-43 and 
CORM-319. Collectively, these findings reinforce the hypothesis that the haem 
oxygenase pathway and its products can be used as an effective method to 
protect cardiovascular tissues against oxidative and inflammatory stresses. And 
therefore, this approach can be used to counteract cardiovascular disease.
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8.4 Future Perspectives
• Utilising a more advanced approach to cell culture, for example, a model 
of co-culture could be utilised, such as co-culture of endothelial cells and 
Girardi cells, and a co-culture model of inflammation using macrophages 
and endothelial cells.
• To utilize primary cells culture models and human cell lines to establish 
the effects of 2-HC and curcumin in these systems.
• To further elucidate the molecular and intracellular mechanisms of 2-HC- 
mediated HO-1 expression, in particular, the PI3K/ AKT pathways.
• To further explore and identify the molecular mechanisms and cellular 
signaling pathways that mediate the cytoprotective effects of 2-HC and 
curcumin.
• To further study CORM-43 and CORM-319 in different cells lines, such 
as endothelial cells, and identify the molecular and intracellular targets of 
these CO-RMs, in addition to further explore the interaction between 
CORM-43 and CORM-319 and the AKT pathway.
• To utilize CORM-319 (as a slow releaser of CO) in models of co-culture, 
and utilizing these models to study the interaction of CO-RMs with 
macrophages and endothelial cells.
• In vivo studies could be utilized to test curcumin and 2-HC to establish 
the potential protective actions of these compounds in models of 
inflammation and cold ischaemia-reperfusion injury.
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HO-1 has grown an important position as a crucial endogenous enzyme as a 
result of the myriad of biological functions. There has been increasing evidence 
that phytochemicals induce a wide range of endogenous detoxifying enzymes 
including HO-1 However, more studies should be undertaken to further explore 
the regulatory mechanisms of HO-1 by phytochemicals, so as to understand the 
physiological function of the HO-1 system in the pathogenesis of vascular 
disease.
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